ITEM 7. Management's Discussion and Analysis of Financial Condition and Results of Operations
This section of this Annual Report on Form 10-K generally discusses the years ended December 31, 2022 and 2021 and year-over-year comparisons between the years ended December 31, 2022 and 2021. Discussions of the periods prior to the year ended December 31, 2021 that are not included in this Annual Report on Form 10-K are found in "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Part II, Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2021 and the discussion therein for the year ended December 31, 2021 compared to the year ended December 31, 2020 is incorporated by reference into this Annual Report.
This Annual Report on Form 10-K contains the names of some of our owned or licensed trademarks, trade names and service marks, which we refer to as our brands. All of the product names included in this Annual Report on Form 10-K are either our registered trademarks or those of our licensors.
OVERVIEW
KDP is a leading beverage company in North America, with a diverse portfolio of flavored CSDs, NCBs, including water (enhanced and flavored), RTD tea and coffee, juice, juice drinks, mixers and specialty coffee, and is a leading producer of innovative single serve brewers. With a wide range of hot and cold beverages that meet virtually any consumer need, KDP key brands include Keurig, Dr Pepper, Canada Dry, Snapple, Mott's, Clamato, Core, Green Mountain Coffee Roasters and The Original Donut Shop. KDP has some of the most recognized beverage brands in North America, with significant consumer awareness levels and long histories that evoke strong emotional connections with consumers. KDP offers more than 125 owned, licensed and partner brands, including the top ten best-selling coffee brands and Dr Pepper as a leading flavored CSD in the U.S. according to IRi, available nearly everywhere people shop and consume beverages.
KDP operates as an integrated brand owner, manufacturer and distributor. We believe our integrated business model strengthens our route-to-market and provides opportunities for net sales and profit growth through the alignment of the economic interests of our brand ownership and our manufacturing and distribution businesses through both our DSD system and our WD system. KDP markets and sells its products to retailers, including supermarkets, mass merchandisers, club stores, pure-play e-commerce retailers, and office superstores; to restaurants, hotel chains, office product and coffee distributors, and partner brand owners; and directly to consumers through its website. Our integrated business model enables us to be more flexible and responsive to the changing needs of our large retail customers and allows us to more fully leverage our scale and reduce costs by creating greater geographic manufacturing and distribution coverage.
SEGMENTS
As of December 31, 2022, our reportable segments were as follows:
•The Coffee Systems segment reflects sales in the U.S. and Canada of the manufacture and distribution of finished goods relating to our single-serve brewers, K-Cup pods and other coffee products.
•The Packaged Beverages segment reflects sales in the U.S. and Canada from the manufacture and distribution of finished beverages and other products, including sales of our own brands and third-party brands, through both the DSD and WD systems.
•The Beverage Concentrates segment reflects sales primarily in the U.S. and Canada of our branded concentrates to third-party bottlers and our syrup to fountain foodservice customers. Most of the brands in this segment are carbonated soft drink brands.
•The Latin America Beverages segment reflects sales primarily in Mexico and the Caribbean from the manufacture and distribution of concentrates, syrup and finished beverages.
VOLUME
In evaluating our performance, we consider different volume measures depending on whether we sell beverage concentrates, finished beverages, pods or brewers.
Coffee Systems K-Cup Pod and Appliance Sales Volume
In our Coffee Systems segments, we measure our sales volume as the number of appliances and the number of individual K-Cup pods sold to our customers.
Packaged Beverages and Latin America Beverages Sales Volume
In our Packaged Beverages and Latin America Beverages segments, we measure volume as case sales to customers. A case sale represents a unit of measurement equal to 288 fluid ounces of packaged beverage sold by us. Case sales include both our owned brands and certain brands licensed to and/or distributed by us.
Beverage Concentrates Sales Volume
In our Beverage Concentrates segment, we measure our sales volume as concentrate case sales for concentrates sold by us to our bottlers and distributors. A concentrate case is the amount of concentrate needed to make one case of 288 fluid ounces of finished beverage, the equivalent of 24 twelve ounce servings. It does not include any other component of the finished beverage other than concentrate.
USE OF NON-GAAP FINANCIAL MEASURES
Non-GAAP financial measures are provided in addition to U.S. GAAP measures, including adjusted income from operations, adjusted net income and adjusted diluted earnings per share. See Non-GAAP Financial Measures for more information, including reconciliations to the corresponding U.S. GAAP measures.
EXECUTIVE SUMMARY
Financial Overview
As Reported, in millions (except Diluted EPS)
As Adjusted, in millions (except Diluted EPS)
On October 6, 2022, we announced a strategic partnership with Red Bull, the iconic global energy brand, to sell and distribute Red Bull Energy Drink products in Mexico, which began in the fourth quarter of 2022.
On November 9, 2022, we invested $51 million, inclusive of incremental third-party costs, in exchange for equity interests in Athletic Brewing, a leading non-alcoholic craft beer maker in the U.S.
On December 8, 2022, we announced a strategic partnership with Nutrabolt, a global active health and wellness company, to sell and distribute C4 Energy RTD beverages in the vast majority of our company-owned DSD territories. We invested $871 million, inclusive of incremental third-party costs, in exchange for an approximately 30% ownership interest in the company and expect to begin distributing C4 Energy RTD beverages in early 2023.
As a result of our quarterly triggering events assessment and our annual impairment assessment, we recorded non-cash impairment charges of $472 million on indefinite-lived brands during the year ended December 31, 2022, led by Bai and Schweppes. Refer to Note 3 of the Notes to our Consolidated Financial Statements for further information.
Uncertainties and Trends Affecting Our Business
We believe the North American beverage market is influenced by certain key trends and uncertainties. Refer to Item 1A, Risk Factors, as well as the Uncertainties and Trends Affecting Liquidity section below, for more information about risks and uncertainties facing us.
Some of these items, such as the ongoing COVID-19 pandemic and the invasion of Ukraine by Russia, and the resulting impacts on the global economy, including supply chain constraints and labor shortages, have led to inflation in input costs, logistics, manufacturing and labor costs, which has further led to fluctuation in interest rates. During the year ended December 31, 2022, we have experienced supply chain disruptions and a significant inflationary impact compared to the prior year. These impacts have created headwinds for our industry that we expect to continue into 2023.
As a result of these inflationary pressures, we have increased the pricing on a number of our products across our portfolio. Consequently, we may incur a reduction of volume or net sales, which, combined with the inflationary pressures, could impact our margins and operating results.
Refer to Note 5 of the Notes to our Consolidated Financial Statements and Item 7A, Quantitative and Qualitative Disclosures About Market Risk for management's discussion of how we manage our exposure to commodity risk.
Impact of COVID-19 on our Financial Statements
The following table sets forth our reconciliation of significant COVID-19-related expenses. Employee compensation expense and employee protection costs, which impact our SG&A expenses and cost of sales, are included as the COVID-19 item affecting comparability and are excluded in our Adjusted financial measures. In addition, reported amounts under U.S. GAAP also include additional costs, not included as the COVID-19 item affecting comparability, as presented in tables below.
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | |
| Items Affecting Comparability(1) | | | | | | |
(in millions) | Employee Compensation Expense(2) | | Employee Protection Costs(3) | | Allowances for Expected Credit Losses(4) | | | | Total |
For the year ended December 31, 2022 | | | | | | | | | |
Coffee Systems | $ | 1 | | | $ | 5 | | | $ | — | | | | | $ | 6 | |
Packaged Beverages | 4 | | | 3 | | | — | | | | | 7 | |
Beverage Concentrates | — | | | — | | | — | | | | | — | |
Latin America Beverages | — | | | 1 | | | — | | | | | 1 | |
Total | $ | 5 | | | $ | 9 | | | $ | — | | | | | $ | 14 | |
| | | | | | | | | |
For the year ended December 31, 2021 | | | | | | | | | |
Coffee Systems | $ | 4 | | | $ | 16 | | | $ | (2) | | | | | $ | 18 | |
Packaged Beverages | 8 | | | 7 | | | (8) | | | | | 7 | |
Beverage Concentrates | — | | | — | | | (3) | | | | | (3) | |
Latin America Beverages | — | | | 2 | | | — | | | | | 2 | |
Total | $ | 12 | | | $ | 25 | | | $ | (13) | | | | | $ | 24 | |
| | | | | | | | | |
(1)Employee compensation expense and employee protection costs are both included as the COVID-19 items affecting comparability in the reconciliation of our Adjusted Non-GAAP financial measures.
(2)Amounts primarily included incremental benefits provided to frontline workers such as extended sick leave, in order to maintain essential operations during the COVID-19 pandemic.
(3)Includes costs associated with personal protective equipment, temperature scans, cleaning and other sanitization services. Impacts both cost of sales and SG&A expenses.
(4)Reflects reversal of allowances initially recorded in 2020 specifically related to the COVID-19 pandemic, driven by improving economic conditions during 2021.
RESULTS OF OPERATIONS
We eliminate from our financial results all intercompany transactions between entities included in our consolidated financial statements and the intercompany transactions with our equity method investees.
References in the financial tables to percentage changes that are not meaningful are denoted by "NM".
Consolidated Operations
The following table sets forth our consolidated results of operations for the years ended December 31, 2022 and 2021:
| | | | | | | | | | | | | | | | | | | | | | | |
| For the Year Ended December 31, | | Dollar | | Percentage |
(in millions, except per share amounts) | 2022 | | 2021 | | Change | | Change |
Net sales | $ | 14,057 | | | $ | 12,683 | | | $ | 1,374 | | | 10.8 | % |
Cost of sales | 6,734 | | | 5,706 | | | 1,028 | | | 18.0 | |
Gross profit | 7,323 | | | 6,977 | | | 346 | | | 5.0 | |
Selling, general and administrative expenses | 4,645 | | | 4,153 | | | 492 | | | 11.8 | |
Impairment of intangible assets | 477 | | | — | | | 477 | | | NM |
Gain on litigation settlement | (299) | | | — | | | (299) | | | NM |
Other operating income, net | (105) | | | (70) | | | (35) | | | NM |
Income from operations | 2,605 | | | 2,894 | | | (289) | | | (10.0) | |
Interest expense | 693 | | | 500 | | | 193 | | | 38.6 | |
Loss on early extinguishment of debt | 217 | | | 105 | | | 112 | | | NM |
Gain on sale of equity method investment | (50) | | | (524) | | | 474 | | | NM |
Impairment of investments and note receivable | 12 | | | 17 | | | (5) | | | NM |
Other expense (income), net | 14 | | | (2) | | | 16 | | | NM |
Income before provision for income taxes | 1,719 | | | 2,798 | | | (1,079) | | | (38.6) | |
Provision for income taxes | 284 | | | 653 | | | (369) | | | (56.5) | |
Net income including non-controlling interest | 1,435 | | | 2,145 | | | (710) | | | (33.1) | |
Less: Net loss attributable to non-controlling interest | (1) | | | (1) | | | — | | | NM |
Net income attributable to KDP | $ | 1,436 | | | $ | 2,146 | | | $ | (710) | | | (33.1) | % |
| | | | | | | |
Earnings per common share: | | | | | | | |
Basic | $ | 1.01 | | | $ | 1.52 | | | $ | (0.51) | | | (33.6) | % |
Diluted | 1.01 | | | 1.50 | | | (0.49) | | | (32.7) | % |
| | | | | | | |
Gross margin | 52.1 | % | | 55.0 | % | | | | (290) bps |
Operating margin | 18.5 | % | | 22.8 | % | | | | (430) bps |
Effective tax rate | 16.5 | % | | 23.3 | % | | | | (680) bps |
Sales Volume. The following table sets forth changes in sales volume for the year ended December 31, 2022 compared to the prior year:
| | | | | | | | |
K-Cup pod volume | | 1.4 | % |
Brewer volume | | (5.2) | % |
CSD sales volume | | 1.5 | % |
NCB sales volume | | 1.3 | % |
Net Sales. Net sales increased $1,374 million, or 10.8%, to $14,057 million for the year ended December 31, 2022 compared to $12,683 million in the prior year. This performance reflected favorable net price realization across all segments totaling 10.6% and volume/mix growth of 0.5%. These benefits were slightly offset by unfavorable FX translation of 0.3%.
Gross Profit. Gross profit increased $346 million, or 5.0%, to $7,323 million for the year ended December 31, 2022 compared to $6,977 million in the prior year. This performance primarily reflected the strong growth in net sales and the benefit of productivity, partially offset by broad-based inflation and an unfavorable change in unrealized commodity mark-to-market impacts of $152 million. Gross margin decreased 290 bps versus the year ago period to 52.1%.
Selling, General and Administrative Expenses. SG&A expenses increased $492 million, or 11.8%, to $4,645 million for the year ended December 31, 2022 compared to $4,153 million in the prior year. The increase reflected higher logistics costs, driven by both inflation and volume/mix impacts, increases in labor and other operating expenses, and an unfavorable comparison of unrealized mark-to-market losses of $55 million on commodity contracts.
Impairment of Intangible Assets. Impairment of intangible assets reflected non-cash impairment charges of $477 million primarily driven by Bai and Schweppes. Refer to Note 3 of the Notes to our Consolidated Financial Statements for further information.
Gain on litigation settlement. Gain on litigation settlement reflects the portion of the settlement payment from BodyArmor which was allocated to the gain on the full settlement of the existing claims against BodyArmor in the first quarter of 2022. Refer to Note 12 of the Notes to our Consolidated Financial Statements for further information.
Other Operating Income, Net. Other operating income, net increased $35 million for the year ended December 31, 2022 compared to the prior year, primarily driven by the portion of the settlement payment from BodyArmor which was allocated to the recovery of legal fees incurred during the litigation process and a business interruption insurance recovery.
Income from Operations. Income from operations decreased $289 million, or 10.0%, to $2,605 million for the year ended December 31, 2022 compared to $2,894 million in the prior year, primarily driven by the non-cash impairment charges of $477 million, which was partially offset by the gain on the litigation settlement. Other factors include higher SG&A expenses, partially offset by increased gross profit. Operating margin decreased 430 bps versus the year ago period to 18.5%.
Interest Expense. Interest expense increased $193 million, or 38.6%, to $693 million for the year ended December 31, 2022 compared to $500 million for the prior year. This change was primarily driven by the unfavorable comparison of unrealized mark-to-market losses of $255 million on interest rate contracts, which was partially offset by reduced interest expense on our senior unsecured notes as a result of our strategic refinancing initiatives.
Loss on Early Extinguishment of Debt. Loss on early extinguishment of debt reflected an unfavorable change of $112 million, with a loss of $217 million during the year ended December 31, 2022 related to our 2022 Strategic Refinancing and our early retirement of our 2038 Notes, the 2021 364-Day Credit Agreement and the KDP Revolver, as compared to a loss of $105 million in the prior year associated with our 2021 strategic refinancing.
Gain on sale of equity method investment. For the years ended December 31, 2022 and 2021 we recorded $50 million and $524 million, respectively, for the sale of our equity method investment in BodyArmor. The amount recorded in 2022 represents the portion of the settlement payment from BodyArmor that was allocated to the satisfaction of the holdback amount owed to us. Refer to Note 12 of the Notes to our Consolidated Financial Statements for further information.
Impairment of Investments and Note Receivable. Impairment on investments and note receivable reflected non-cash impairment charges of $12 million and $17 million for the years ended December 31, 2022 and 2021, respectively, associated with the wind-down of Bedford. Refer to Note 12 of the Notes to our Consolidated Financial Statements for further information.
Effective Tax Rate. The effective tax rate decreased 680 bps to 16.5% for the year ended December 31, 2022, compared to 23.3% in the prior year, primarily driven by the revaluation of state deferred tax liabilities due to legislative changes and the favorable mix of our incremental income in low tax jurisdictions in the year.
Net Income Attributable to KDP. Net income attributable to KDP decreased $710 million, or 33.1%, to $1,436 million for the year ended December 31, 2022 as compared to $2,146 million in the prior year, primarily driven by the unfavorable change in gain on sale of our equity method investment in BodyArmor, lower income from operations, increased interest expense, and the unfavorable change in loss on early extinguishment of debt, partially offset by the decrease in our effective tax rate.
Diluted EPS. Diluted EPS decreased 32.7% to $1.01 per diluted share as compared to $1.50 in the prior year.
Results of Operations by Segment
The following tables set forth net sales and income from operations for our segments for the years ended December 31, 2022 and 2021, as well as the other amounts necessary to reconcile our total segment results to our consolidated results presented in accordance with U.S. GAAP:
| | | | | | | | | | | |
(in millions) | For the Year Ended December 31, |
Segment Results — Net sales | 2022 | | 2021 |
Coffee Systems | $ | 4,982 | | | $ | 4,716 | |
Packaged Beverages | 6,607 | | | 5,882 | |
Beverage Concentrates | 1,725 | | | 1,486 | |
Latin America Beverages | 743 | | | 599 | |
Net sales | $ | 14,057 | | | $ | 12,683 | |
| | | |
| For the Year Ended December 31, |
(in millions) | 2022 | | 2021 |
Segment Results — Income from Operations | | | |
Coffee Systems | $ | 1,316 | | | $ | 1,446 | |
Packaged Beverages | 1,014 | | | 1,023 | |
Beverage Concentrates | 1,061 | | | 1,047 | |
Latin America Beverages | 158 | | | 133 | |
Unallocated corporate costs | (944) | | | (755) | |
Income from operations | $ | 2,605 | | | $ | 2,894 | |
COFFEE SYSTEMS
The following table provides selected information for our Coffee Systems segment for the years ended December 31, 2022 and 2021:
| | | | | | | | | | | | | | | | | | | | | | | |
| For the Year Ended December 31, | | Dollar | | Percentage |
(in millions) | 2022 | | 2021 | | Change | | Change |
Net sales | $ | 4,982 | | | $ | 4,716 | | | $ | 266 | | | 5.6 | % |
Income from operations | 1,316 | | | 1,446 | | | (130) | | | (9.0) | % |
Operating margin | 26.4 | % | | 30.7 | % | | | | (430) bps |
Sales Volume. Inclusive of the impact of the 53rd week, K-Cup pod volume increased 1.4% for the year ended December 31, 2022, which reflected the segment’s coffee recovery program to increase pod manufacturing output and rebuild finished goods inventories to satisfy consumer demand and restore customer service levels. Brewer volume decreased 5.2% in the year ended December 31, 2022, driven by the unfavorable comparison to brewer shipment growth of 10.0% in the prior year as appliance household penetration growth rates returned to expected long-term trends.
Net Sales. Net sales increased 5.6% to $4,982 million for the year ended December 31, 2022 compared to $4,716 million in the prior year, driven by favorable net price realization of 7.0%, partially offset by volume/mix declines of 0.8% and unfavorable FX translation of 0.6%.
Income from Operations. Income from operations decreased $130 million, or 9.0%, to $1,316 million for the year ended December 31, 2022, compared to $1,446 million in the prior year, as a result of broad-based inflation, particularly in green coffee and packaging and increases in other operating expenses. These decreases were partially offset by the benefits of net sales growth, productivity, favorable asset sale-leaseback activity of $44 million in the Coffee Systems segment associated with our strategic asset investment program and a business interruption insurance recovery. Operating margin declined 430 bps versus the prior year to 26.4%, primarily due to the aforementioned inflationary headwinds.
PACKAGED BEVERAGES
The following table provides selected information for our Packaged Beverages segment for the years ended December 31, 2022 and 2021:
| | | | | | | | | | | | | | | | | | | | | | | |
| For the Year Ended December 31, | | Dollar | | Percentage |
(in millions) | 2022 | | 2021 | | Change | | Change |
Net sales | $ | 6,607 | | | $ | 5,882 | | | $ | 725 | | | 12.3 | % |
Income from operations | 1,014 | | | 1,023 | | | (9) | | | (0.9) | % |
Operating margin | 15.3 | % | | 17.4 | % | | | | (210) bps |
Sales Volume. Sales volume for the year ended December 31, 2022 decreased 0.5% compared to the prior year. Reductions in contract manufacturing more than offset growth in our branded portfolio, with strength in Motts, Core, Polar, Hawaiian Punch, and our CSD portfolio, partially offset by declines in Bai.
Net Sales. Net sales increased 12.3% to $6,607 million in the year ended December 31, 2022, compared to $5,882 million in the prior year, driven by favorable net price realization of 12.1% and volume/mix growth of 0.3%, slightly offset by unfavorable FX translation of 0.1%.
Income from Operations. Income from operations decreased $9 million, or 0.9%, to $1,014 million for the year ended December 31, 2022 compared to $1,023 million for the prior year, primarily driven by the $316 million non-cash impairment charges in the segment, predominantly related to Bai, which were partially offset by the gain on the settlement of litigation with BodyArmor of $271 million. Other offsetting factors included the benefits of net sales growth, productivity, and reduced restructuring and integration expense, partially offset by broad-based inflation, higher costs to serve the ongoing strong consumer demand, and the unfavorable year-over-year comparison in the Packaged Beverages segment of asset sale-leaseback activity associated with our strategic asset investment program. Operating margin declined 210 bps versus the prior year to 15.3%.
BEVERAGE CONCENTRATES
The following table provides selected information for our Beverage Concentrates segment for the years ended December 31, 2022 and 2021:
| | | | | | | | | | | | | | | | | | | | | | | |
| For the Year Ended December 31, | | Dollar | | Percentage |
(in millions) | 2022 | | 2021 | | Change | | Change |
Net sales | $ | 1,725 | | | $ | 1,486 | | | $ | 239 | | | 16.1 | % |
Income from operations | 1,061 | | | 1,047 | | | 14 | | | 1.3 | % |
Operating margin | 61.5 | % | | 70.5 | % | | | | (900) bps |
Sales Volume. Sales volume for the year ended December 31, 2022 increased 1.6% compared to the prior year, primarily driven by Dr Pepper and Canada Dry, partially offset by Schweppes and Crush.
Net Sales. Net sales increased 16.1% to $1,725 million in the year ended December 31, 2022, compared to $1,486 million in the prior year, reflecting higher net price realization of 14.7% and volume/mix growth of 1.7%, slightly offset by unfavorable FX translation effects of 0.3%.
Income from Operations. Income from operations increased $14 million, or 1.3%, to $1,061 million for the year ended December 31, 2022 compared to $1,047 million in the prior year. This performance reflected the impact of strong net sales growth, partially offset by the non-cash impairment charges in the segment of $161 million, led by Schweppes, broad-based inflation and costs associated with the start-up and operation of our new manufacturing facility. Operating margin decreased 900 bps versus the prior year to 61.5%.
LATIN AMERICA BEVERAGES
The following table provides selected information for our Latin America Beverages segment for the years ended December 31, 2022 and 2021:
| | | | | | | | | | | | | | | | | | | | | | | |
| For the Year Ended December 31, | | Dollar | | Percentage |
(in millions) | 2022 | | 2021 | | Change | | Change |
Net sales | $ | 743 | | | $ | 599 | | | $ | 144 | | | 24.0 | % |
Income from operations | 158 | | | 133 | | | 25 | | | 18.8 | % |
Operating margin | 21.3 | % | | 22.2 | % | | | | (90) bps |
Sales Volume. Sales volume for the year ended December 31, 2022 increased 7.2% versus the prior year, driven by strong in-market execution across the segment’s portfolio, with particular strength in Peñafiel and Squirt.
Net Sales. Net sales grew 24.0% to $743 million for the year ended December 31, 2022, compared to $599 million in the prior year, reflecting favorable net price realization of 13.9%, volume/mix growth of 9.1%, and favorable FX translation of 1.0%.
Income from Operations. Income from operations increased $25 million, or 18.8%, to $158 million for the year ended December 31, 2022 compared to $133 million in the prior year, driven by the benefits of net sales growth and productivity, partially offset by the impacts of broad-based inflation, logistics and operating costs associated with incremental volumes, and increased marketing expense. Operating margin decreased 90 bps versus the prior year to 21.3%.
LIQUIDITY AND CAPITAL RESOURCES
Overview
We believe our financial condition and liquidity remain strong. We continue to manage all aspects of our business, including, but not limited to, monitoring the financial health of our customers, suppliers and other third-party relationships, implementing cost management strategies through our productivity initiatives, and developing new opportunities for growth such as innovation and agreements with partners to distribute brands that are accretive to our portfolio.
The following summarizes our cash activity for the years ended December 31, 2022, 2021 and 2020:
Cash, cash equivalents, restricted cash and restricted cash equivalents decreased $33 million from December 31, 2021 to December 31, 2022 primarily as a result of our investment in Nutrabolt, offset by proceeds from the cash settlement with BodyArmor.
Cash generated by our foreign operations is generally repatriated to the U.S. periodically as working capital funding requirements where allowed. We do not expect restrictions or taxes on repatriation of cash held outside the U.S. to have a material effect on our overall business, liquidity, financial condition or results of operations for the foreseeable future .
Additionally, in April 2022, we chose to undertake our 2022 Strategic Refinancing, issuing approximately $3 billion of senior unsecured notes and using the net proceeds to voluntarily prepay and retire several tranches of existing senior unsecured notes with higher interest rates, which reduced our overall interest payments and our annual cash requirements. As part of this transaction, we additionally unwound approximately $1.5 billion of notional amount of our outstanding designated forward starting swaps and received cash proceeds of approximately $125 million. Refer to Note 4 of the Notes to our Consolidated Financial Statements for further information about the 2022 strategic refinancing initiative.
Principal Sources of Capital Resources
Our principal sources of liquidity are our existing cash and cash equivalents, cash generated from our operations and borrowing capacity currently available under our 2022 Revolving Credit Agreement. Additionally, we have an uncommitted commercial paper program where we can issue unsecured commercial paper notes on a private placement basis. Based on our current and anticipated level of operations, we believe that our operating cash flows will be sufficient to meet our anticipated obligations for the next twelve months. To the extent that our operating cash flows are not sufficient to meet our liquidity needs, we may utilize cash on hand or amounts available under our financing arrangements, if necessary.
Sources of Liquidity - Operations
Net cash provided by operating activities decreased $37 million for the year ended December 31, 2022, as compared to the year ended December 31, 2021, driven by the decrease in net income adjusted for non-cash items and the impact of the change in working capital.
Cash Conversion Cycle
Our cash conversion cycle is defined as DIO and DSO less DPO. The calculation of each component of the cash conversion cycle is provided below:
| | | | | | | | |
Component | | Calculation (on a trailing twelve month basis) |
DIO | | (Average inventory divided by cost of sales) * Number of days in the period |
DSO | | (Accounts receivable divided by net sales) * Number of days in the period |
DPO | | (Accounts payable * Number of days in the period) divided by cost of sales and SG&A expenses |
The following table summarizes our cash conversion cycle.
| | | | | | | | | | | | | | |
| | December 31, |
| | 2022 | | 2021 |
DIO | | 68 | | | 58 | |
DSO | | 39 | | | 33 | |
DPO | | 167 | | | 160 | |
Cash conversion cycle | | (60) | | | (69) | |
Our cash conversion cycle increased 9 days to approximately (60) days as of December 31, 2022 as compared to (69) days as of December 31, 2021. The increases in DSO and DPO were primarily driven by rising inflation during the year, and the increase in DIO reflects our efforts to restore inventory to meet customer service levels.
Accounts Payable Program
As part of our ongoing efforts to improve our cash flow and related liquidity, we work with our suppliers to optimize our terms and conditions, which include the extension of payment terms. Excluding our suppliers who require cash at date of purchase or sale, our current payment terms with our suppliers generally range from 10 to 360 days. We also enter into agreements with third party administrators to allow participating suppliers to track payment obligations from us, and if voluntarily elected by the supplier, sell payment obligations from us to financial institutions. Suppliers can sell one or more of our payment obligations at their sole discretion and our rights and obligations to our suppliers are not impacted. We have no economic interest in a supplier’s decision to enter into these agreements and no direct financial relationship with the financial institutions. Our obligations to our suppliers, including amounts due and scheduled payment terms, are not impacted.
We have been informed by the third party administrators that as of December 31, 2022 and December 31, 2021, $3,839 million and $3,194 million, respectively, of our outstanding payment obligations were voluntarily elected by the supplier and sold to financial institutions. The amounts settled through the program and paid to the financial institutions were $3,935 million, $3,331 million and $2,770 million for the years ended December 31, 2022, 2021 and 2020, respectively.
Impact of the CARES Act
Beginning in the second quarter of 2020, we deferred payments of employer-related payroll taxes as allowed under the CARES Act. Payment of at least 50% of the deferred amount was due on January 3, 2022, with the remainder due by January 3, 2023. We deferred a total of $59 million in such payments since the CARES Act was implemented, and we timely paid approximately $30 million as of January 3, 2022 and the remainder as of January 3, 2023.
Sources of Liquidity - Financing
In February 2022, we terminated our 2021 364-Day Credit Agreement and our KDP Revolver and replaced them with the 2022 Revolving Credit Agreement, which provides for a $4 billion revolving credit facility.
In April 2022, we undertook our 2022 Strategic Refinancing and issued a $3 billion aggregate face value of Notes, consisting of the 2029 Notes, the 2032 Notes, and the 2052 Notes. The proceeds from the issuance were used to voluntarily prepay and retire the remaining 2023 Merger Notes and to tender portions of the 2025 Merger Notes, the 2028 Merger Notes, the 2038 Merger Notes, and the 2048 Merger Notes.
We have a commercial paper program, under which we may issue unsecured commercial paper notes on a private placement basis up to a maximum aggregate amount outstanding at any time of $2,400 million. As of December 31, 2022, we had borrowings of $399 million outstanding.
We also have an active shelf registration statement, filed with the SEC on August 19, 2022, which allows us to issue an indeterminate number or amount of common stock, preferred stock, debt securities and warrants from time to time in one or more offerings at the direction of our Board of Directors.
Refer to Note 4 of the Notes to our Consolidated Financial Statements for management's discussion of our financing arrangements.
Sources of Liquidity - Asset Sale-Leaseback Transactions
We have leveraged our strategic asset investment program to create value from certain assets to enable reinvestment in KDP. These transactions are accounted for as sale-leaseback transactions. We received $168 million, $102 million, and $200 million of net cash proceeds from our strategic asset investment program during the years ended December 31, 2022, 2021 and 2020, respectively, which are included in Proceeds from sales of property, plant and equipment in the Consolidated Statements of Cash Flows.
Debt Ratings
As of December 31, 2022, our credit ratings were as follows:
| | | | | | | | | | | | | | |
Rating Agency | Long-Term Debt Rating | Commercial Paper Rating | Outlook | Date of Last Change |
Moody's | Baa2 | P-2 | Stable | February 26, 2021 |
S&P | BBB | A-2 | Stable | April 19, 2022 |
These debt and commercial paper ratings impact the interest we pay on our financing arrangements. A downgrade of one or both of our debt and commercial paper ratings could increase our interest expense and decrease the cash available to fund anticipated obligations. As of December 31, 2022, we were in compliance with all debt covenants and we have no reason to believe that we will be unable to satisfy these covenants.
LIBOR Considerations
In 2017, the U.K. Financial Conduct Authority announced that LIBOR will no longer be published after 2021. In the U.S., the Alternative Reference Rates Committee selected the SOFR as the preferred alternative reference rate to LIBOR. Certain LIBOR tenors will continue to be published through June 30, 2023.
We have a number of financing arrangements which incorporate LIBOR as a benchmark rate and which extend past 2022. The agreements related to such financing arrangements use LIBOR tenors which will continue to be published through June 30, 2023. Additionally, these agreements contain provisions for alternative reference rates. We do not expect a significant change to our cost of debt as a result of the transition from LIBOR to an alternative reference rate.
Principal Uses of Capital Resources
Over the past several years, our principal uses of our capital resources were deleveraging, providing shareholder return to our investors through regular quarterly dividends, and investing in KDP to capture market share and drive growth through innovation and routes to market.
Now that we have met our post-merger goals, we plan to further reduce our leverage ratio. We also plan to invest in inorganic value creation through M&A, including portfolio expansion, distribution scale, geographic expansion, and new capabilities. In addition to M&A, we have repurchased shares of our outstanding common stock, as described below.
Deleveraging and Other Debt Repayments
During the year ended December 31, 2022, we made net debt repayments of $115 million, primarily driven by the redemption and retirement of the remainder of our 2023 Merger Notes and 2038 Notes, as well as the tender of portions of the 2025 Merger Notes, the 2028 Merger Notes, the 2038 Merger Notes, and the 2048 Merger Notes.
Regular Quarterly Dividends
For the year ended December 31, 2022, we have declared total dividends of $0.775 per share, versus $0.7125 per share for the year ended December 31, 2021.
Repurchases of Common Stock
Our Board authorized a four-year share repurchase program of up to $4 billion of our outstanding common stock potentially enabling us to return value to shareholders. We repurchased and retired $379 million of common stock during the year ended December 31, 2022.
Capital Expenditures
We are investing in state-of-the-art manufacturing and warehousing facilities, including expansive investments in facilities in Newbridge, Ireland; Spartanburg, South Carolina; and Allentown, Pennsylvania, in 2022 and 2021, in order to optimize our supply chain network.
Purchases of property, plant and equipment were $353 million, $423 million and $461 million for the years ended December 31, 2022, 2021 and 2020, respectively. Capital expenditures, which includes both purchases of property, plant and equipment and amounts included in accounts payable and accrued expenses, for the years ended December 31, 2022, 2021 and 2020 primarily related to the manufacturing and warehousing facilities discussed above. Capital expenditures included in accounts payable and accrued expenses were $213 million, $189 million and $280 million for the years ended December 31, 2022, 2021 and 2020, respectively, which primarily related to these investments.
Investments in Unconsolidated Affiliates
From time to time, we expect to invest in beverage startup companies or in brand ownership companies to grow our presence in certain product categories, or enter into various licensing and distribution agreements to expand our product portfolio. Our investments in beverage startup companies generally involve acquiring a minority interest in equity securities of a company, in certain cases with a protected path to ownership at our future option. During the year ended December 31, 2022, we invested $972 million in exchange for equity interests in Nutrabolt, Tractor and Athletic Brewing.
Purchases of Intangible Assets
We have invested in the expansion of our DSD network through transactions with strategic independent bottlers to ensure competitive distribution scale for our brands. From time to time, we additionally acquire brand ownership companies to expand our portfolio. These transactions are generally accounted for as an asset acquisition, as the majority of the transaction price represents the acquisition of an intangible asset. Purchases of intangible assets were $45 million, $32 million and $56 million for the years ended December 31, 2022, 2021 and 2020, respectively.
RESIDUAL VALUE GUARANTEES
We have a number of leasing arrangements and one licensing arrangement with special purpose entities associated with the same sponsor. Each one of these arrangements contain a residual value guarantee. As of December 31, 2022, we have not recorded any liabilities as it is not probable that we will have to make any payments required under the residual value guarantee. Refer to Note 19 of the Notes to our Consolidated Financial Statements for further information.
UNCERTAINTIES AND TRENDS AFFECTING LIQUIDITY AND CAPITAL RESOURCES
Disruptions in financial and credit markets, including those caused by inflation due to global economic uncertainty and the associated rise in interest rates, may impact our ability to manage normal commercial relationships with our customers, suppliers and creditors. These disruptions could have a negative impact on the ability of our customers to timely pay their obligations to us, thus reducing our cash flow, or the ability of our vendors to timely supply materials.
Customer and consumer demand for our products may also be impacted by the risk factors discussed under "Risk Factors" in Part 1, Item 1A of our Annual Report, as well as subsequent filings with the SEC, that could have a material effect on production, delivery and consumption of our products, which could result in a reduction in our sales volume.
We believe that the following events, trends and uncertainties may also impact liquidity:
•Our ability to either repay existing debt maturities through cash flow from operations or refinance through future issuances of senior unsecured notes;
•Our ability to access and/or renew our committed financing arrangements;
•A significant downgrade in our credit ratings could limit i) our ability to issue debt at terms that are favorable to us, or ii) a financial institution's willingness to participate in our accounts payable program and reduce the attractiveness of the accounts payable program to participating suppliers who may sell payment obligations from us to financial institutions, which could impact our accounts payable program;
•Our continued payment of regular quarterly dividends;
•Future opportunistic repurchases of our common stock or special dividends to drive total shareholder return;
•Our continued capital expenditures;
•Future equity investments;
•Seasonality of our operating cash flows, which could impact short-term liquidity;
•Our ability to issue unsecured uncommitted commercial paper notes on a private placement basis up to a maximum aggregate amount outstanding at any time of $2,400 million;
•Future mergers or acquisitions, which may include brand ownership companies, regional bottling companies, distributors and/or distribution rights to further extend our geographic coverage; and
•Fluctuations in our tax obligations.
CRITICAL ACCOUNTING ESTIMATES
The process of preparing our consolidated financial statements in conformity with U.S. GAAP requires the use of estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expenses. Critical accounting estimates are both fundamental to the portrayal of a company’s financial condition and results and require difficult, subjective or complex estimates and assessments. These estimates and judgments are based on historical experience, future expectations and other factors and assumptions we believe to be reasonable under the circumstances. The most significant estimates and judgments are reviewed on an ongoing basis and revised when necessary. We have not made any material changes in the accounting methodology we use to assess or measure our critical accounting estimates. We have identified the items described below as our critical accounting estimates. We do not believe there is a reasonable likelihood that there will be a material change in the future estimates or assumptions we use in our critical accounting estimates. However, if actual results are not consistent with our estimates or assumptions, we may be exposed to gains or losses that could be material to our consolidated financial statements. See Note 2 of the Notes to our Consolidated Financial Statements for a discussion of these and other accounting policies.
Goodwill and Other Indefinite Lived Intangible Assets
We conduct tests for impairment of our goodwill and our other indefinite lived intangible assets annually, as of October 1, or more frequently if events or circumstances indicate the carrying amount may not be recoverable. We use present value and other valuation techniques to make this assessment. If the carrying amount of goodwill or an intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. For purposes of impairment testing, we assign goodwill to the reporting unit that benefits from the synergies arising from each business combination, and we also assign indefinite lived intangible assets to our reporting units.
Effective January 1, 2021, we modified our internal reporting and operating segments to reflect changes in the executive leadership team to further enhance speed-to-market and decision effectiveness. Although this did not change our reportable segments, our reporting units and operating segments were redefined. For 2022 and 2021, we defined our six reporting units as follows:
| | | | | | | | |
Reportable Segments | | Reporting Units |
Packaged Beverages | | DSD |
| | WD |
Coffee Systems | | Coffee Systems |
Beverage Concentrates | | Branded Concentrates |
| | Fountain Foodservice |
Latin America Beverages | | Latin America Beverages |
For both goodwill and other indefinite lived intangible assets, we have the option to first assess qualitative factors to determine whether the fair value of either the reporting unit or indefinite lived intangible asset is "more likely than not" less than its carrying value, also known as a Step 0 analysis. If a quantitative analysis is required, the following would be required:
•The impairment test for indefinite lived intangible assets encompasses calculating a fair value of an indefinite lived intangible asset and comparing the fair value to its carrying value. If the carrying value exceeds the estimated fair value, impairment is recorded.
•The impairment tests for goodwill include comparing fair value of the respective reporting unit with its carrying value, including goodwill and considering any indefinite lived intangible asset impairment charges.
As of October 1, 2022, we performed a quantitative analysis for goodwill and certain indefinite lived brand assets, whereby we used an income approach, or in some cases a combination of income and market based approaches, to determine the fair value of our assets, as well as an overall consideration of market capitalization and enterprise value. We performed a qualitative Step 0 analysis for other indefinite lived intangible assets, including certain brands, trade names, contractual arrangements, and distribution rights. These types of analyses contain uncertainties because they require management to make assumptions and to apply judgment to estimate industry and economic factors and the profitability of future business strategies. These assumptions could be negatively impacted by various risks discussed in Item 1A, Risk Factors, in this Annual Report on Form 10-K.
Critical assumptions for quantitative analyses include revenue growth and profit performance over the next five year period, as well as an appropriate discount rate and long-term growth rate, as applicable. Discount rates are based on a weighted average cost of equity and cost of debt, adjusted with various risk premiums. Long-term growth rates are based on the long-term inflation forecast, industry growth and the long-term economic growth potential.
The following table provides the range of rates used in the analysis as of October 1, 2022:
| | | | | | | | | | | | | | |
Rate | | Minimum | | Maximum |
Discount rates | | 7.3 | % | | 10.3 | % |
Long-term growth rates | | — | % | | 3.8 | % |
| | | | |
The following table shows the non-cash impairment charges that were recorded for the years presented:
| | | | | | | | | | | | | | | | | | | | |
| | Year Ended December 31, |
(in millions) | | 2022 | | 2021 | | 2020 |
Non cash-impairment charges for indefinite lived brand assets | | $ | 472 | | | $ | — | | | $ | 67 | |
Sensitivity Analysis - Discount Rate
For goodwill, holding all other assumptions in the analysis constant, including the revenue and profit performance assumption, the effect of a 0.50% increase in the discount rate used to determine the fair value of the reporting units as of October 1, 2022, would not change our conclusion.
For the indefinite-lived intangible assets quantitatively assessed, holding all other assumptions in the analysis constant, including the revenue and profit performance assumption, the effect of a 0.50% increase in the discount rate used to determine the fair value of those brands as of October 1, 2022, would impact the amount of headroom over the carrying value of those brands as follows (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Selected Discount Rate | | Discount Rate Increase of 0.50% |
Headroom Percentage | | Carrying Value | | Fair Value | | Carrying Value | | Fair Value |
Brands | | | | | | | | |
0%(1) | | $ | 2,136 | | | $ | 2,136 | | | $ | 2,710 | | | $ | 2,537 | |
Less than 25% | | 2,186 | | | 2,547 | | | 1,612 | | | 1,799 | |
26 - 50% | | — | | | — | | | 2,351 | | | 3,446 | |
In excess of 50% | | 14,848 | | | 28,942 | | | 12,497 | | | 22,797 | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
(1)Carrying value reflects the results of the annual impairment analysis recognized during the year ended December 31, 2022.
Sensitivity Analysis - Long-Term Growth Rate
For goodwill, holding all other assumptions in the analysis constant, including the discrete period revenue and profit performance assumptions as well as the discount rates, the effect of a 0.50% decrease in the long-term growth rate used to determine the fair value of the reporting units as of October 1, 2022, would not change our conclusion.
For the indefinite-lived intangible assets quantitatively assessed, holding all other assumptions in the analysis constant, including the discrete period revenue and profit performance assumptions as well as the discount rates, the effect of a 0.50% decrease in the long-term revenue growth rate used to determine the fair value of those brands as of October 1, 2022, would impact the amount of headroom over the carrying value of those brands as follows (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Selected Long-Term Growth Rate | | Long-Term Growth Rate Decrease of 0.50% |
Headroom Percentage | | Carrying Value | | Fair Value | | Carrying Value | | Fair Value |
Brands | | | | | | | | |
0%(1) | | $ | 2,136 | | | $ | 2,136 | | | $ | 2,396 | | | $ | 2,271 | |
Less than 25% | | 2,186 | | | 2,547 | | | 1,926 | | | 2,153 | |
26 - 50% | | — | | | — | | | 2,351 | | | 3,515 | |
In excess of 50% | | 14,848 | | | 28,942 | | | 12,497 | | | 23,257 | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
(1)Carrying value reflects the results of the annual impairment analysis recognized during the year ended December 31, 2022.
Refer to Note 3 of the Notes to our Consolidated Financial Statements for additional information about our impairment assessments.
Revenue Recognition
We recognize revenue when performance obligations under the terms of a contract with the customer are satisfied. Accruals for customer incentives, sales returns and marketing programs are established for the expected payout based on contractual terms, volume-based metrics and/or historical trends.
Our customer incentives, sales returns and marketing accrual methodology contains uncertainties because it requires management to make assumptions and to apply judgment regarding our contractual terms in order to estimate our customer participation and volume performance levels which impact the expense recognition. Our estimates are based primarily on a combination of known or historical transaction experiences. Differences between estimated expenses and actual costs are normally insignificant and are recognized to earnings in the period differences are determined.
Additionally, judgment is required to ensure the classification of the spend is correctly recorded as either a reduction from gross sales or advertising and marketing expense, which is a component of our SG&A expenses.
A 10% change in the accrual for our customer incentives, sales returns and marketing programs would have affected our income from operations by $50 million for the year ended December 31, 2022.
Income Taxes
We establish income tax liabilities to remove some or all of the income tax benefit of any of our income tax positions based upon one of the following:
•the tax position is not “more likely than not” to be sustained,
•the tax position is “more likely than not” to be sustained, but for a lesser amount, or
•the tax position is “more likely than not” to be sustained, but not in the financial period in which the tax position was originally taken.
Our liability for uncertain tax positions contains uncertainties because management is required to make assumptions and to apply judgment to estimate the exposures associated with our various tax positions.
Our income tax returns, like those of most companies, are periodically audited by domestic and foreign tax authorities. These audits include questions regarding our tax positions, including the timing and amount of deductions and the allocation of income among various tax jurisdictions. As these audits progress, events may occur that cause us to change our liability for uncertain tax positions. To the extent we prevail in matters for which a liability for uncertain tax positions has been established, or are required to pay amounts in excess of our established liability, our effective tax rate in a given financial statement period could be materially affected. An unfavorable tax settlement generally would require use of our cash and may result in an increase in our effective tax rate in the period of resolution. A favorable tax settlement may be recognized as a reduction in our effective tax rate in the period of resolution.
We also assess the likelihood of realizing our deferred tax assets. Valuation allowances reduce deferred tax assets to the amount more likely than not to be realized. We base our judgment of the recoverability of our deferred tax assets primarily on historical earnings, our estimate of current and expected future earnings and prudent and feasible tax planning strategies.
If results differ from our assumptions, a valuation allowance against deferred tax assets may be increased or decreased which would impact our effective tax rate.
Business Combinations
We record acquisitions using the purchase method of accounting. All of the assets acquired and liabilities assumed are recorded at fair value as of the acquisition date. The excess of the purchase price over the estimated fair values of the net tangible and intangible assets acquired is recorded as goodwill.
The application of the purchase method of accounting for business combinations requires management to make significant estimates and assumptions in the determination of the fair value of assets acquired and liabilities assumed, in order to properly allocate purchase price consideration between assets that are depreciated and amortized from goodwill. The fair value assigned to tangible and intangible assets acquired and liabilities assumed are based on management’s estimates and assumptions, as well as other information compiled by management, including valuations that utilize customary valuation procedures and techniques. Significant assumptions and estimates include, but are not limited to, the cash flows that an asset is expected to generate in the future, the appropriate weighted-average cost of capital, and the cost savings expected to be derived from acquiring an asset, if applicable.
If the actual results differ from the estimates and judgments used in these estimates, the amounts recorded in the consolidated financial statements may be exposed to potential impairment of the intangible assets and goodwill, as discussed in the Goodwill and Other Indefinite Lived Intangible Assets critical accounting estimate section above.
EFFECT OF RECENT ACCOUNTING PRONOUNCEMENTS
Refer to Note 2 of the Notes to our Consolidated Financial Statements for a discussion of recently issued accounting standards and recently adopted provisions of U.S. GAAP.
SUPPLEMENTAL GUARANTOR FINANCIAL INFORMATION
The Notes are fully and unconditionally guaranteed by certain of our direct and indirect subsidiaries (the "Guarantors"), as defined in the indentures governing the Notes. The Guarantors are 100% owned either directly or indirectly by us and jointly and severally guarantee, subject to the release provisions described below, our obligations under the Notes. None of our subsidiaries organized outside of the U.S., immaterial subsidiaries used for charitable purposes, any of the subsidiaries held by Maple Parent Holdings Corp. prior to the DPS Merger or any of the subsidiaries acquired after the DPS Merger (collectively, the "Non-Guarantors") guarantee the Notes. The subsidiary guarantees with respect to the Notes are subject to release upon the occurrence of certain events, including the sale of all or substantially all of a subsidiary's assets, the release of the subsidiary's guarantee of our other indebtedness, our exercise of the legal defeasance option with respect to the Notes and the discharge of our obligations under the applicable indenture.
The following schedules present the summarized financial information for the Parent and the Guarantors on a combined basis after intercompany eliminations; the Parent and the Guarantors' amounts due from; amounts due to, and transactions with Non-Guarantors are disclosed separately. The consolidating schedules are provided in accordance with the reporting requirements of Rule 13-01 under SEC Regulation S-X for the issuer and guarantor subsidiaries.
The summarized financial information for the Parent and Guarantors were as follows:
| | | | | |
(in millions) | For the Year Ended December 31, 2022 |
Net sales | $ | 8,242 | |
| |
Income from operations | 1,008 | |
Net income attributable to KDP | 1,436 | |
| | | | | | | | | | | |
| December 31, |
(in millions) | 2022 | | 2021 |
Current assets | $ | 1,712 | | | $ | 1,594 | |
Non-current assets | 45,721 | | | 43,972 | |
Total assets(1) | $ | 47,433 | | | $ | 45,566 | |
| | | |
Current liabilities | $ | 4,797 | | | $ | 3,470 | |
Non-current liabilities | 17,463 | | | 17,125 | |
Total liabilities(2) | $ | 22,260 | | | $ | 20,595 | |
(1)Includes $3 million and $209 million of intercompany receivables due to the Parent and Guarantors from the Non-Guarantors as of December 31, 2022 and December 31, 2021, respectively.
(2)Includes $1,186 million and $40 million of intercompany payables due to the Non-Guarantors from the Parent and Guarantors as of December 31, 2022 and December 31, 2021, respectively.
NON-GAAP FINANCIAL MEASURES
To supplement the consolidated financial statements presented in accordance with U.S. GAAP, we have presented for certain constant currency adjusted or adjusted financial measures for the years ended December 31, 2022 and 2021, which are considered non-GAAP financial measures. The non-GAAP financial measures provided should be viewed in addition to, and not as an alternative for, results prepared in accordance with U.S. GAAP. The non-GAAP financial measures presented may differ from similarly titled non-GAAP financial measures presented by other companies, and other companies may not define these non-GAAP financial measures in the same way. The non-GAAP financial measures are not substitutes for their comparable U.S. GAAP financial measures, such as income from operations, net income, diluted EPS or other measures prescribed by U.S. GAAP, and there are limitations to using non-GAAP financial measures. We use these non-GAAP financial measures, in addition to U.S. GAAP financial measures, to evaluate our operating and financial performance and to compare such performance to that of prior periods and to the performance of our competitors. Additionally, we use these non-GAAP financial measures in making operational and financial decisions and in our budgeting and planning process. We believe that providing these non-GAAP financial measures to investors helps investors evaluate our operating performance, profitability and business trends in a way that is consistent with how management evaluates such performance and consistent with guidance previously provided by us. The non-GAAP measures are defined as follows:
Adjusted: Defined as certain financial statement captions and metrics adjusted for certain items affecting comparability.
Items affecting comparability: Defined as certain items that are excluded for comparison to prior year periods, adjusted for the tax impact as applicable. Tax impact is determined based upon an approximate rate for each item. For each period, management adjusts for (i) the unrealized mark-to-market impact of derivative instruments not designated as hedges in accordance with U.S. GAAP that do not have an offsetting risk reflected within the financial results, as well as the unrealized mark-to-market impact of our Vita Coco investment; (ii) the amortization associated with definite-lived intangible assets; (iii) the amortization of the deferred financing costs associated with the DPS Merger; (iv) the amortization of the fair value adjustment of the senior unsecured notes obtained as a result of the DPS Merger; (v) stock compensation expense and the associated windfall tax benefit attributable to the matching awards made to employees who made an initial investment in KDP; (vi) non-cash changes in deferred tax liabilities related to goodwill and other intangible assets as a result of tax rate or apportionment changes; and (vii) other certain items that are excluded for comparison purposes to prior year periods.
For the year ended December 31, 2022, the other certain items excluded for comparison purposes include (i) restructuring and integration expenses related to significant business combinations; (ii) productivity expenses; (iii) costs related to significant non-routine legal matters, specifically the antitrust litigation; (iv) the loss on early extinguishment of debt related to the redemption of debt; (v) incremental costs to our operations related to risks associated with the COVID-19 pandemic, which were incurred to either maintain the health and safety of our front-line employees or temporarily increase compensation to such employees to ensure essential operations continue during the pandemic; (vi) the gain on the sale of our investment in BodyArmor as a result of the settlement of the associated holdback liability; (vii) the gain on the settlement of our prior litigation with BodyArmor, excluding recoveries of previously incurred litigation expenses which were included in our adjusted results; (viii) losses recognized with respect to our equity method investment in Bedford as a result of funding our share of their wind-down costs; (ix) transaction costs for significant business combinations (completed or abandoned); (x) foundational projects, which are transformative and non-recurring in nature; and (xi) impairments recognized on certain intangible brand assets.
For the year ended December 31, 2021, the other certain items excluded for comparison purposes include (i) restructuring and integration expenses related to significant business combinations; (ii) productivity expenses; (iii) costs related to significant non-routine legal matters; (iv) the loss on early extinguishment of debt related to the redemption of debt; (v) incremental costs to our operations related to risks associated with the COVID-19 pandemic; (vi) gains from insurance recoveries related to the February 2019 organized malware attack on our business operation networks in the Coffee Systems segment; (vii) the gain on the sale of our investment in BodyArmor; (viii) impairment recognized on our equity method investment with Bedford as a result of funding our share of their wind-down costs; and (ix) transaction costs for significant business combinations (completed or abandoned).
Constant currency adjusted: Defined as certain financial statement captions and metrics adjusted for certain items affecting comparability, calculated on a constant currency basis by converting our current period local currency financial results using the prior period foreign currency exchange rates.
For the years ended December 31, 2022 and 2021, the supplemental financial data set forth below includes reconciliations of adjusted and constant currency adjusted financial measures to the applicable financial measure presented in the consolidated financial statements for the same period.
KEURIG DR PEPPER INC.
RECONCILIATION OF CERTAIN REPORTED ITEMS TO CERTAIN NON-GAAP ADJUSTED ITEMS
(Unaudited, in millions, except per share and percentages)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | Cost of sales | | Gross profit | | Gross margin | | Selling, general and administrative expenses | | Impairment of intangible assets | | Gain on litigation settlement | | Other operating income, net | | Income from operations | | Operating margin |
For the Year Ended December 31, 2022 | | | | | | | | | | | | | | | | | | | |
Reported | | | $ | 6,734 | | | $ | 7,323 | | | 52.1 | % | | $ | 4,645 | | | $ | 477 | | | $ | (299) | | | $ | (105) | | | $ | 2,605 | | | 18.5 | % |
Items Affecting Comparability: | | | | | | | | | | | | | | | | | | | |
Mark to market | | | (120) | | | 120 | | | | | (30) | | | — | | | — | | | — | | | 150 | | | |
Amortization of intangibles | | | — | | | — | | | | | (138) | | | — | | | — | | | — | | | 138 | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Stock compensation | | | — | | | — | | | | | (5) | | | — | | | — | | | — | | | 5 | | | |
Restructuring and integration costs | | | — | | | — | | | | | (170) | | | — | | | — | | | (2) | | | 172 | | | |
Productivity | | | (116) | | | 116 | | | | | (114) | | | — | | | — | | | — | | | 230 | | | |
Impairment of intangible assets | | | — | | | — | | | | | — | | | (477) | | | — | | | — | | | 477 | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Non-routine legal matters | | | — | | | — | | | | | (13) | | | — | | | — | | | — | | | 13 | | | |
COVID-19 | | | (9) | | | 9 | | | | | (5) | | | — | | | — | | | — | | | 14 | | | |
Gain on litigation | | | — | | | — | | | | | — | | | — | | | 271 | | | — | | | (271) | | | |
| | | | | | | | | | | | | | | | | | | |
Transaction costs | | | — | | | — | | | | | (1) | | | — | | | — | | | — | | | 1 | | | |
| | | | | | | | | | | | | | | | | | | |
Foundational projects | | | — | | | — | | | | | (4) | | | — | | | — | | | — | | | 4 | | | |
| | | | | | | | | | | | | | | | | | | |
Adjusted | | | $ | 6,489 | | | $ | 7,568 | | | 53.8 | % | | $ | 4,165 | | | $ | — | | | $ | (28) | | | $ | (107) | | | $ | 3,538 | | | 25.2 | % |
Impact of foreign currency | | | | | | | — | % | | | | | | | | | | | | — | % |
Constant currency adjusted | | | | | | | 53.8 | % | | | | | | | | | | | | 25.2 | % |
| | | | | | | | | | | | | | | | | | | |
For the Year Ended December 31, 2021 | | | | | | | | | | | | | | | | | | | |
Reported | | | $ | 5,706 | | | $ | 6,977 | | | 55.0 | % | | $ | 4,153 | | | $ | — | | | $ | — | | | $ | (70) | | | $ | 2,894 | | | 22.8 | % |
Items Affecting Comparability: | | | | | | | | | | | | | | | | | | | |
Mark to market | | | 32 | | | (32) | | | | | 25 | | | — | | | — | | | — | | | (57) | | | |
Amortization of intangibles | | | — | | | — | | | | | (134) | | | — | | | — | | | — | | | 134 | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Stock compensation | | | — | | | — | | | | | (18) | | | — | | | — | | | — | | | 18 | | | |
Restructuring and integration costs | | | — | | | — | | | | | (202) | | | — | | | — | | | — | | | 202 | | | |
Productivity | | | (72) | | | 72 | | | | | (91) | | | — | | | — | | | — | | | 163 | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Non-routine legal matters | | | — | | | — | | | | | (30) | | | — | | | — | | | — | | | 30 | | | |
COVID-19 | | | (26) | | | 26 | | | | | (11) | | | — | | | — | | | — | | | 37 | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Transaction costs | | | — | | | — | | | | | (2) | | | — | | | — | | | — | | | 2 | | | |
Malware incident | | | — | | | — | | | | | 2 | | | — | | | — | | | — | | | (2) | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Adjusted | | | $ | 5,640 | | | $ | 7,043 | | | 55.5 | % | | $ | 3,692 | | | $ | — | | | $ | — | | | $ | (70) | | | $ | 3,421 | | | 27.0 | % |
Refer to page 46 for reconciliations of reported net sales to constant currency net sales and adjusted income from operations to constant currency adjusted income from operations. 43
KEURIG DR PEPPER INC.
RECONCILIATION OF CERTAIN REPORTED ITEMS TO CERTAIN NON-GAAP ADJUSTED ITEMS
(Unaudited, in millions, except per share and percentages)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Interest expense | | Loss on early extinguishment of debt | | Gain on sale of equity method investment | | Impairment of investments and note receivable | | Other expense (income), net | | Income before provision for income taxes | | Provision for income taxes | | Effective tax rate | | Net income attributable to KDP | | Diluted earnings per share |
For the Year Ended December 31, 2022 | | | | | | | | | | | | | | | | | | | |
Reported | $ | 693 | | | $ | 217 | | | $ | (50) | | | $ | 12 | | | $ | 14 | | | $ | 1,719 | | | $ | 284 | | | 16.5 | % | | $ | 1,436 | | | $ | 1.01 | |
Items Affecting Comparability: | | | | | | | | | | | | | | | | | | | |
Mark to market | (249) | | | — | | | — | | | — | | | 4 | | | 395 | | | 93 | | | | | 302 | | | 0.21 | |
Amortization of intangibles | — | | | — | | | — | | | — | | | — | | | 138 | | | 35 | | | | | 103 | | | 0.07 | |
Amortization of deferred financing costs | (2) | | | — | | | — | | | — | | | — | | | 2 | | | — | | | | | 2 | | | — | |
Amortization of fair value debt adjustment | (19) | | | — | | | — | | | — | | | — | | | 19 | | | 4 | | | | | 15 | | | 0.01 | |
Stock compensation | — | | | — | | | — | | | — | | | — | | | 5 | | | (1) | | | | | 6 | | | — | |
Restructuring and integration costs | — | | | — | | | — | | | — | | | — | | | 172 | | | 41 | | | | | 131 | | | 0.09 | |
Productivity | — | | | — | | | — | | | — | | | — | | | 230 | | | 56 | | | | | 174 | | | 0.12 | |
Impairment of intangible assets | — | | | — | | | — | | | — | | | — | | | 477 | | | 126 | | | | | 351 | | | 0.25 | |
Impairment of investment | — | | | — | | | — | | | (12) | | | — | | | 12 | | | 3 | | | | | 9 | | | 0.01 | |
Loss on early extinguishment of debt | — | | | (217) | | | — | | | — | | | — | | | 217 | | | 51 | | | | | 166 | | | 0.12 | |
Non-routine legal matters | — | | | — | | | — | | | — | | | — | | | 13 | | | 3 | | | | | 10 | | | 0.01 | |
COVID-19 | — | | | — | | | — | | | — | | | — | | | 14 | | | 4 | | | | | 10 | | | 0.01 | |
Gain on litigation | — | | | — | | | — | | | — | | | — | | | (271) | | | (68) | | | | | (203) | | | (0.14) | |
Gain on sale of equity-method investment | — | | | — | | | 50 | | | — | | | — | | | (50) | | | (12) | | | | | (38) | | | (0.03) | |
Transaction costs | — | | | — | | | — | | | — | | | — | | | 1 | | | — | | | | | 1 | | | — | |
| | | | | | | | | | | | | | | | | | | |
Foundational projects | — | | | — | | | — | | | — | | | — | | | 4 | | | 1 | | | | | 3 | | | — | |
Change in deferred tax liabilities related to goodwill and other intangible assets | — | | | — | | | — | | | — | | | — | | | — | | | 80 | | | | | (80) | | | (0.06) | |
Adjusted | $ | 423 | | | $ | — | | | $ | — | | | $ | — | | | $ | 18 | | | $ | 3,097 | | | $ | 700 | | | 22.6 | % | | $ | 2,398 | | | $ | 1.68 | |
Impact of foreign currency | | | | | | | | | | | | | | | — | % | | | | |
Constant currency adjusted | | | | | | | | | | | | | | | 22.6 | % | | | | |
| | | | | | | | | | | | | | | | | | | |
Diluted earnings per common share may not foot due to rounding.
44
KEURIG DR PEPPER INC.
RECONCILIATION OF CERTAIN REPORTED ITEMS TO CERTAIN NON-GAAP ADJUSTED ITEMS
(Unaudited, in millions, except per share and percentages)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| Interest expense | | Loss on early extinguishment of debt | | Gain on sale of equity method investment | | Impairment of investments and note receivable | | Other expense (income), net | | Income before provision for income taxes | | Provision for income taxes | | Effective tax rate | | Net income attributable to KDP | | Diluted earnings per share |
For the Year Ended December 31, 2021 | | | | | | | | | | | | | | | | | | | |
Reported | $ | 500 | | | $ | 105 | | | $ | (524) | | | $ | 17 | | | $ | (2) | | | $ | 2,798 | | | $ | 653 | | | 23.3 | % | | $ | 2,146 | | | $ | 1.50 | |
Items Affecting Comparability: | | | | | | | | | | | | | | | | | | | |
Mark to market | 6 | | | — | | | — | | | — | | | (6) | | | (57) | | | (13) | | | | | (44) | | | (0.03) | |
Amortization of intangibles | — | | | — | | | — | | | — | | | — | | | 134 | | | 31 | | | | | 103 | | | 0.07 | |
Amortization of deferred financing costs | (7) | | | — | | | — | | | — | | | — | | | 7 | | | 2 | | | | | 5 | | | — | |
Amortization of fair value of debt adjustment | (19) | | | — | | | — | | | — | | | — | | | 19 | | | 5 | | | | | 14 | | | 0.01 | |
Stock compensation | — | | | — | | | — | | | — | | | — | | | 18 | | | 15 | | | | | 3 | | | — | |
Restructuring and integration costs | — | | | — | | | — | | | — | | | — | | | 202 | | | 47 | | | | | 155 | | | 0.11 | |
Productivity | — | | | — | | | — | | | — | | | — | | | 163 | | | 40 | | | | | 123 | | | 0.09 | |
| | | | | | | | | | | | | | | | | | | |
Impairment of investment | — | | | — | | | — | | | (17) | | | — | | | 17 | | | (45) | | | | | 62 | | | 0.04 | |
Loss on early extinguishment of debt | — | | | (105) | | | — | | | — | | | — | | | 105 | | | 24 | | | | | 81 | | | 0.06 | |
Non-routine legal matters | — | | | — | | | — | | | — | | | — | | | 30 | | | 7 | | | | | 23 | | | 0.01 | |
COVID-19 | — | | | — | | | — | | | — | | | — | | | 37 | | | 9 | | | | | 28 | | | 0.02 | |
| | | | | | | | | | | | | | | | | | | |
Gain on sale of equity-method investment | — | | | — | | | 524 | | | — | | | — | | | (524) | | | (124) | | | | | (400) | | | (0.28) | |
Transaction costs | — | | | — | | | — | | | — | | | — | | | 2 | | | — | | | | | 2 | | | — | |
Malware incident | — | | | — | | | — | | | — | | | — | | | (2) | | | — | | | | | (2) | | | — | |
| | | | | | | | | | | | | | | | | | | |
Change in deferred tax liabilities related to goodwill and other intangible assets | — | | | — | | | — | | | — | | | — | | | — | | | 19 | | | | | (19) | | | (0.01) | |
Adjusted | $ | 480 | | | $ | — | | | $ | — | | | $ | — | | | $ | (8) | | | $ | 2,949 | | | $ | 670 | | | 22.7 | % | | $ | 2,280 | | | $ | 1.60 | |
| | | | | | | | | | | | | | | | | | | |
Change - adjusted | (11.9) | % | | | | | | | | | | | | | | | | 5.2 | % | | 5.0 | % |
Impact of foreign currency | — | % | | | | | | | | | | | | | | | | 0.2 | % | | — | % |
Change - constant currency adjusted | (11.9) | % | | | | | | | | | | | | | | | | 5.4 | % | | 5.0 | % |
Diluted earnings per common share may not foot due to rounding.
45
KEURIG DR PEPPER INC.
RECONCILIATION OF CERTAIN REPORTED SEGMENT MEASURES
TO CERTAIN NON-GAAP ADJUSTED AND CURRENCY NEUTRAL ADJUSTED SEGMENT MEASURES
(Unaudited)
| | | | | | | | | | | | | | | | | |
(in millions) | Reported | | Items Affecting Comparability | | Adjusted |
For the year ended December 31, 2022 | | | | | |
Income from operations | | | | | |
Coffee Systems | $ | 1,316 | | | $ | 198 | | | $ | 1,514 | |
Packaged Beverages | 1,014 | | | 119 | | | 1,133 | |
Beverage Concentrates | 1,061 | | | 173 | | | 1,234 | |
Latin America Beverages | 158 | | | 4 | | | 162 | |
Unallocated corporate costs | (944) | | | 439 | | | (505) | |
Total income from operations | $ | 2,605 | | | $ | 933 | | | $ | 3,538 | |
| | | | | |
For the year ended December 31, 2021 | | | | | |
Income from operations | | | | | |
Coffee Systems | $ | 1,446 | | | $ | 197 | | | $ | 1,643 | |
Packaged Beverages | 1,023 | | | 99 | | | 1,122 | |
Beverage Concentrates | 1,047 | | | 11 | | | 1,058 | |
Latin America Beverages | 133 | | | 2 | | | 135 | |
Unallocated corporate costs | (755) | | | 218 | | | (537) | |
Total income from operations | $ | 2,894 | | | $ | 527 | | | $ | 3,421 | |
| | | | | | | | | | | | | | | | | | | | |
| | Reported | | Impact of Foreign Currency | | Constant Currency |
For the year ended December 31, 2022 | | | | | | |
Net sales | | | | | | |
Coffee Systems | | 5.6 | % | | 0.6 | % | | 6.2 | % |
Packaged Beverages | | 12.3 | | | 0.1 | | | 12.4 | % |
Beverage Concentrates | | 16.1 | | | 0.3 | | | 16.4 | % |
Latin America Beverages | | 24.0 | | | (1.0) | | | 23.0 | % |
Total net sales | | 10.8 | | | 0.3 | | | 11.1 | % |
| | | | | | | | | | | | | | | | | | | | |
| | Adjusted | | Impact of Foreign Currency | | Constant Currency Adjusted |
For the year ended December 31, 2022 | | | | | | |
Income from operations | | | | | | |
Coffee Systems | | (7.9) | % | | 0.4 | % | | (7.5) | % |
Packaged Beverages | | 1.0 | | | 0.2 | | | 1.2 | % |
Beverage Concentrates | | 16.6 | | | 0.3 | | | 16.9 | % |
Latin America Beverages | | 20.0 | | | (1.5) | | | 18.5 | % |
Total income from operations | | 3.4 | | | 0.3 | | | 3.7 | % |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Reported | | Items Affecting Comparability | | Adjusted | | Impact of Foreign Currency | | Constant Currency Adjusted |
For the year ended December 31, 2022 | | | | | | | | | | |
Operating margin | | | | | | | | | | |
Coffee Systems | | 26.4 | % | | 4.0 | % | | 30.4 | % | | (0.1) | % | | 30.3 | % |
Packaged Beverages | | 15.3 | | | 1.8 | % | | 17.1 | | | 0.1 | % | | 17.2 | |
Beverage Concentrates | | 61.5 | | | 10.0 | % | | 71.5 | | | — | % | | 71.5 | |
Latin America Beverages | | 21.3 | | | 0.5 | % | | 21.8 | | | (0.1) | % | | 21.7 | |
Total operating margin | | 18.5 | | | 6.7 | % | | 25.2 | | | — | % | | 25.2 | |
CONSTANT CURRENCY ADJUSTED RESULTS OF OPERATIONS
Year Ended December 31, 2022 Compared to Year Ended December 31, 2021
The following discussion of our results for the year ended December 31, 2022 is presented on a constant currency adjusted basis. These adjusted financial results are calculated on a constant currency basis by converting our current-period local currency financial results using the prior-period FX rates.
Consolidated Operations
Constant Currency Net Sales. Constant currency net sales increased 11.1% in the year ended December 31, 2022 compared to the prior year, driven by favorable net price realization of 10.6% and volume/mix growth of 0.5%.
Constant Currency Adjusted Income from Operations. Constant currency adjusted income from operations increased 3.7% compared to the prior year, primarily driven by the strong growth in net sales and the benefit of productivity. These benefits were partially offset by the impact of broad-based inflation and increases in other operating costs.
Constant Currency Adjusted Interest Expense. Constant currency adjusted interest expense decreased 11.9% compared to the prior year, driven by reduced interest expense on our senior unsecured notes as a result of our strategic refinancing initiatives.
Constant Currency Adjusted Effective Tax Rate. The constant currency adjusted effective tax rate was 22.6% for the year ended December 31, 2022 compared to 22.7% for the prior year, primarily driven by our incremental income in low tax jurisdictions in the current year, mostly offset by the unfavorable comparison to the tax benefit received in the prior year from the release of our valuation allowance against our U.S. foreign tax credit carryforwards.
Constant Currency Adjusted Net Income Attributable to KDP. Constant currency adjusted net income attributable to KDP increased 5.4% compared to the prior year, primarily driven by income from operations growth and lower interest expense.
Constant Currency Adjusted Diluted EPS. Constant currency adjusted diluted EPS increased approximately 5.0% over the prior year.
Results of Operations by Segment
COFFEE SYSTEMS
Constant Currency Net Sales. Constant currency net sales increased 6.2%, driven by higher net price realization of 7.0%, partially offset by unfavorable volume/mix of 0.8%.
Constant Currency Adjusted Income from Operations. Constant currency adjusted income from operations for the year ended December 31, 2022 decreased 7.5% compared to the prior year period, as a result of broad-based inflation, particularly in green coffee and increases in other operating expenses. These decreases were partially offset by the benefits of net sales growth, productivity, favorable asset sale-leaseback activity in the Coffee Systems segment associated with our strategic asset investment program and a business interruption insurance recovery.
PACKAGED BEVERAGES
Constant Currency Net Sales. Constant currency net sales increased 12.4%, reflecting favorable net price realization of 12.1% and volume/mix growth of 0.3%.
Constant Currency Adjusted Income from Operations. Constant currency adjusted income from operations for the year ended December 31, 2022 increased 1.2% compared to the prior year period, driven by the benefits of net sales growth and increased productivity. These benefits were partially offset by broad-based inflation, higher costs to serve the ongoing strong consumer demand, and the unfavorable year-over-year comparison in the Packaged Beverages segment of asset sale-leaseback activity associated with our strategic asset investment program.
BEVERAGE CONCENTRATES
Constant Currency Net Sales. Constant currency net sales increased 16.4%, reflecting higher net price realization of 14.7% and volume/mix growth of 1.7%.
Constant Currency Adjusted Income from Operations. Constant currency adjusted income from operations for the year ended December 31, 2022 increased 16.9% compared to the prior year period. This performance reflected the impact of net sales growth, partially offset by costs associated with the operation of our new manufacturing facility in Newbridge, Ireland.
LATIN AMERICA BEVERAGES
Constant Currency Net Sales. Constant currency net sales increased 23.0%, driven by favorable net price realization of 13.9% and volume/mix growth of 9.1%.
Constant Currency Adjusted Income from Operations. Constant currency adjusted income from operations for the year ended December 31, 2022 increased 18.5% compared to the prior year period, driven by the benefits of net sales growth and productivity, partially offset by the impacts of broad-based inflation, logistics and operating costs associated with incremental volumes, and increased marketing expense.
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the stockholders and the Board of Directors of Keurig Dr Pepper Inc.
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of Keurig Dr Pepper Inc. and subsidiaries (the "Company") as of December 31, 2022 and 2021, the related consolidated statements of income, comprehensive income, changes in stockholders’ equity, and cash flows, for each of the three years in the period ended December 31, 2022, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2022, in conformity with accounting principles generally accepted in the United States of America.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 23, 2023, expressed an unqualified opinion on the Company's internal control over financial reporting.
Basis for Opinion
These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
Indefinite-Lived Intangible Assets Valuation - Certain Brand Assets - Refer to Notes 2 and 3 to the financial statements
Critical Audit Matter Description
As discussed in Notes 2 and 3, the Company has indefinite-lived brand intangible assets (“brand assets”) with a balance of $19,291 million as of December 31, 2022. Management recognized non-cash impairment losses of $472 million for the year ended December 31, 2022. The Company’s evaluation of the brand assets for impairment is performed annually as of October 1, or more frequently if events or circumstances indicate the carrying amount may not be recoverable and involves the comparison of the fair value of each brand asset to its carrying value. Management estimates the fair value of the brand assets using a multi-period excess earnings method, which is a specific discounted cash flow method. The fair value determination of these assets requires management to make significant estimates and assumptions related to revenue growth projections, operating margins, and discount rates. Each of these assumptions is sensitive to future market or industry conditions, as well as company-specific conditions. Changes in these assumptions could have a significant impact on the fair value of certain indefinite-lived brand intangible assets (“certain brand assets”) that have a lower headroom percentage, the amount of any impairment, or both. Given the significant judgments made by management to estimate the fair value of certain brand assets, a high degree of auditor judgment and an increased extent of effort were required to perform audit procedures that evaluated the timing and reasonableness of management’s estimates and assumptions.
How the Critical Audit Matter Was Addressed in the Audit
Our audit procedures consisted of risk assessment and testing the timing of management’s impairment assessment and the underlying business and valuation assumptions for certain brand assets. Those procedures included, but were not limited to, the following:
•We tested the effectiveness of controls over the Company’s indefinite-lived brand intangible asset impairment review process, including annual and interim controls when circumstances indicated that the carrying amount may not be recoverable.
•We evaluated the reasonableness of management’s ability to forecast revenue growth and operating margins by comparing the forecasts to:
–Historical revenue and operating margins.
–Underlying analysis of business strategies and growth plans.
–Internal communication to senior management.
–Forecasted information in industry reports.
–Historical and forecasted peer data.
•We considered the impact of changes in management's forecast from the October 1, 2022 annual assessment date to December 31, 2022.
•With the assistance of our fair value specialists, we evaluated the reasonableness of the valuation methodology and discount rates, including testing the mathematical accuracy of the calculation, and developed a range of independent estimates and compared those to the discount rates selected by management.
/s/ Deloitte & Touche LLP
Dallas, Texas
February 23, 2023
We have served as the Company’s auditor since 2016.
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the stockholders and the Board of Directors of Keurig Dr Pepper Inc.
Opinion on Internal Control over Financial Reporting
We have audited the internal control over financial reporting of Keurig Dr Pepper Inc. and subsidiaries (the "Company") as of December 31, 2022, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control - Integrated Framework (2013) issued by COSO.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended December 31, 2022, of the Company and our report dated February 23, 2023, expressed an unqualified opinion on those financial statements.
Basis for Opinion
The Company's management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying management’s Report on Internal Control over Financial Reporting, appearing under item 9A. Our responsibility is to express an opinion on the Company's internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
/s/ Deloitte & Touche LLP
Dallas, Texas
February 23, 2023
KEURIG DR PEPPER INC.
CONSOLIDATED STATEMENTS OF INCOME
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
(in millions, except per share data) | 2022 | | 2021 | | 2020 |
Net sales | $ | 14,057 | | | $ | 12,683 | | | $ | 11,618 | |
Cost of sales | 6,734 | | | 5,706 | | | 5,132 | |
Gross profit | 7,323 | | | 6,977 | | | 6,486 | |
Selling, general and administrative expenses | 4,645 | | | 4,153 | | | 3,978 | |
Impairment of intangible assets | 477 | | | — | | | 67 | |
Gain on litigation settlement | (299) | | | — | | | — | |
Other operating income, net | (105) | | | (70) | | | (39) | |
Income from operations | 2,605 | | | 2,894 | | | 2,480 | |
Interest expense | 693 | | | 500 | | | 604 | |
Loss on early extinguishment of debt | 217 | | | 105 | | | 4 | |
Gain on sale of equity method investment | (50) | | | (524) | | | — | |
Impairment of investments and note receivable | 12 | | | 17 | | | 102 | |
Other expense (income), net | 14 | | | (2) | | | 17 | |
Income before provision for income taxes | 1,719 | | | 2,798 | | | 1,753 | |
Provision for income taxes | 284 | | | 653 | | | 428 | |
Net income including non-controlling interest | 1,435 | | | 2,145 | | | 1,325 | |
Less: Net loss attributable to non-controlling interest | (1) | | | (1) | | | — | |
Net income attributable to KDP | $ | 1,436 | | | $ | 2,146 | | | $ | 1,325 | |
| | | | | |
Earnings per common share: | | | | | |
Basic | $ | 1.01 | | | $ | 1.52 | | | $ | 0.94 | |
Diluted | 1.01 | | | 1.50 | | | 0.93 | |
Weighted average common shares outstanding: | | | | | |
Basic | 1,416.8 | | | 1,415.7 | | | 1,407.2 | |
Diluted | 1,428.5 | | | 1,427.9 | | | 1,422.1 | |
The accompanying notes are an integral part of these consolidated financial statements.
KEURIG DR PEPPER INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
(in millions) | 2022 | | 2021 | | 2020 |
Net income including non-controlling interest | $ | 1,435 | | | $ | 2,145 | | | $ | 1,325 | |
Other comprehensive income | | | | | |
Foreign currency translation adjustments | (167) | | | (14) | | | (9) | |
Net change in pension and post-retirement liability, net of tax of $3, $—, and $1, respectively | (6) | | | — | | | (4) | |
Net change in cash flow hedges, net of tax of $(87), $30 and $1, respectively | 328 | | | (89) | | | (14) | |
Total other comprehensive income (loss) | 155 | | | (103) | | | (27) | |
Comprehensive income | 1,590 | | | 2,042 | | | 1,298 | |
Comprehensive income attributable to non-controlling interest | — | | | — | | | — | |
Comprehensive income attributable to KDP | $ | 1,590 | | | $ | 2,042 | | | $ | 1,298 | |
The accompanying notes are an integral part of these consolidated financial statements.
KEURIG DR PEPPER INC.
CONSOLIDATED BALANCE SHEETS
| | | | | | | | | | | |
| December 31, |
(in millions, except share and per share data) | 2022 | | 2021 |
Assets |
Current assets: | | | |
Cash and cash equivalents | $ | 535 | | | $ | 567 | |
Restricted cash and restricted cash equivalents | — | | | 1 | |
Trade accounts receivable, net | 1,484 | | | 1,148 | |
Inventories | 1,314 | | | 894 | |
Prepaid expenses and other current assets | 471 | | | 447 | |
Total current assets | 3,804 | | | 3,057 | |
Property, plant and equipment, net | 2,491 | | | 2,494 | |
Investments in unconsolidated affiliates | 1,000 | | | 30 | |
Goodwill | 20,072 | | | 20,182 | |
Other intangible assets, net | 23,183 | | | 23,856 | |
Other non-current assets | 1,252 | | | 937 | |
Deferred tax assets | 35 | | | 42 | |
Total assets | $ | 51,837 | | | $ | 50,598 | |
Liabilities and Stockholders' Equity |
Current liabilities: | | | |
Accounts payable | $ | 5,206 | | | $ | 4,316 | |
Accrued expenses | 1,153 | | | 1,110 | |
Structured payables | 137 | | | 142 | |
Short-term borrowings and current portion of long-term obligations | 895 | | | 304 | |
Other current liabilities | 685 | | | 613 | |
Total current liabilities | 8,076 | | | 6,485 | |
Long-term obligations | 11,072 | | | 11,578 | |
Deferred tax liabilities | 5,739 | | | 5,986 | |
Other non-current liabilities | 1,825 | | | 1,577 | |
Total liabilities | 26,712 | | | 25,626 | |
Commitments and contingencies | | | |
Stockholders' equity: | | | |
Preferred stock, $0.01 par value, 15,000,000 shares authorized, no shares issued | — | | | — | |
Common stock, $0.01 par value, 2,000,000,000 shares authorized, 1,408,394,293 and 1,418,119,197 shares issued and outstanding as of December 31, 2022 and 2021, respectively | 14 | | | 14 | |
Additional paid-in capital | 21,444 | | | 21,785 | |
Retained earnings | 3,539 | | | 3,199 | |
Accumulated other comprehensive income (loss) | 129 | | | (26) | |
Total stockholders' equity | 25,126 | | | 24,972 | |
Non-controlling interest | (1) | | | — | |
Total equity | 25,125 | | | 24,972 | |
Total liabilities and equity | $ | 51,837 | | | $ | 50,598 | |
The accompanying notes are an integral part of these consolidated financial statements.
KEURIG DR PEPPER INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
(in millions) | 2022 | | 2021 | | 2020 |
Operating activities: | | | | | |
Net income attributable to KDP | $ | 1,436 | | | $ | 2,146 | | | $ | 1,325 | |
Adjustments to reconcile net income to net cash provided by operating activities: | | | | | |
Depreciation expense | 399 | | | 410 | | | 362 | |
Amortization of intangibles | 138 | | | 134 | | | 133 | |
Other amortization expense | 172 | | | 164 | | | 158 | |
Provision for sales returns | 61 | | | 63 | | | 54 | |
Deferred income taxes | (289) | | | 31 | | | (51) | |
Employee stock-based compensation expense | 52 | | | 88 | | | 85 | |
Loss on early extinguishment of debt | 217 | | | 105 | | | 4 | |
Gain on sale of equity method investment | (50) | | | (524) | | | — | |
Gain on disposal of property, plant and equipment | (80) | | | (75) | | | (36) | |
Unrealized loss (gain) on foreign currency | 26 | | | 9 | | | (1) | |
Unrealized loss (gain) on derivatives | 383 | | | (70) | | | 8 | |
Settlements of interest rate contracts | 125 | | | — | | | — | |
Equity in losses of unconsolidated affiliates | 5 | | | 5 | | | 20 | |
Impairment of intangible assets | 477 | | | — | | | 67 | |
Impairment on investments and note receivable of unconsolidated affiliates | 12 | | | 17 | | | 102 | |
Other, net | 28 | | | 20 | | | 60 | |
Changes in assets and liabilities: | | | | | |
Trade accounts receivable | (398) | | | (152) | | | (5) | |
Inventories | (426) | | | (133) | | | (107) | |
Income taxes receivable and payables, net | (105) | | | 114 | | | (91) | |
Other current and non current assets | (456) | | | (243) | | | (435) | |
Accounts payable and accrued expenses | 903 | | | 762 | | | 624 | |
Other current and non current liabilities | 207 | | | 3 | | | 180 | |
Net change in operating assets and liabilities | (275) | | | 351 | | | 166 | |
Net cash provided by operating activities | 2,837 | | | 2,874 | | | 2,456 | |
Investing activities: | | | | | |
Proceeds from sale of investment in unconsolidated affiliates | 50 | | | 578 | | | — | |
Purchases of property, plant and equipment | (353) | | | (423) | | | (461) | |
Proceeds from sales of property, plant and equipment | 168 | | | 122 | | | 203 | |
Purchases of intangibles | (26) | | | (32) | | | (56) | |
| | | | | |
| | | | | |
Issuance of related party note receivable | (18) | | | (19) | | | (6) | |
Investments in unconsolidated affiliates | (962) | | | — | | | (5) | |
| | | | | |
Other, net | 6 | | | (16) | | | 9 | |
Net cash (used in) provided by investing activities | $ | (1,135) | | | $ | 210 | | | $ | (316) | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
The accompanying notes are an integral part of these consolidated financial statements.
KEURIG DR PEPPER INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(continued)
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
(in millions) | 2022 | | 2021 | | 2020 |
Financing activities: | | | | | |
Proceeds from issuance of Notes | $ | 3,000 | | | $ | 2,150 | | | $ | 1,500 | |
Repayment of Notes | (3,365) | | | (3,595) | | | (250) | |
Proceeds from issuance of commercial paper | 1,198 | | | 5,406 | | | 7,288 | |
Repayments of commercial paper | (948) | | | (5,257) | | | (8,534) | |
Proceeds from KDP Revolver | — | | | — | | | 1,850 | |
Repayment of KDP Revolver | — | | | — | | | (1,850) | |
| | | | | |
Repayments of term loan | — | | | (425) | | | (955) | |
Repurchases of common stock | (379) | | | — | | | — | |
Proceeds from issuance of common stock | — | | | 140 | | | — | |
Proceeds from structured payables | 155 | | | 156 | | | 171 | |
Payments on structured payables | (158) | | | (167) | | | (341) | |
Cash dividends paid | (1,080) | | | (955) | | | (846) | |
Tax withholdings related to net share settlements | (15) | | | (125) | | | — | |
Payments on finance leases | (90) | | | (54) | | | (52) | |
| | | | | |
Proceeds from controlling shareholder stock transactions | — | | | — | | | 29 | |
Other, net | (46) | | | (36) | | | — | |
Net cash used in financing activities | (1,728) | | | (2,762) | | | (1,990) | |
Net change from: | | | | | |
Operating, investing and financing activities | (26) | | | 322 | | | 150 | |
Effect of exchange rate changes | (7) | | | (9) | | | (6) | |
Beginning of period | 568 | | | 255 | | | 111 | |
End of period | $ | 535 | | | $ | 568 | | | $ | 255 | |
| | | | | |
Non-cash investing activities: | | | | | |
Capital expenditures included in accounts payable and accrued expenses | $ | 213 | | | $ | 189 | | | $ | 280 | |
Transaction costs included in accounts payable and accrued expenses | 8 | | | — | | | — | |
Conversion of note receivable to equity method investment | 6 | | | 15 | | | — | |
Non-cash acquisition of controlling interest | — | | | — | | | 3 | |
Non-cash purchases of intangibles | 19 | | | — | | | — | |
| | | | | |
Non-cash financing activities: | | | | | |
Dividends declared but not yet paid | 281 | | | 265 | | | 212 | |
| | | | | |
| | | | | |
Supplemental cash flow disclosures: | | | | | |
Cash paid for interest | 363 | | | 477 | | | 515 | |
Cash paid for income taxes | 686 | | | 506 | | | 582 | |
The accompanying notes are an integral part of these consolidated financial statements.
KEURIG DR PEPPER INC.
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Common Stock Issued | | Additional Paid-In Capital | | Retained Earnings | | Accumulated Other Comprehensive Income (Loss) | | Total Stockholders' Equity | | Non-Controlling Interest | | Total Equity |
(in millions) | Shares | | Amount | | | | | | |
Balance as of December 31, 2019 | 1,406.8 | | $ | 14 | | | $ | 21,557 | | | $ | 1,582 | | | $ | 104 | | | $ | 23,257 | | | $ | — | | | $ | 23,257 | |
| | | | | | | | | | | | | | | |
Net income | — | | | — | | | — | | | 1,325 | | | — | | | 1,325 | | | — | | | 1,325 | |
Other comprehensive loss | — | | | — | | | — | | | — | | | (27) | | | (27) | | | — | | | (27) | |
Dividends declared, $0.60 per share | — | | | — | | | — | | | (846) | | | — | | | (846) | | | — | | | (846) | |
Proceeds from sale of stock by JAB | — | | | — | | | 29 | | | — | | | — | | | 29 | | | — | | | 29 | |
Non-cash acquisition of controlling interest | — | | | — | | | 3 | | | — | | | — | | | 3 | | | 1 | | | 4 | |
Shares issued under employee stock-based compensation plans and other | 0.5 | | | — | | | — | | | — | | | — | | | — | | | — | | | — | |
Stock-based compensation | — | | | — | | | 88 | | | — | | | — | | | 88 | | | — | | | 88 | |
Balance as of December 31, 2020 | 1,407.3 | | | $ | 14 | | | $ | 21,677 | | | $ | 2,061 | | | $ | 77 | | | $ | 23,829 | | | $ | 1 | | | $ | 23,830 | |
Net income | — | | | — | | | — | | | 2,146 | | | — | | | 2,146 | | | (1) | | | 2,145 | |
Other comprehensive loss | — | | | — | | | — | | | — | | | (103) | | | (103) | | | — | | | (103) | |
Issuance of common stock | 4.3 | | | — | | | 140 | | | — | | | — | | | 140 | | | — | | | 140 | |
Dividends declared, $0.7125 per share | — | | | — | | | — | | | (1,008) | | | — | | | (1,008) | | | — | | | (1,008) | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
Shares issued under employee stock-based compensation plans and other | 6.5 | | | — | | | — | | | — | | | — | | | — | | | — | | | — | |
Tax withholdings related to net share settlements | — | | | — | | | (125) | | | — | | | — | | | (125) | | | | | (125) | |
Stock-based compensation | — | | | — | | | 93 | | | — | | | — | | | 93 | | | — | | | 93 | |
Balance as of December 31, 2021 | 1,418.1 | | | $ | 14 | | | $ | 21,785 | | | $ | 3,199 | | | $ | (26) | | | $ | 24,972 | | | $ | — | | | $ | 24,972 | |
Net income | — | | | — | | | — | | | 1,436 | | | — | | | 1,436 | | | (1) | | | 1,435 | |
Other comprehensive income | — | | | — | | | — | | | — | | | 155 | | | 155 | | | — | | | 155 | |
| | | | | | | | | | | | | | | |
Dividends declared, $0.775 per share | — | | | — | | | — | | | (1,096) | | | — | | | (1,096) | | | — | | | (1,096) | |
Repurchases of common stock | (10.6) | | | — | | | (379) | | | — | | | — | | | (379) | | | — | | | (379) | |
Shares issued under employee stock-based compensation plans and other | 0.9 | | | — | | | — | | | — | | | — | | | — | | | — | | | — | |
Tax withholdings related to net share settlements | — | | | — | | | (15) | | | — | | | — | | | (15) | | | — | | | (15) | |
Stock-based compensation | — | | | — | | | 53 | | | — | | | — | | | 53 | | | — | | | 53 | |
Balance as of December 31, 2022 | 1,408.4 | | | $ | 14 | | | $ | 21,444 | | | $ | 3,539 | | | $ | 129 | | | $ | 25,126 | | | $ | (1) | | | $ | 25,125 | |
The accompanying notes are an integral part of these consolidated financial statements.
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. Business and Basis of Presentation
ORGANIZATION AND NATURE OF OPERATIONS
Keurig Dr Pepper Inc. is a leading coffee and beverage company in North America with a diverse portfolio of flavored CSDs, specialty coffee, and NCBs, and is a leader in single serve coffee brewers in the U.S. and Canada.
References in this Annual Report on Form 10-K to "KDP" or "the Company" refer to Keurig Dr Pepper Inc. and all wholly-owned subsidiaries included in the consolidated financial statements. Definitions of terms used in this Annual Report on Form 10-K are included within the Master Glossary.
This Annual Report on Form 10-K refers to some of KDP's owned or licensed trademarks, trade names and service marks, which are referred to as the Company's brands. All of the product names included herein are either KDP registered trademarks or those of the Company's licensors.
BASIS OF PRESENTATION
The accompanying consolidated financial statements have been prepared in accordance with U.S. GAAP.
FISCAL YEAR END
KDP's fiscal year end is December 31, and its interim fiscal quarters are March 31, June 30, and September 30. KDP's significant subsidiary, Maple Parent Holdings Corp., has a fiscal year end of the last Saturday in December, and its interim fiscal quarters end every thirteenth Saturday. The fiscal year for Maple Parent Holdings Corp. includes 53 weeks for the year ended December 31, 2022 and 52 weeks for the years ended December 31, 2021 and 2020. KDP does not adjust for the difference in fiscal year, as the difference is within the range permitted by the Exchange Act.
PRINCIPLES OF CONSOLIDATION
KDP consolidates all wholly owned subsidiaries.
The Company consolidates investments in companies in which it holds the majority interest. In these cases, the third party equity interest is referred to as non-controlling interest. Non-controlling interests are presented as a separate component within equity in the Consolidated Balance Sheets, and net earnings attributable to the non-controlling interests are presented separately in the Consolidated Statements of Income.
The Company would be required to consolidate VIEs for which KDP has been determined to be the primary beneficiary. To determine if KDP is the primary beneficiary, the Company assesses specific criteria and uses judgment when determining if it has the power to direct the significant activities of the VIE and the obligation to absorb losses or receive benefits from the VIE that may be significant to the VIE. Factors considered include risk and reward sharing, voting rights, involvement in day-to-day capital and operating decisions, representation on a VIE’s governance structure, existence of unilateral kick-out rights exclusive of protective rights or voting rights, and level of economic disproportionality between the Company and the VIE’s other partner(s). The Company has determined that it is not the primary beneficiary of any VIEs. However, future events may require the Company to consolidate VIEs if the Company becomes the primary beneficiary.
The Company uses the equity method to account for investments in companies if the investment provides the Company with the ability to exercise significant influence over operating and financial policies of the investee. Consolidated net income includes KDP's proportionate share of the net income or loss of these companies. Judgment regarding the level of influence over each equity method investment includes considering key factors such as ownership interest, representation on the Board or similar governing body, participation in policy-making decisions and material intercompany transactions.
KDP eliminates from its financial results all intercompany transactions between entities included in the consolidated financial statements.
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
UNALLOCATED CORPORATE COST ALIGNMENT
Effective January 1, 2022, the Company updated its presentation of certain of KDP's unallocated corporate costs, primarily related to IT, to be aligned among the Company's segments and to more consistently reflect controllable costs at the segment level. Refer to Note 7 for current year presentation. The following table summarizes the revised and prior presentations of income from operations at the segment level:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Year Ended December 31, |
(in millions) | | 2021 | | 2020 |
Segment Results – Income from operations | | Current Presentation | | Prior Presentation | | Current Presentation | | Prior Presentation |
Coffee Systems | | $ | 1,446 | | | $ | 1,318 | | | $ | 1,398 | | | $ | 1,268 | |
Packaged Beverages | | 1,023 | | | 1,010 | | | 835 | | | 822 | |
Beverage Concentrates | | 1,047 | | | 1,044 | | | 935 | | | 932 | |
Latin America Beverages | | 133 | | | 133 | | | 105 | | | 105 | |
Unallocated corporate costs | | (755) | | | (611) | | | (793) | | | (647) | |
Income from operations | | $ | 2,894 | | | $ | 2,894 | | | $ | 2,480 | | | $ | 2,480 | |
2. Significant Accounting Policies
USE OF ESTIMATES
The process of preparing the Company's consolidated financial statements in conformity with U.S. GAAP requires the use of estimates and judgments that affect the reported amount of assets, liabilities, revenue and expenses. These estimates and judgments are based on historical experience, future expectations and other factors and assumptions the Company believes to be reasonable under the circumstances. These estimates and judgments are reviewed on an ongoing basis and are revised when necessary. Changes in estimates are recorded in the period of change. Actual amounts may differ from these estimates.
SIGNIFICANT ACCOUNTING POLICIES
Fair Value
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Based upon the transparency of inputs to the valuation of an asset or liability, a three-level hierarchy has been established for fair value measurements. The three-level hierarchy for disclosure of fair value measurements is as follows:
Level 1 - Quoted market prices in active markets for identical assets or liabilities.
Level 2 - Observable inputs such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets.
Level 3 - Valuations with one or more unobservable significant inputs that reflect the reporting entity's own assumptions.
The fair value of Notes and marketable securities as of December 31, 2022 and 2021 are based on quoted market prices for publicly traded securities.
The Company estimates fair values of financial instruments measured at fair value in the Company’s consolidated financial statements on a recurring basis to ensure they are calculated based on market rates to settle the instruments. These values represent the estimated amounts the Company would pay or receive to terminate agreements, taking into consideration current market rates and creditworthiness.
As of December 31, 2022 and 2021, the Company did not have any assets or liabilities measured on a recurring basis without observable market values that would require a high level of judgment to determine fair value (Level 3).
Transfers between levels are recognized at the end of each reporting period. There were no transfers of financial instruments between the three levels of fair value hierarchy during the years ended December 31, 2022, 2021 and 2020.
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
Acquisitions
The Company evaluates the facts and circumstances of each acquisition to determine whether the transaction should be accounted for as an asset acquisition or a business combination.
Asset Acquisitions
When substantially all of the fair value of the assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets, the transaction is accounted for as an asset acquisition. Direct transaction costs associated with asset acquisitions are capitalized.
Business Combinations
The Company includes the results of operations of the acquired business in the Company’s consolidated financial statements prospectively from the acquisition date. The Company allocates the purchase consideration to the assets acquired and liabilities assumed in the acquired entity generally based on their fair values at the acquisition date. The excess of the fair value of purchase consideration over the fair value of these assets acquired and liabilities assumed in the acquired entity is recorded as goodwill. During the measurement period, the Company will continue to obtain information to assist in determining the fair value of net assets acquired, which may differ materially from these preliminary estimates. Measurement period adjustments, if applicable, will be applied in the reporting period in which the adjustment amounts are determined.
Transaction expenses are recognized separately from the business combination and are expensed as incurred. These charges primarily include direct third-party professional fees for advisory and consulting services and other incremental costs related to the acquisition.
Cash and Cash Equivalents
Cash and cash equivalents include cash and investments in short-term, highly liquid securities, with original maturities of three months or less.
The Company is exposed to potential risks associated with its cash and cash equivalents. The Company places its cash and cash equivalents with high credit quality financial institutions. Deposits with these financial institutions may exceed the amount of insurance provided; however, these deposits typically are redeemable upon demand and, therefore, the Company believes the financial risks associated with these financial instruments are minimal.
Trade Accounts Receivable and Allowance for Expected Credit Losses
Trade accounts receivable are recorded at the invoiced amount and do not bear interest.
The Company is exposed to potential credit risks associated with its accounts receivable, as it generally does not require collateral on its accounts receivable. The Company determines the required allowance for expected credit losses using information such as its customer credit history and financial condition, industry and market segment information, credit reports, and economic trends and conditions such as the impacts of COVID-19 in the year ended December 31, 2022. Allowances can be affected by changes in the industry, customer credit issues or customer bankruptcies or expectations of any such events in a future period when reasonable and supportable. Historical information is utilized beyond reasonable and supportable forecast periods. Amounts are charged against the allowance when it is determined that expected credit losses may occur.
Activity in the allowance for expected credit loss accounts was as follows:
| | | | | | | | | | | | | | | | | |
| For the Year Ended December 31, |
(in millions) | 2022 | | 2021 | | 2020 |
Balance, beginning of the period | $ | 7 | | | $ | 21 | | | $ | 9 | |
Charges to (reversals of) bad debt expense | 3 | | | (13) | | | 17 | |
Write-offs and adjustments | (1) | | | (1) | | | (5) | |
Balance, end of the period | $ | 9 | | | $ | 7 | | | $ | 21 | |
The majority of the Company's customers are located in the U.S. and Canada. Concentration of credit risk with respect to accounts receivable is limited due to the large number of customers in various channels comprising the Company's customer base. Walmart is a major customer as of December 31, 2022 and 2021 as described in Note 7. As of December 31, 2022 and 2021, Walmart accounted for approximately $303 million and $157 million of trade receivables, respectively, which exceeded 10% of the Company's total trade accounts receivable.
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
Inventories
Inventories consist of raw materials, work in process and finished goods. Raw materials include various commodity costs for the Company's ingredients and materials sourced from various providers. The costs of finished goods inventories manufactured by the Company include raw materials, direct labor and indirect production and overhead costs. Finished goods also include the purchases of brewing systems and certain beverages from third-party manufacturers. Inventories are stated at the lower of cost or net realizable value. Cost is measured using standard cost method which approximates first-in, first-out. The Company regularly reviews whether the net realizable value of its inventory is lower than its carrying value. If the valuation shows that the net realizable value is lower than the carrying value, the Company takes a charge to cost of sales and directly reduces the carrying value of the inventory.
The Company estimates any required write downs for inventory obsolescence by examining its inventories on a quarterly basis to determine if there are indicators that the carrying values exceed net realizable value. Indicators that could result in additional inventory write downs include age of inventory, damaged inventory, slow moving products and products at the end of their life cycles. While management believes that inventory is appropriately stated, judgment is involved in determining the net realizable value of inventory. Adjustments for excess and obsolete inventories are based on an assessment of slow-moving and obsolete inventories, determined by historical usage and demand.
Property, Plant and Equipment, Net
Property, plant and equipment is stated at cost plus capitalized interest on borrowings during the actual construction period of major capital projects, net of accumulated depreciation. Significant improvements which substantially extend the useful lives of assets are capitalized and expenditures for repairs and maintenance which do not improve or extend the life of the assets are expensed as incurred. The Company capitalizes certain computer software and software development costs incurred in connection with developing or obtaining computer software for internal use, which are included in property, plant and equipment. When property, plant and equipment is sold, the costs and the related accumulated depreciation are removed from the accounts, and any net gain or loss is recorded in Other operating income, net in the Consolidated Statements of Income.
For financial reporting purposes, depreciation is computed on the straight-line method over the estimated useful asset lives as follows:
| | | | | | | | | | | | | | |
Type of Asset | | Useful Life |
Buildings and improvements | | 3 | to | 40 years |
Machinery and equipment | | 2 | to | 20 years |
Cold drink equipment | | 2 | to | 7 years |
Computer software | | 2 | to | 8 years |
Leasehold improvements, which are primarily considered building improvements, are depreciated over the shorter of the estimated useful life of the assets or the lease term. Estimated useful lives are periodically reviewed and, when warranted, are updated.
The Company periodically reviews long-lived assets for impairment whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. In order to assess recoverability, the Company compares the estimated undiscounted future pre-tax cash flows from the use of the group of assets, as defined, to the carrying amount of such assets. Measurement of an impairment loss is based on the excess of the carrying amount of the group of assets over the long-lived asset's fair value. For the years ended December 31, 2022 and 2021, the Company recorded no impairment loss related to these assets. For the year ended December 31, 2020, the Company recorded an impairment loss of $1 million. Impairment loss is recorded in Other operating income, net, in the Consolidated Statements of Income.
Leases
The Company leases certain facilities and machinery and equipment, including fleet. These leases expire at various dates through 2044. Some lease agreements contain standard renewal provisions that allow us to renew the lease at rates equivalent to fair market value at the end of the lease term. The Company's lease agreements do not contain any material restrictive covenants. KDP has certain leases of manufacturing and distribution properties and the Frisco headquarters that contain a residual value guarantee at the end of the term. Refer to Note 19 for additional information about the Company’s residual value guarantees.
Operating leases are included within other non-current assets, other current liabilities, and other non-current liabilities within our Consolidated Balance Sheets. Finance leases are included within Property, plant and equipment, net, other current liabilities, and other non-current liabilities. Leases with an initial term of 12 months or less are not recognized on the Consolidated Balance Sheets.
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
Right of use assets and lease liabilities are recognized in the Consolidated Balance Sheets at the present value of future minimum lease payments over the lease term on the commencement date. When the rate implicit in the lease is not provided to the Company, KDP will use its incremental borrowing rate based on information available at the commencement date to determine the present value of future minimum lease payments. KDP's incremental borrowing rate is determined using a portfolio of secured borrowing rates commensurate with the term of the lease and is reassessed on a quarterly basis.
KDP has lease agreements with lease and non-lease components, which are generally accounted for as a single lease component.
Sale-and-leaseback transactions occur when the Company sells assets to a third-party and subsequently leases them back. The resulting leases that qualify for sale-and-leaseback accounting are evaluated and accounted for as an operating lease. A transaction that does not qualify for sale-and-leaseback accounting as a result of finance lease classification or the failure to meet certain revenue recognition criteria is accounted for as a financing transaction. For a financing transaction, the Company will retain the assets sold within Property, plant and equipment, net and record a financing obligation equal to the amount of cash proceeds received. Rental payments under such transactions are recognized as a reduction of the financing obligation and as interest expense using an effective interest method.
Investments
Deferred Compensation Plan
The Company has a U.S. non-qualified defined contribution plan. Contributions under the non-qualified defined contribution plan are maintained in a rabbi trust and are not readily available to the Company. The rabbi trust consists of readily marketable equity securities, which are included in Other non-current assets in the Consolidated Balance Sheets. Gains or losses from such investments are classified as trading and are charged to Other expense (income), net in the Consolidated Statements of Income.
The corresponding deferred compensation liability is included in Other non-current liabilities in the Consolidated Balance Sheets, with changes in this obligation recognized as adjustments to compensation expense and recorded in SG&A expenses.
Investments in Other Equity Securities
The Company consolidates investments in companies in which it holds the majority interest. In these cases, the third party equity interest is referred to as non-controlling interest. Non-controlling interests are presented as a separate component within equity in the Consolidated Balance Sheets, and net earnings attributable to the non-controlling interests are presented separately in the Consolidated Statements of Income.
The Company also holds non-controlling investments in certain privately held entities which are accounted for as equity method investments, equity securities with readily determinable fair value, or equity securities without readily determinable value.
The companies over which we exert significant influence, but do not control the financial and operating decisions, are accounted for as equity method investments. The Company's equity method investments are reported at cost, which includes third-party transaction costs, and are adjusted each period for the Company’s share of the investee’s net income (loss) and dividends paid, if any. The Company's proportionate share of the net income (loss) resulting from these investments is recorded in Other expense (income), net in the Consolidated Statements of Income. Any gains and losses resulting from the sale of these investments are recorded in Gain on sale of equity method investment. The carrying value of the Company's equity method investments is reported in Investments in unconsolidated affiliates in the Company's Consolidated Balance Sheets. The Company classifies distributions received from equity method investments using the cumulative earnings approach on the Consolidated Statements of Cash Flows.
Investments with readily determinable fair values for which we do not have the ability to exercise significant influence are measured at fair value and reported in Other non-current assets in the Company's Consolidated Balance Sheets. As of December 31, 2022 and 2021, all such investments were categorized as Level 1. Unrealized gains and losses on these investments are recorded in Other (income) expense, net in the Consolidated Statements of Income.
Investments without readily determinable fair values for which we do not have the ability to exercise significant influence are accounted for at cost and reported in Other non-current assets in the Company's Consolidated Balance Sheets. Any gains or losses resulting from the sales of these investments are recorded in Other operating income, net, in the Consolidated Statements of Income.
The Company's non-controlling investments in certain privately held entities do not have readily determinable fair values and are periodically evaluated for impairment. An impairment loss would be recorded whenever a decline in value of an investment below its carrying amount is determined to be other than temporary.
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
Goodwill and Other Intangible Assets
The Company classifies other intangible assets into two categories:
•intangible assets with definite lives subject to amortization, and
•intangible assets with indefinite lives not subject to amortization.
The majority of the Company's intangible asset balance is made up of brands which the Company has determined to have indefinite useful lives. In arriving at the conclusion that a brand has an indefinite useful life, management reviews factors such as size, diversification and market share of each brand. Management expects to acquire, hold and support brands for an indefinite period through consumer marketing and promotional support. The Company also considers factors such as its ability to continue to protect the legal rights that arise from these intangible assets indefinitely or the absence of any regulatory, economic or competitive factors that could truncate the life of these intangible assets. If the criteria are not met to assign an indefinite life, the brand is amortized over its expected useful life.
Identifiable intangible assets deemed by the Company to have determinable finite useful lives are amortized on a straight-line basis over the period of which the expected economic benefit is derived. The estimated useful lives of the Company's intangible assets with definite lives are as follows:
| | | | | | | | | | | | | | |
Type of Asset | | Useful Life |
Acquired technology | | | | 20 years |
Customer relationships | | 10 | to | 40 years |
Trade names | | | | 10 years |
Distribution rights | | 4 | to | 10 years |
Brands | | | | 5 years |
Contractual arrangements | | 10 | to | 12 years |
For intangible assets with definite lives, tests for impairment are performed if conditions exist that indicate the carrying value may not be recoverable. For goodwill and indefinite-lived intangible assets, the Company conducts tests for impairment annually on the first day of the fourth quarter, or more frequently if events or circumstances indicate the carrying amount may not be recoverable.
The tests for impairment include significant judgment in estimating the fair value of reporting units and intangible assets. Management's estimates of fair value, which fall under Level 3 and are non-recurring, are based on historical and forecasted revenues and profit performance and discount rates. Fair value is based on what the reporting units and intangible assets would be worth to a third party market participant. Discount rates are based on a weighted average cost of equity and cost of debt, adjusted with various risk premiums.
Goodwill is assigned to reporting units for purposes of impairment testing. A reporting unit is the same as an operating segment or one level below an operating segment. KDP's six reporting units are as follows:
| | | | | | | | |
Reportable Segments | | Reporting Units |
Packaged Beverages | | DSD |
| | WD |
Coffee Systems | | Coffee Systems |
Beverage Concentrates | | Branded Concentrates |
| | Fountain Foodservice |
Latin America Beverages | | Latin America Beverages |
If the carrying value of the reporting unit or intangible asset exceeds its fair value, an impairment charge will be recorded in current earnings for the difference up to the carrying value of the goodwill or intangible asset recorded. Refer to Note 3 for additional information.
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
Capitalized Customer Incentive Programs
The Company provides support to certain customers to cover various programs and initiatives to increase net sales, including contributions to customers or vendors for cold drink equipment used to market and sell the Company's products. These programs and initiatives generally directly benefit the Company over a period of time. Accordingly, costs of these programs and initiatives are recorded in Prepaid expenses and other current assets and Other non-current assets in the Consolidated Balance Sheets. Refer to Note 17 for additional information. The costs for these programs are amortized over the period to be directly benefited based upon a methodology consistent with the Company's contractual rights under these arrangements.
Accounts Payable
KDP has agreements with third party administrators which allow participating suppliers to track payment obligations from KDP, and if
voluntarily elected by the supplier, to sell payment obligations from KDP to financial institutions. Suppliers can sell one or more of KDP's payment obligations at their sole discretion and the rights and obligations of KDP to its suppliers are not impacted. KDP has no economic interest in a supplier’s decision to enter into these agreements and no direct financial relationship with the financial institutions. KDP's obligations to its suppliers, including amounts due and scheduled payment terms, are not impacted. KDP has been informed by the third party administrator that as of December 31, 2022 and 2021, $3,839 million and $3,194 million, respectively, of KDP's outstanding payment obligations were voluntarily elected by the supplier and sold to financial institutions.
Structured Payables
The Company has entered into an agreement with a supply chain payment processing intermediary, for the intermediary to act as a virtual credit card sponsor, whereby the card sponsor pays amounts on behalf of the Company and sells the amounts due from the Company to a participating financial institution. The card sponsor then bills the Company the original payment amount, effectively financing the transaction. The agreement permits the Company to utilize the third party and participating financial institutions to make a broad range of payments, including commercial payables to suppliers, business acquisitions, purchases of property, plant and equipment, and employee-related payments
Additionally, the Company has commercial arrangements with suppliers who use third party administrators to sell payment obligations from KDP to financial institutions. The Company evaluates the commercial arrangements with suppliers to determine if they are more representative of debt or accounts payable classification. If the Company determines these commercial arrangements are more representative of a financing transaction, then the Company records those payment obligations as structured payables.
Structured payables have equal priority with accounts payable and are treated as non-recourse obligations. The Company records interest for the period the structured payables obligation is outstanding and reflects the proceeds and payments related to these transactions as a financing activity on the Consolidated Statements of Cash Flows.
Pension and Post-retirement Medical Benefits
The Company has U.S. and foreign pension and PRMB plans which provide benefits to a defined group of employees who satisfy age and length of service requirements at the discretion of the Company. As of December 31, 2022, the Company has several stand-alone non-contributory defined benefit plans and PRMB plans. Depending on the plan, pension and PRMB benefits are based on a combination of factors, which may include salary, age and years of service.
Employee pension and PRMB plan obligations and the associated expense included in the consolidated financial statements are determined from actuarial analyses based on plan assumptions, employee demographic data, years of service, compensation, benefits and claims paid and employer contributions. Non-cash settlement charges occur when the total amount of lump sum payments made to participants of various U.S. defined pension plans exceed the estimated annual interest and service costs.
The components of net periodic benefit cost other than the service cost component are included in Other expense (income), net, in the Company's Consolidated Statements of Income. The service cost component is included in either Cost of sales or SG&A expenses, depending on the classification of the employee's other compensation costs.
The Company's objective with respect to the funding of its pension plans is to provide adequate assets for the payment of future benefits. Pursuant to this objective, the Company will fund the pension plans as required by governmental regulations and may consider discretionary contributions as conditions warrant.
The Company participates in three multi-employer pension plans and makes contributions to those plans, which are recorded in either Cost of sales or SG&A expenses, depending on the classification of the employee's other compensation costs.
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
Risk Management Programs
The Company retains selected levels of property, casualty, workers' compensation, health, cyber and other business risks. Many of these risks are covered under conventional insurance programs with deductibles or self-insured retentions. Accrued liabilities related to the retained casualty and health risks are calculated based on loss experience and development factors, which contemplate a number of variables including claim history and expected trends, and are recorded in Other current liabilities and Other non-current liabilities in the Consolidated Balance Sheets.
Income Taxes
Income taxes are accounted for using the asset and liability approach, which involves determining the temporary differences between assets and liabilities recognized for financial reporting and the corresponding amounts recognized for tax purposes and computing the tax-related carryforwards at the enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be reversed. The resulting amounts are deferred tax assets or liabilities. The total of taxes currently payable per the tax return, the deferred tax expense or benefit and the impact of uncertain tax positions represents the income tax expense or benefit for the year for financial reporting purposes.
The Company periodically assesses the likelihood of realizing its deferred tax assets based on the amount that the Company believes is more likely than not to be realized. The Company bases its judgment of the recoverability of its deferred tax assets primarily on historical earnings, its estimate of current and expected future earnings and prudent and feasible tax planning strategies.
The Company establishes income tax liabilities to remove some or all of the income tax benefit of any of the Company's income tax positions at the time the Company determines that the positions become uncertain based upon one of the following: (1) the tax position is not "more likely than not" to be sustained, (2) the tax position is "more likely than not" to be sustained, but for a lesser amount, or (3) the tax position is "more likely than not" to be sustained, but not in the financial period in which the tax position was originally taken. The Company's evaluation of whether or not a tax position is uncertain is based on the following: (1) the Company presumes the tax position will be examined by the relevant taxing authority such as the IRS that has full knowledge of all relevant information, (2) the technical merits of a tax position are derived from authorities such as legislation and statutes, legislative intent, regulations, rulings and case law and their applicability to the facts and circumstances of the tax position, and (3) each tax position is evaluated without considerations of the possibility of offset or aggregation with other tax positions taken. The Company adjusts these income tax liabilities when the Company's judgment changes as a result of new information. Any change will impact income tax expense in the period in which such determination is made.
Derivative Instruments
KDP is exposed to market risks arising from adverse changes in interest rates, commodity prices, and FX rates. KDP manages these risks through a variety of strategies, including the use of interest rate contracts, FX forward contracts, commodity forward, future, swap and option contracts and supplier pricing agreements. KDP does not hold or issue derivative financial instruments for trading or speculative purposes.
The Company records all derivative instruments on a gross basis, including those subject to master netting arrangements.
KDP formally designates and accounts for certain foreign exchange forward contracts and interest rate contracts that meet established accounting criteria under U.S. GAAP as cash flow hedges. For such contracts, the effective portion of the gain or loss on the derivative instruments is recorded, net of applicable taxes, in AOCI. When net income is affected by the variability of the underlying transaction, the applicable offsetting amount of the gain or loss from the derivative instrument deferred in AOCI is reclassified to net income. Cash flows from derivative instruments designated in a qualifying hedging relationship are classified in the same category as the cash flows from the underlying hedged items. If a cash flow hedge were to cease to qualify for hedge accounting, or were terminated, the derivatives would continue to be carried on the balance sheet at fair value until settled and hedge accounting would be discontinued prospectively. If the underlying hedged transaction ceases to exist, any associated amounts reported in AOCI would be reclassified to earnings at that time.
For derivatives that are not designated or for which the designated hedging relationship is discontinued, the gain or loss on the instrument is recognized in earnings in the period of change.
The Company has exposure to credit losses from derivative instruments in an asset position in the event of nonperformance by the counterparties to the agreements. Historically, the Company has not experienced material credit losses as a result of counterparty nonperformance. The Company selects and periodically reviews counterparties based on credit ratings, limits its exposure to a single counterparty under defined guidelines and monitors the market position of the programs upon execution of a hedging transaction and at least on a quarterly basis.
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
Loss Contingencies
Legal Matters
The Company is involved from time to time in various claims, proceedings, and litigation, including those described in Note 18. The Company establishes reserves for specific legal proceedings when it determines that the likelihood of an unfavorable outcome is probable and the amount of loss can be reasonably estimated. Management has also identified certain other legal matters where it believes an unfavorable outcome is reasonably possible and/or for which no estimate of possible losses can be made, and where applicable, the Company provides disclosure of such legal matters in Note 18.
Product Warranties
The Company provides for the estimated cost of product warranties associated with its brewers in cost of sales, at the time product revenue is recognized. Warranty costs are estimated primarily using historical warranty information in conjunction with current engineering assessments applied to the Company's expected repair or replacement costs. The estimate for warranties requires assumptions relating to expected warranty claims which are based on the Company's historical claims and known current year factors.
Revenue Recognition
The Company recognizes revenue when performance obligations under the terms of a contract with the customer are satisfied. Branded product sales, which include CSDs, NCBs, K-Cup pods, appliances and other, occur once control is transferred upon delivery to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods. The amount of consideration the Company receives and revenue the Company recognizes varies with changes in customer incentives the Company offers to its customers and their customers. These incentives and discounts, which are recorded as a reduction of revenue, include cash discounts, price allowances, volume-based rebates, product placement fees and other financial support for items such as trade promotions, displays, new products, consumer incentives and advertising assistance. Accruals are established for the expected payout based on contractual terms, volume-based metrics and/or historical trends and require management judgment with respect to estimating customer participation and performance levels. Sales taxes and other similar taxes are excluded from revenue. Costs associated with shipping and handling activities, such as merchandising, are included in SG&A expenses as revenue is recognized.
Cost of Sales
Cost of goods sold includes all costs to acquire and manufacture the Company's products including raw materials, direct and indirect labor, manufacturing overhead, including depreciation expense, and all other costs incurred to bring the product to salable condition. All other costs incurred after this condition is met are considered selling costs and included in SG&A expenses.
Selling, General and Administrative Expenses
Transportation and Warehousing Costs
The Company incurred $1,746 million, $1,475 million and $1,326 million of transportation and warehousing costs during the years ended December 31, 2022, 2021 and 2020, respectively. These amounts, which primarily relate to shipping and handling costs, are recorded in SG&A expenses in the Consolidated Statements of Income.
Advertising and Marketing Expense
Advertising and marketing production costs related to television, print, radio and other marketing investments are expensed as of the first date the advertisement takes place. All other advertising and marketing costs are expensed as incurred. Advertising and marketing expenses were approximately $537 million, $540 million and $489 million for the years ended December 31, 2022, 2021 and 2020, respectively. Advertising and marketing expenses are recorded in SG&A expenses in the Consolidated Statements of Income. Prepaid advertising and marketing costs are recorded as Other current and Other non-current assets in the Consolidated Balance Sheets.
Research and Development Costs
Research and development costs are expensed when incurred and amounted to $65 million, $66 million and $69 million for the years ended December 31, 2022, 2021 and 2020, respectively. These expenses are recorded primarily in SG&A expenses in the Consolidated Statements of Income.
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
Stock-Based Compensation Expense
The Company recognizes compensation expense in the Consolidated Statements of Income related to the fair value of employee stock-based awards. Compensation cost is based on the grant-date fair value. The fair value of RSUs is determined based on the number of units granted and the grant date price of common stock. The fair value of PSUs is estimated at the date of grant using a Monte-Carlo simulation. Prior to January 1, 2022, the Company recorded forfeitures as incurred.
Effective January 1, 2022, the Company changed its accounting policy election to record expense only for awards expected to vest. Estimated forfeiture rates are based on historical data and are periodically reassessed. The cumulative effect of this change in accounting policy was recorded effective January 1, 2022, as the impact of forfeitures on stock-based compensation has historically been insignificant to the Company. Stock-based compensation expense is recognized ratably over the vesting period and is recorded SG&A expenses in the Consolidated Statements of Income. Refer to Note 11 for additional information .
Integration and Restructuring Costs
The Company implements restructuring programs from time to time and incurs costs that are designed to improve operating effectiveness and lower costs. When the Company implements these programs, the Company incurs expenses, such as employee separations, lease terminations and other direct exit costs, that qualify as exit and disposal costs under U.S. GAAP.
The Company also incurs expenses that are an integral component of, and directly attributable to, the Company's restructuring activities, which do not qualify as exit and disposal costs, such as accelerated depreciation, asset impairments, IT implementation costs and other incremental costs. The Company has recorded these costs within SG&A expenses on the Consolidated Statements of Income, and these costs are held within unallocated corporate costs.
Foreign Currency Translation and Transaction
The Company translates assets and liabilities of our foreign subsidiaries from their respective functional currencies to U.S. dollars at the appropriate spot rates as of the balance sheet date. The functional currency of the Company's operations outside the U.S. is generally the local currency of the country where the operations are located, or U.S. dollars. The results of operations are translated into U.S. dollars at a monthly average rate, calculated using daily exchange rates.
Differences arising from the translation of opening balance sheets of these entities to the rate at the end of the financial year are recognized in AOCI. The differences arising from the translation of foreign results at the average rate are also recognized in AOCI. Such translation differences are recognized as income or expense in the period in which the Company disposes of the operations.
Transactions in foreign currencies are recorded at the approximate rate of exchange at the transaction date. Assets and liabilities resulting from these transactions are translated at the rate of exchange in effect at the balance sheet date. Such differences are recorded in Cost of sales or Other expense (income), net in the Consolidated Statements of Income, depending on the nature of the underlying transaction.
Earnings per Share
Basic EPS is computed by dividing Net income attributable to KDP by the weighted average number of common shares outstanding for the period. Diluted EPS reflects the assumed conversion of all dilutive securities.
Repurchases of Common Stock
Shares repurchased under authorized share repurchase programs are retired, and the excess purchase price over the par value is recorded to additional paid-in capital.
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
RECENTLY ISSUED ACCOUNTING STANDARDS
In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, later amended by ASU 2021-01, Reference Rate Reform (Topic 848) Scope and ASU 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848. The objective of ASU 2020-04 is to provide optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This was further clarified by ASU 2021-01, which confirmed that certain optional expedients and exceptions in Topic 848 apply to derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. ASU 2020-04 is effective and can be elected for all entities from the issuance date of ASU 2020-04 through December 31, 2024, as amended by ASU 2022-06. The Company is currently evaluating ASU 2020-04 but expects the impact to be immaterial to KDP’s consolidated financial statements.
In September 2022, the FASB issued ASU 2022-04, Liabilities — Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations. The objective of ASU 2022-04 is to require entities to disclose information about the use of supplier finance programs in connection with the purchase of goods and services. ASU 2022-04 is effective for all entities for annual periods beginning after December 15, 2022. The Company is currently evaluating ASU 2022-04 but expects the impact to be immaterial to KDP’s current consolidated financial statement disclosures.
3. Goodwill and Other Intangible Assets
GOODWILL
Changes in the carrying amount of goodwill by reportable segment for the years ended December 31, 2022 and 2021 are as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(in millions) | Coffee Systems | | Packaged Beverages | | Beverage Concentrates | | Latin America Beverages | | Total |
Balance as of December 31, 2020 | $ | 9,795 | | | $ | 5,314 | | | $ | 4,536 | | | $ | 539 | | | $ | 20,184 | |
Foreign currency translation | 5 | | | 5 | | | 3 | | | (15) | | | (2) | |
Balance as of December 31, 2021 | 9,800 | | | 5,319 | | | 4,539 | | | 524 | | | 20,182 | |
Foreign currency translation | (64) | | | (46) | | | (31) | | | 31 | | | (110) | |
| | | | | | | | | |
Balance as of December 31, 2022 | $ | 9,736 | | | $ | 5,273 | | | $ | 4,508 | | | $ | 555 | | | $ | 20,072 | |
INTANGIBLE ASSETS OTHER THAN GOODWILL
The net carrying amounts of intangible assets other than goodwill with indefinite lives are as follows:
| | | | | | | | | | | | | | |
(in millions) | | December 31, 2022 | | December 31, 2021 |
Brands(1) | | $ | 19,291 | | | $ | 19,865 | |
Trade names | | 2,480 | | | 2,480 | |
Contractual arrangements(2) | | 122 | | | 123 | |
Distribution rights(3) | | 100 | | | 85 | |
Total | | $ | 21,993 | | | $ | 22,553 | |
(1)The decrease in brands with indefinite lives was driven by impairment charges of $472 million, led by Bai and Schweppes, and $102 million of FX translation during the year ended December 31, 2022. Refer to Impairment Analysis below.
(2)The decrease in contractual arrangements is driven by FX translation during the year ended December 31, 2022.
(3)The Company executed seven agreements to acquire distribution rights during the year ended December 31, 2022, which resulted in an increase of $15 million.
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
The net carrying amounts of intangible assets other than goodwill with definite lives are as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2022 | | December 31, 2021 |
(in millions) | Gross Amount | | Accumulated Amortization | | Net Amount | | Gross Amount | | Accumulated Amortization | | Net Amount |
Acquired technology | $ | 1,146 | | | $ | (475) | | | $ | 671 | | | $ | 1,146 | | | $ | (401) | | | $ | 745 | |
Customer relationships | 638 | | | (204) | | | 434 | | | 638 | | | (169) | | | 469 | |
Trade names(1) | 127 | | | (101) | | | 26 | | | 128 | | | (86) | | | 42 | |
Brands(2) | 51 | | | (19) | | | 32 | | | 21 | | | (8) | | | 13 | |
Distribution rights | 29 | | | (16) | | | 13 | | | 29 | | | (11) | | | 18 | |
Contractual arrangements | 24 | | | (10) | | | 14 | | | 24 | | | (8) | | | 16 | |
Total | $ | 2,015 | | | $ | (825) | | | $ | 1,190 | | | $ | 1,986 | | | $ | (683) | | | $ | 1,303 | |
(1)The decrease in trade names is driven by FX translation during the year ended December 31, 2022.
(2)The increase in brands with definite lives during the year ended December 31, 2022 is driven by the acquisition of Atypique, which was recorded as a definite lived brand asset of $30 million with an estimated useful life of five years. This increase was partially offset by impairment expense recognized through accumulated amortization of $5 million on a definite lived brand asset.
Amortization expense for intangible assets with definite lives was as follows:
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
(in millions) | 2022 | | 2021 | | 2020 |
Amortization expense for intangible assets with definite lives | $ | 138 | | | $ | 134 | | | $ | 133 | |
Amortization expense of these intangible assets is expected to be as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| For the Years Ending December 31, |
(in millions) | 2023 | | 2024 | | 2025 | | 2026 | | 2027 |
Expected amortization expense for intangible assets with definite lives | $ | 138 | | | $ | 130 | | | $ | 117 | | | $ | 113 | | | $ | 95 | |
IMPAIRMENT ANALYSIS
The following table summarizes impairment recognized on indefinite lived intangible assets as a result of the annual impairment analyses as of October 1 of each year and interim triggering analyses during the periods:
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
(in millions) | 2022 | | 2021 | | 2020 |
Interim triggering analysis | $ | 311 | | | $ | — | | | $ | — | |
Annual analysis | 161 | | | — | | | 67 | |
Total impairment of indefinite lived intangible assets | $ | 472 | | | $ | — | | | $ | 67 | |
Quarterly Triggering Event Analysis
The Company performed an analysis as of September 30, 2022 to evaluate whether any triggering events occurred during the third quarter of 2022. Management identified specific performance and margin challenges for Bai and performed a Step 1 quantitative discounted cash flow analysis using the income approach. As a result of this analysis, KDP recorded an impairment charge of $311 million in the Packaged Beverages segment.
Annual Analysis
For both goodwill and other indefinite lived intangible assets, KDP has the option to first assess qualitative factors to determine whether the fair value of either the reporting unit or indefinite lived intangible asset is "more likely than not" less than its carrying value, also known as a Step 0 analysis.
For the years ended December 31, 2022 and 2021, KDP performed a Step 0 analysis for certain indefinite lived intangible assets, including trade names, contractual arrangements and distribution rights and did not identify any indicators of impairment. For goodwill and the primary indefinite-lived brands, KDP performed a quantitative analysis, using the income approach, or in some cases a combination of income and market based approaches, to determine the fair value of the Company's assets, as well as an overall consideration of market capitalization and enterprise value.
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
For the year ended December 31, 2020, KDP performed a quantitative analysis, using the income approach, or in some cases a combination of income and market based approaches, to determine the fair value of the Company's assets, as well as an overall consideration of market capitalization and enterprise value.
The following table provides the range of rates used in the analysis as of October 1, 2022, 2021, and 2020:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | 2022 | | 2021 | | 2020 |
Rate | | Minimum | | Maximum | | Minimum | | Maximum | | Minimum | | Maximum |
Discount rates | | 7.3 | % | | 10.3 | % | | 6.5 | % | | 10.0 | % | | 6.0 | % | | 10.0 | % |
Long-term growth rates | | — | % | | 3.8 | % | | — | % | | 3.8 | % | | — | % | | 3.5 | % |
Royalty rates(1) | | N/A | | N/A | | N/A | | N/A | | 1.0 | % | | 10.0 | % |
(1)Royalty rates were not used for the impairment analysis for the years ended December 31, 2022 or 2021, as KDP performed a Step 0 qualitative analysis for the trade names which historically utilized the Relief From Royalty Method.
The primary factors that led to the brand impairment determination in the fourth quarter of 2022, driven primarily by Schweppes, was the change in the macroeconomic environment leading to increases in discount rates, as shown in the table above, as well as supply chain disruptions within third-party distribution networks.
The factors that led to the Bai brand impairment determination in the fourth quarter of 2020 were primarily performance of the brand during the COVID-19 pandemic, related shifts in consumer behaviors that were expected to be other-than-temporary, and updated forecasts of brand performance based on a refined strategic vision to market and sell the product.
The results of the impairment analysis of the Company's indefinite lived brands as of October 1, 2022, 2021, and 2020 are as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | 2022 | | 2021 | | 2020 |
Headroom Percentage | | Carrying Value | | Fair Value | | Carrying Value | | Fair Value | | Carrying Value | | Fair Value |
Brands | | | | | | | | | | | | |
0%(1) | | $ | 2,136 | | | $ | 2,136 | | | $ | — | | | $ | — | | | $ | 415 | | | $ | 415 | |
Less than 25% | | 2,186 | | | 2,547 | | | 3,311 | | | 3,663 | | | 5,052 | | | 5,775 | |
26 - 50% | | — | | | — | | | 5,335 | | | 7,456 | | | 2,261 | | | 2,993 | |
In excess of 50% | | 14,848 | | | 28,942 | | | 11,173 | | | 21,982 | | | 11,946 | | | 19,835 | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
(1)Carrying value reflects the results of the annual impairment analysis recognized during the years ended December 31, 2022 and 2020.
4. Long-term Obligations and Borrowing Arrangements
The following table summarizes the Company's long-term obligations:
| | | | | | | | | | | |
| December 31, |
(in millions) | 2022 | | 2021 |
Notes | $ | 11,568 | | | $ | 11,733 | |
Less: current portion of long-term obligations | (496) | | | (155) | |
Long-term obligations | $ | 11,072 | | | $ | 11,578 | |
The following table summarizes the Company's short-term borrowings and current portion of long-term obligations:
| | | | | | | | | | | |
| December 31, |
(in millions) | 2022 | | 2021 |
Commercial paper notes | $ | 399 | | | $ | 149 | |
Current portion of long-term obligations: | 496 | | | 155 | |
Short-term borrowings and current portion of long-term obligations | $ | 895 | | | $ | 304 | |
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
SENIOR UNSECURED NOTES
The Company's Notes consisted of the following:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
(in millions) | | | | | | December 31, |
Issuance | | Maturity Date | | Rate | | 2022 | 2021 |
2023 Merger Notes | | May 25, 2023 | | 4.057% | | — | | | 1,000 | |
2023 Notes | | December 15, 2023 | | 3.130% | | 500 | | | 500 | |
2024 Notes | | March 15, 2024 | | 0.750% | | 1,150 | | | 1,150 | |
2025 Merger Notes | | May 25, 2025 | | 4.417% | | 529 | | | 1,000 | |
2025 Notes | | November 15, 2025 | | 3.400% | | 500 | | | 500 | |
2026 Notes | | September 15, 2026 | | 2.550% | | 400 | | | 400 | |
2027 Notes | | June 15, 2027 | | 3.430% | | 500 | | | 500 | |
2028 Merger Notes | | May 25, 2028 | | 4.597% | | 1,112 | | | 2,000 | |
2029 Notes | | April 15, 2029 | | 3.950% | | 1,000 | | | — | |
2030 Notes | | May 1, 2030 | | 3.200% | | 750 | | | 750 | |
2031 Notes | | March 15, 2031 | | 2.250% | | 500 | | | 500 | |
2032 Notes | | April 15, 2032 | | 4.050% | | 850 | | | — | |
2038 Notes | | May 1, 2038 | | 7.450% | | — | | | 125 | |
2038 Merger Notes | | May 25, 2038 | | 4.985% | | 211 | | | 500 | |
2045 Notes | | November 15, 2045 | | 4.500% | | 550 | | | 550 | |
2046 Notes | | December 15, 2046 | | 4.420% | | 400 | | | 400 | |
2048 Merger Notes | | May 25, 2048 | | 5.085% | | 391 | | | 750 | |
2050 Notes | | May 1, 2050 | | 3.800% | | 750 | | | 750 | |
2051 Notes | | March 15, 2051 | | 3.350% | | 500 | | | 500 | |
2052 Notes | | April 15, 2052 | | 4.500% | | 1,150 | | | — | |
Principal amount | | | | | | $ | 11,743 | | | $ | 11,875 | |
Adjustment from principal amount to carrying amount(1) | | (175) | | | (142) | |
Carrying amount | | | | | | $ | 11,568 | | | $ | 11,733 | |
(1)The carrying amount includes unamortized discounts, debt issuance costs and fair value adjustments related to the DPS Merger.
On January 24, 2022, KDP redeemed and retired the remainder of its 2038 Notes. The loss on early extinguishment of the 2038 Notes was approximately $45 million, comprised of the make-whole premium and the write-off of the associated unamortized fair value adjustment related to the DPS Merger.
On April 22, 2022, the Company undertook the 2022 Strategic Refinancing and completed the issuance of the 2029 Notes, the 2032 Notes, and the 2052 Notes. The discount associated with these notes was approximately $16 million, and the Company incurred $23 million in debt issuance costs. The proceeds from the issuance were used to voluntarily prepay and retire the remaining 2023 Merger Notes and to tender portions of the 2025 Merger Notes, the 2028 Merger Notes, the 2038 Merger Notes, and the 2048 Merger Notes. The Company recorded approximately $169 million of loss on early extinguishment of debt, comprised of the tender and make-whole premiums, the write-off of debt issuance costs, and the impact of terminating reverse treasury lock contracts.
Notes, among other things, contain customary default provisions and limit the Company's ability to incur indebtedness secured by principal properties, to enter into certain sale and leaseback transactions and to enter into certain mergers or transfers of substantially all of the Company's assets. The Notes are fully and unconditionally guaranteed by certain direct and indirect subsidiaries of the Company. As of December 31, 2022, the Company was in compliance with all financial covenant requirements of the Notes.
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
BORROWING ARRANGEMENTS
Revolving Credit Agreement
On February 23, 2022, KDP terminated the 2021 364-Day Credit Agreement and the KDP Revolver. The loss on early extinguishment of these instruments was approximately $3 million, comprised of termination fees and the write-off of the associated deferred financing fees. There were no amounts drawn upon the 2021 364-Day Credit Agreement or the KDP Revolver prior to termination.
Also on February 23, 2022, KDP entered into the 2022 Revolving Credit Agreement among KDP, as borrower, the lenders from time to time party thereto and JPMorgan Chase, Bank, N.A., as administrative agent. The Company incurred approximately $4 million in deferred financing fees related to the issuance.
The following table summarizes information about the 2022 Revolving Credit Agreement:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
(in millions) | | | | December 31, 2022 | | December 31, 2021 |
Issuance | | Maturity Date | | Capacity | | Carrying Value | | Carrying Value |
2022 Revolving Credit Agreement(1) | | February 23, 2027 | | $ | 4,000 | | | $ | — | | | $ | — | |
| | | | | | | | |
| | | | | | | | |
(1)The 2022 Revolving Credit Agreement has $200 million letters of credit available, none of which were utilized as of December 31, 2022.
The 2022 Revolving Credit Agreement replaced the KDP Revolver and the 2021 364-Day Credit Agreement and the proceeds of the credit facility are intended to be used for working capital and for other general corporate purposes of KDP.
Borrowings under the 2022 Revolving Credit Agreement will bear interest at a rate per annum equal to, at KDP's option, an adjusted SOFR rate plus a margin of 0.875% to 1.500% or a base rate plus a margin of 0.000% to 0.500%, in each case, depending on the rating of certain index debt of KDP. The 2022 Revolving Credit Agreement contains customary representations and warranties for investment grade financings. The 2022 Revolving Credit Agreement also contains (i) certain customary affirmative covenants, including those that impose certain reporting and/or performance obligations on KDP and its subsidiaries, (ii) certain customary negative covenants that generally limit, subject to various exceptions, KDP and its subsidiaries from taking certain actions, including, without limitation, incurring liens, consummating certain fundamental changes and entering into transactions with affiliates, (iii) a financial covenant in the form of a minimum interest coverage ratio (as defined therein) of 3.25 to 1.00 and (iv) customary events of default (including a change of control) for financings of this type.
As of December 31, 2022, KDP was in compliance with its minimum interest coverage ratio relating to the 2022 Revolving Credit Agreement.
Commercial Paper Program
KDP has a commercial paper program, under which the Company may issue unsecured commercial paper notes on a private placement basis up to a maximum aggregate amount outstanding at any time of $2,400 million. The maturities of the commercial paper notes vary, but commercial paper notes are classified as short-term, as maturities do not exceed one year. The Company issues commercial paper notes as needed for general corporate purposes. Outstanding commercial paper notes rank equally with all of the commercial paper notes' existing and future unsecured borrowings.
The following table provides information about the Company's weighted average borrowings under its commercial paper program:
| | | | | | | | | | | | | | | | | |
| For the Year Ended December 31, |
(in millions, except %) | 2022 | | 2021 | | 2020 |
Weighted average commercial paper borrowings | $ | 40 | | | $ | 943 | | | $ | 789 | |
Weighted average borrowing rates | 2.36 | % | | 0.25 | % | | 1.24 | % |
Letters of Credit Facility
In addition to the portion of the 2022 Revolving Credit Agreement reserved for issuance of letters of credit, the Company has an incremental letters of credit facility. Under this facility, $150 million is available for the issuance of letters of credit, $68 million of which was utilized as of December 31, 2022 and $82 million of which remains available for use.
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
FAIR VALUE DISCLOSURES
The fair values of the Company's commercial paper notes approximate the carrying value and are considered Level 2 within the fair value hierarchy.
The fair values of the Company's Notes are based on current market rates available to the Company and are considered Level 2 within the fair value hierarchy. The difference between the fair value and the carrying value represents the theoretical net premium or discount that would be paid or received to retire all the Notes and related unamortized costs to be incurred at such date. The fair value of the Company's Notes was $10,495 million and $13,078 million as of December 31, 2022 and December 31, 2021, respectively.
5. Derivatives
INTEREST RATES
Economic Hedges
KDP is exposed to interest rate risk related to its borrowing arrangements and obligations. The Company enters into interest rate contracts to provide predictability in the Company's overall cost structure and to manage the balance of fixed-rate and variable-rate debt. KDP primarily enters into receive-fixed, pay-variable and receive-variable, pay-fixed swaps and swaption contracts. A natural hedging relationship exists in which changes in the fair value of the instruments act as an economic offset to changes in the fair value of the underlying items. Changes in the fair value of these instruments are recorded in earnings throughout the term of the derivative instrument and are reported in interest expense in the Consolidated Statements of Income. As of December 31, 2022, economic interest rate derivative instruments have maturities ranging from January 2027 to April 2032.
Additionally, during the year ended December 31, 2022, KDP entered into reverse treasury lock contracts in order to manage the interest rate risk related to changes in value of the tender offers in the 2022 Strategic Refinancing prior to the pricing date. These contracts terminated during the year ended December 31, 2022, and the realized losses associated with these contracts are reported in loss on early extinguishment of debt in the Consolidated Statements of Income.
Cash Flow Hedges
In order to hedge the variability in cash flows from interest rate changes associated with the Company’s planned future issuances of long-term debt, during the first quarter of 2021, the Company entered into forward starting swaps and designated them as cash flow hedges.
In April 2022, concurrently with the 2022 Strategic Refinancing, KDP terminated $1.5 billion of notional amount of the forward starting swaps. Upon termination, KDP received $125 million to settle the contracts with the counterparties, which will be amortized to interest expense over the respective terms of the issued Notes.
On September 30, 2022, KDP de-designated $500 million of notional amount of the forward starting swaps. As the forecasted debt transaction is still probable to occur, the fair value of the these instruments as of September 30, 2022 was recorded in AOCI. Changes in fair value of the these instruments from the point of de-designation will be recorded as unrealized gains or losses in interest expense in the Consolidated Statements of Income. As of December 31, 2022, the remaining forward starting swaps designated as cash flow hedges have a mandatory termination date in May 2025.
FOREIGN EXCHANGE
KDP is exposed to foreign exchange risk in its international subsidiaries, which may transact in currencies that are different from the functional currencies of those subsidiaries. The balance sheets of each of these businesses are also subject to exposure from movements in exchange rates.
Economic Hedges
During the years ended December 31, 2022, 2021 and 2020, KDP held FX forward contracts to economically manage the balance sheet exposures resulting from changes in the FX exchange rates described above. The intent of these FX contracts is to minimize the impact of FX risk associated with balance sheet positions not in local currency. In these cases, a hedging relationship exists in which changes in the fair value of the instruments act as an economic offset to changes in the fair value of the underlying items. Changes in the fair value of these instruments are recorded in earnings throughout the term of the derivative instrument and are reported in the same caption of the Consolidated Statements of Income as the associated risk. As of December 31, 2022, these FX contracts have maturities ranging from January 2023 to September 2024.
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
Cash Flow Hedges
KDP designates certain FX forward contracts as cash flow hedges in order to manage the exposures resulting from changes in the FX rates described above. These designated FX forward contracts relate to either forecasted inventory purchases in U.S. dollars of the Canadian and Mexican businesses or forecasted capital expenditures of certain equipment in euros for KDP’s U.S. manufacturing facilities. The intent of these FX contracts is to provide predictability in the Company's overall cost structure. As of December 31, 2022, these FX contracts have maturities ranging from January 2023 to October 2024.
COMMODITIES
Economic Hedges
KDP centrally manages the exposure to volatility in the prices of certain commodities used in its production process and transportation through various derivative contracts. During the years ended December 31, 2022, 2021 and 2020, the Company held forward, future, swap and option contracts that economically hedged certain of its risks. In these cases, a hedging relationship exists in which changes in the fair value of the instruments act as an economic offset to changes in the fair value of the underlying items or as an offset to certain costs of production. Changes in the fair value of these instruments are recorded in earnings throughout the term of the derivative instrument and are reported in the same line item of the Consolidated Statements of Income as the hedged transaction. Unrealized gains and losses are recognized as a component of unallocated corporate costs until the Company's operating segments are affected by the completion of the underlying transaction, at which time the gain or loss is reflected as a component of the respective segment's income from operations. As of December 31, 2022, these commodity contracts have maturities ranging from January 2023 to April 2024.
NOTIONAL AMOUNTS OF DERIVATIVE INSTRUMENTS
The following table presents the notional amounts of the Company's outstanding derivative instruments by type:
| | | | | | | | | | | |
| December 31, |
(in millions) | 2022 | | 2021 |
Interest rate contracts | | | |
Forward starting swaps, designated as cash flow hedges | $ | 500 | | | $ | 2,500 | |
Forward starting swaps, not designated as hedging instruments | 1,000 | | | — | |
| | | |
Receive-fixed, pay-variable interest rate swaps, not designated as hedging instruments | 1,900 | | | 400 | |
| | | |
FX contracts | | | |
Forward contracts, not designated as hedging instruments | 490 | | | 463 | |
Forward contracts, designated as cash flow hedges | 511 | | | 385 | |
Commodity contracts, not designated as hedging instruments(1) | 754 | | | 529 | |
(1)Notional value for commodity contracts is calculated as the expected volume times strike price per unit on a gross basis.
FAIR VALUE OF DERIVATIVE INSTRUMENTS
The fair values of commodity contracts, interest rate contracts and FX forward contracts are determined based on inputs that are readily available in public markets or can be derived from information available in publicly quoted markets. The fair value of commodity contracts are valued using the market approach based on observable market transactions, primarily underlying commodities futures or physical index prices, at the reporting date. Interest rate contracts are valued using models based primarily on readily observable market parameters, such as LIBOR or SOFR forward rates, for all substantial terms of the Company's contracts and credit risk of the counterparties. FX forward contracts are valued using quoted FX forward rates at the reporting date. Therefore, the Company has categorized these contracts as Level 2.
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
Not Designated as Hedging Instruments
The following table summarizes the fair value hierarchy and the location of the fair value of the Company's derivative instruments not designated as hedging instruments within the Consolidated Balance Sheets:
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | December 31, |
(in millions) | Fair Value Hierarchy | | Balance Sheet Location | | 2022 | | 2021 |
Assets: | | | | | | | |
Interest rate contracts | 2 | | Prepaid expenses and other current assets | | $ | — | | | $ | 2 | |
FX forward contracts | 2 | | Prepaid expenses and other current assets | | 8 | | | 3 | |
Commodity contracts | 2 | | Prepaid expenses and other current assets | | 6 | | | 133 | |
Interest rate contracts | 2 | | Other non-current assets | | 49 | | | — | |
FX forward contracts | 2 | | Other non-current assets | | 1 | | | — | |
Commodity contracts | 2 | | Other non-current assets | | 1 | | | 2 | |
| | | | | | | |
Liabilities: | | | | | | | |
Interest rate contracts | 2 | | Other current liabilities | | $ | 58 | | | $ | — | |
FX forward contracts | 2 | | Other current liabilities | | — | | | 2 | |
Commodity contracts | 2 | | Other current liabilities | | 51 | | | 28 | |
Interest rate contracts | 2 | | Other non-current liabilities | | 194 | | | 5 | |
FX forward contracts | 2 | | Other non-current liabilities | | — | | | 9 | |
Commodity contracts | 2 | | Other non-current liabilities | | 1 | | | 1 | |
Designated as Hedging Instruments
The following table summarizes the fair value hierarchy and the location of the fair value of the Company's derivative instruments which are designated as hedging instruments within the Consolidated Balance Sheets:
| | | | | | | | | | | | | | | | | | | | |
| | | | December 31, |
(in millions) | | Balance Sheet Location | | 2022 | | 2021 |
Assets: | | | | | | |
FX contracts | | Prepaid expenses and other current assets | | $ | 21 | | | $ | 6 | |
FX contracts | | Other non-current assets | | 1 | | | 1 | |
| | | | | | |
Interest rate contracts | | Other non-current assets | | 88 | | | — | |
| | | | | | |
Liabilities: | | | | | | |
FX contracts | | Other current liabilities | | $ | 3 | | | $ | 1 | |
| | | | | | |
Interest rate contracts | | Other current liabilities | | — | | | 8 | |
| | | | | | |
Interest rate contracts | | Other non-current liabilities | | — | | | 128 | |
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
IMPACT OF DERIVATIVE INSTRUMENTS NOT DESIGNATED AS HEDGING INSTRUMENTS
The following table presents the amount of (gains) losses recognized in the Consolidated Statements of Income related to derivative instruments not designated as hedging instruments under U.S. GAAP during the periods presented. Amounts include both realized and unrealized gains and losses.
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | For the Year Ended December 31, |
(in millions) | | Income Statement Location | | 2022 | | 2021 | | 2020 |
Interest rate contracts | | Interest expense | | $ | 231 | | | $ | (25) | | | $ | 7 | |
Interest rate contracts | | Loss on early extinguishment of debt | | 31 | | | — | | | — | |
FX forward contracts | | Cost of sales | | (7) | | | 4 | | | (6) | |
FX forward contracts | | Other expense (income), net | | (9) | | | — | | | 6 | |
Commodity contracts | | Cost of sales | | 12 | | | (148) | | | (35) | |
Commodity contracts | | SG&A expenses | | (46) | | | (60) | | | 22 | |
IMPACT OF CASH FLOW HEDGES
The following table presents the amount of (gains) losses, net, reclassified from AOCI into the Consolidated Statements of Income related to derivative instruments designated as cash flow hedging instruments during the periods presented:
| | | | | | | | | | | | | | | | | | | | | | | |
| | | For the Year Ended December 31, |
(in millions) | Income Statement Location | | 2022 | | 2021 | | 2020 |
Interest rate contracts | Interest expense | | $ | (6) | | | $ | — | | | $ | — | |
FX contracts | Cost of sales | | 5 | | | 18 | | | 2 | |
KDP expects to reclassify approximately $8 million and $15 million of pre-tax net gains from AOCI into net income during the next twelve months related to interest rate contracts and FX contracts, respectively.
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
6. Leases
The following table presents the components of lease cost:
| | | | | | | | | | | | | | | | | |
| For the Year Ended December 31, |
(in millions) | 2022 | | 2021 | | 2020 |
Operating lease cost | $ | 137 | | | $ | 121 | | | $ | 113 | |
Finance lease cost | | | | | |
Amortization of right-of-use assets | 76 | | | 63 | | | 47 | |
Interest on lease liabilities | 23 | | | 18 | | | 14 | |
Variable lease cost(1) | 35 | | | 31 | | | 27 | |
Short-term lease cost | 2 | | | — | | | 1 | |
Sublease income | — | | | (1) | | | (2) | |
Total lease cost | $ | 273 | | | $ | 232 | | | $ | 200 | |
(1)Variable lease cost primarily consists of common area maintenance costs, property taxes, and adjustments for inflation.
The following table presents supplemental cash flow and other information about the Company's leases:
| | | | | | | | | | | | | | | | | |
| For the Year Ended December 31, |
(in millions) | 2022 | | 2021 | | 2020 |
Cash paid for amounts included in the measurement of lease liabilities: | | | | | |
Operating cash flows from operating leases | $ | 125 | | | $ | 113 | | | $ | 103 | |
Operating cash flows from finance leases | 23 | | | 18 | | | 14 | |
Financing cash flows from finance leases | 90 | | | 54 | | | 52 | |
Right-of-use assets obtained in exchange for lease obligations: | | | | | |
Operating leases | $ | 320 | | | $ | 293 | | | $ | 234 | |
Finance leases | 104 | | | 408 | | | 90 | |
The following table presents information about the Company's weighted average discount rate and remaining lease term:
| | | | | | | | | | | |
| December 31, |
| 2022 | | 2021 |
Weighted average discount rate | | | |
Operating leases | 5.0 | % | | 4.3 | % |
Finance leases | 3.7 | % | | 3.6 | % |
Weighted average remaining lease term | | | |
Operating leases | 11 years | | 12 years |
Finance leases | 9 years | | 10 years |
SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS
Future minimum lease payments under non-cancellable leases as of December 31, 2022 were as follows:
| | | | | | | | | | | |
(in millions) | Operating Leases | | Finance Leases |
2023 | $ | 128 | | | $ | 119 | |
2024 | 132 | | | 114 | |
2025 | 124 | | | 109 | |
2026 | 115 | | | 146 | |
2027 | 94 | | | 59 | |
Thereafter | 585 | | | 299 | |
Total future minimum lease payments | 1,178 | | | 846 | |
Less: imputed interest | (275) | | | (133) | |
Present value of minimum lease payments | $ | 903 | | | $ | 713 | |
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
SIGNIFICANT LEASES THAT HAVE NOT YET COMMENCED
As of December 31, 2022, the Company has entered into leases that have not yet commenced with estimated aggregated future lease payments of approximately $220 million. These leases will commence between 2023 and 2025, with initial lease terms ranging from 4 to 10 years.
ASSET SALE-LEASEBACK TRANSACTIONS
Transactions with Special Purpose Entities with Same Sponsor
The Company has entered into a number of asset sale-leaseback transactions with the same sponsor, the Veyron SPEs. The following table presents details of the transactions. Gains on the sale-leasebacks are recorded in Other operating income, net, and the leasebacks are accounted for as operating leases.
| | | | | | | | | | | | | | | | | | | | |
(in millions) | | Sale Proceeds | | Carrying Value | | Gain on Sale |
2022 | | | | | | |
March 31, 2022(1) | | $ | 77 | | | $ | 39 | | | $ | 38 | |
November 30, 2022(2) | | 26 | | | 12 | | | 14 | |
December 14, 2022(3) | | 65 | | | 35 | | | 30 | |
2021 | | | | | | |
December 29, 2021(4) | | 102 | | | 32 | | | 70 | |
2020 | | | | | | |
January 6, 2020(5) | | 150 | | | 131 | | | 19 | |
(1)The sale-leaseback transaction included one manufacturing property and one distribution property.
(2)The sale-leaseback transaction included one manufacturing property and one multipurpose property.
(3)The sale-leaseback transaction included one distribution property.
(4)The sale-leaseback transaction included two manufacturing properties and two distribution properties.
(5)The sale-leaseback transaction included two manufacturing properties.
The initial term of each leaseback is 15 years, with two 10-year renewal options. The renewal options are not reasonably assured as (i) the Company's position that the dynamic environment in which it operates precludes the Company's ability to be reasonably certain of exercising the renewal options in the distant future and (ii) the options are contingent on the Company remaining investment grade and no change-in-control as of the end of the lease term. Each leaseback has a RVG. Refer to Note 19 for additional information about RVGs associated with asset sale-leaseback transactions.
Others
The Company has additionally entered into an asset sale-leaseback transaction with another entity. The following table presents details of the transaction. The gain on the sale-leaseback is recorded in Other operating income, net, and the leaseback is accounted for as an operating lease.
| | | | | | | | | | | | | | | | | | | | |
| | Sale Proceeds | | Carrying Value | | Gain on Sale |
| | | | | | |
January 10, 2020(1) | | $ | 50 | | | $ | 27 | | | $ | 23 | |
(1)The sale-leaseback transaction included two distribution properties. The initial term of the leaseback is five years and has two three-year renewal options.
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
7. Segments
Effective January 1, 2022, the Company updated its presentation of certain of KDP's corporate costs, primarily related to IT, to be aligned among the Company's segments and to more consistently reflect controllable costs at the segment level. The prior period segment disclosures reflect the revised presentation.
Effective January 1, 2021, the Company modified its internal reporting and operating segments to reflect changes in the executive leadership team to further enhance speed-to-market and decision effectiveness. These changes did not change the Company’s reportable segments.
As of December 31, 2022 and 2021 and for the years ended December 31, 2022, 2021 and 2020, the Company's reportable segments consist of the following:
•The Coffee Systems segment reflects sales in the U.S. and Canada of the manufacture and distribution of finished goods relating to the Company's coffee system, K-Cup pods and brewers.
•The Packaged Beverages segment reflects sales in the U.S. and Canada from the manufacture and distribution of finished beverages and other products, including sales of the Company's own brands and third-party brands, through both the DSD and WD systems. DSD and WD have both been identified as operating segments that the Company aggregated into Packaged Beverages due to similar economic characteristics and similarities in the nature of finished goods sales and route-to-markets.
•The Beverage Concentrates segment reflects sales of the Company's branded concentrates and syrup to third-party bottlers primarily in the U.S. and Canada. Most of the brands in this segment are CSD brands. Our FFS operating segment is aggregated with our Branded Concentrates operating segment into our Beverage Concentrates reportable segment due to similar economic characteristics and similarities in the nature of the product sold.
•The Latin America Beverages segment reflects sales in Mexico, the Caribbean, and other international markets from the manufacture and distribution of concentrates, syrup and finished beverages.
Segment results are based on management reports. Net sales and income from operations are the significant financial measures used to assess the operating performance of the Company's operating segments. Intersegment sales are recorded at cost and are eliminated in the Consolidated Statements of Income. “Unallocated corporate costs” are excluded from the Company's measurement of segment performance and include unrealized commodity derivative gains and losses, and certain general corporate expenses.
Information about the Company's operations by reportable segment is as follows:
| | | | | | | | | | | | | | | | | |
| For the Year Ended December 31, |
(in millions) | 2022 | | 2021 | | 2020 |
Net sales | | | | | |
Coffee Systems | $ | 4,982 | | | $ | 4,716 | | | $ | 4,433 | |
Packaged Beverages | 6,607 | | | 5,882 | | | 5,363 | |
Beverage Concentrates | 1,725 | | | 1,486 | | | 1,325 | |
Latin America Beverages | 743 | | | 599 | | | 497 | |
Total net sales | $ | 14,057 | | | $ | 12,683 | | | $ | 11,618 | |
| | | | | |
Income from operations | | | | | |
Coffee Systems | $ | 1,316 | | | $ | 1,446 | | | $ | 1,398 | |
Packaged Beverages | 1,014 | | | 1,023 | | | 835 | |
Beverage Concentrates | 1,061 | | | 1,047 | | | 935 | |
Latin America Beverages | 158 | | | 133 | | | 105 | |
Unallocated corporate costs | (944) | | | (755) | | | (793) | |
Income from operations | $ | 2,605 | | | $ | 2,894 | | | $ | 2,480 | |
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
| | | | | | | | | | | |
| December 31, |
(in millions) | 2022 | | 2021 |
Identifiable operating assets | | | |
Coffee Systems | $ | 15,830 | | | $ | 15,397 | |
Packaged Beverages | 11,870 | | | 11,819 | |
Beverage Concentrates | 20,495 | | | 20,674 | |
Latin America Beverages | 1,885 | | | 1,763 | |
Segment total | 50,080 | | | 49,653 | |
Unallocated corporate assets | 757 | | | 915 | |
Total identifiable operating assets | 50,837 | | | 50,568 | |
Investments in unconsolidated affiliates | 1,000 | | | 30 | |
Total assets | $ | 51,837 | | | $ | 50,598 | |
GEOGRAPHIC DATA
The following table presents information about the Company's operations by geographic region:
| | | | | | | | | | | | | | | | | |
| For the Year Ended December 31, |
(in millions) | 2022 | | 2021 | | 2020 |
Net sales | | | | | |
U.S. | $ | 12,454 | | | $ | 11,267 | | | $ | 10,318 | |
International | 1,603 | | | 1,416 | | | 1,300 | |
Net sales | $ | 14,057 | | | $ | 12,683 | | | $ | 11,618 | |
| | | | | | | | | | | |
| December 31, |
(in millions) | 2022 | | 2021 |
Property, plant and equipment, net | | | |
U.S. | $ | 2,088 | | | $ | 2,084 | |
International | 403 | | | 410 | |
Total property, plant and equipment, net | $ | 2,491 | | | $ | 2,494 | |
MAJOR CUSTOMER
Walmart is considered a major customer, accounting for more than 10% of the Company's total net sales, and is represented in all four of the Company’s reportable segments. The following table provides KDP’s net sales to Walmart:
| | | | | | | | | | | | | | | | | |
| For the Year Ended December 31, |
(in millions) | 2022 | | 2021 | | 2020 |
Net sales | | | | | |
Walmart | $ | 2,184 | | | $ | 1,989 | | | $ | 1,782 | |
Additionally, customers in the Company's Beverage Concentrates segment buy concentrate from the Company, which is used in finished goods sold by the Company's third party bottlers to Walmart. These indirect sales further increase the concentration of risk associated with the Company's consolidated net sales as it relates to Walmart.
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
8. Revenue Recognition
The following table disaggregates the Company's revenue by portfolio:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(in millions) | Coffee Systems | | Packaged Beverages | | Beverage Concentrates | | Latin America Beverages | | Total |
For the Year Ended December 31, 2022 | | | | | | | | | |
CSD(1) | $ | — | | | $ | 3,193 | | | $ | 1,700 | | | $ | 542 | | | $ | 5,435 | |
NCB(1) | — | | | 2,993 | | | 14 | | | 201 | | | 3,208 | |
K-cup pods(2) | 3,772 | | | — | | | — | | | — | | | 3,772 | |
Appliances | 923 | | | — | | | — | | | — | | | 923 | |
Other | 287 | | | 421 | | | 11 | | | — | | | 719 | |
Net sales | $ | 4,982 | | | $ | 6,607 | | | $ | 1,725 | | | $ | 743 | | | $ | 14,057 | |
| | | | | | | | | |
For the Year Ended December 31, 2021 | | | | | | | | | |
CSD(1) | $ | — | | | $ | 2,825 | | | $ | 1,463 | | | $ | 435 | | | $ | 4,723 | |
NCB(1) | — | | | 2,617 | | | 11 | | | 163 | | | 2,791 | |
K-cup pods(2) | 3,546 | | | — | | | — | | | — | | | 3,546 | |
Appliances | 907 | | | — | | | — | | | — | | | 907 | |
Other | 263 | | | 440 | | | 12 | | | 1 | | | 716 | |
Net sales | $ | 4,716 | | | $ | 5,882 | | | $ | 1,486 | | | $ | 599 | | | $ | 12,683 | |
| | | | | | | | | |
For the Year Ended December 31, 2020 | | | | | | | | | |
CSD(1) | $ | — | | | $ | 2,489 | | | $ | 1,304 | | | $ | 361 | | | $ | 4,154 | |
NCB(1) | — | | | 2,477 | | | 10 | | | 135 | | | 2,622 | |
K-cup pods(2) | 3,369 | | | — | | | — | | | — | | | 3,369 | |
Appliances | 850 | | | — | | | — | | | — | | | 850 | |
Other | 214 | | | 397 | | | 11 | | | 1 | | | 623 | |
Net sales | $ | 4,433 | | | $ | 5,363 | | | $ | 1,325 | | | $ | 497 | | | $ | 11,618 | |
(1)Represents net sales of owned and partner brands within the Company's portfolio.
(2)Represents net sales from owned brands, partner brands and private label owners. Net sales for partner brands and private label owners are contractual and long term in nature.
9. Earnings Per Share
The following table presents the Company's basic and diluted EPS and shares outstanding. Anti-dilutive stock-based awards excluded from the calculations of diluted EPS were immaterial during the periods presented.
| | | | | | | | | | | | | | | | | |
| For the Year Ended December 31, |
(in millions, except per share data) | 2022 | | 2021 | | 2020 |
Net income attributable to KDP | $ | 1,436 | | | $ | 2,146 | | | $ | 1,325 | |
| | | | | |
Weighted average common shares outstanding | 1,416.8 | | | 1,415.7 | | | 1,407.2 | |
Dilutive effect of stock-based awards | 11.7 | | | 12.2 | | | 14.9 | |
Weighted average common shares outstanding and common stock equivalents | 1,428.5 | | | 1,427.9 | | | 1,422.1 | |
| | | | | |
Basic EPS | $ | 1.01 | | | $ | 1.52 | | | $ | 0.94 | |
Diluted EPS | $ | 1.01 | | | $ | 1.50 | | | $ | 0.93 | |
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
10. Employee Benefit Plans
DEFINED BENEFIT PENSION PLANS
Overview
The Company has several non-contributory defined benefit plans, each having a measurement date of December 31. To participate in the defined benefit plans, eligible employees must have been employed by the Company for at least one year. Employee benefit plan obligations and expenses included in the Company's consolidated financial statements are determined using actuarial analyses based on plan assumptions including employee demographic data such as years of service and compensation, benefits and claims paid and employer contributions, among others. The Company also participates in various multi-employer defined benefit plans.
The Company's largest U.S. defined benefit pension plan, which is a cash balance plan, was suspended and the accrued benefit was frozen effective December 31, 2008. Participants in this plan no longer earn additional benefits for future services or salary increases. The cash balance plans maintain individual record-keeping accounts for each participant, which are annually credited with interest credits equal to the 12-month average of one-year U.S. Treasury Bill rates, plus 1%, with a required minimum rate of 5%.
Financial Statement Impact
The following table sets forth amounts recognized in the Company's financial statements and the pension plans' funded status:
| | | | | | | | | | | |
| As of December 31, |
(in millions) | 2022 | | 2021 |
Projected Benefit Obligations | | | |
Beginning balance | $ | 215 | | | $ | 228 | |
Service cost | 4 | | | 4 | |
Interest cost | 7 | | | 6 | |
Actuarial losses, net | (53) | | | (9) | |
Benefits paid | (4) | | | (5) | |
Impact of changes in FX rates | 1 | | | — | |
Plan amendments | 3 | | | — | |
Settlements | (14) | | | (9) | |
Ending balance | $ | 159 | | | $ | 215 | |
| | | |
Fair Value of Plan Assets | | | |
Beginning balance | $ | 190 | | | $ | 203 | |
Actual return on plan assets | (49) | | | 1 | |
Employer contributions | 3 | | | — | |
Benefits paid | (4) | | | (5) | |
| | | |
Settlements | (14) | | | (9) | |
Ending balance | $ | 126 | | | $ | 190 | |
| | | |
Net liability recognized | $ | (33) | | | $ | (25) | |
Non-current assets | $ | 2 | | | $ | 14 | |
Current liability | (1) | | | (1) | |
Non-current liability | (34) | | | (38) | |
The accumulated benefit obligations for the defined benefit pension plans were $156 million and $195 million as of December 31, 2022 and 2021. The pension plan assets and the projected benefit obligations of KDP's U.S. pension plans represent approximately 98% of the total plan assets and 92% of the total projected benefit obligation of all plans combined as of December 31, 2022.
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
The following table summarizes key pension plan information regarding plans whose accumulated benefit obligations exceed the fair value of their respective plan assets:
| | | | | | | | | | | |
| As of December 31, |
(in millions) | 2022 | | 2021 |
Aggregate projected benefit obligation | $ | 81 | | | $ | 104 | |
Aggregate accumulated benefit obligation | 78 | | | 101 | |
Aggregate fair value of plan assets | 45 | | | 65 | |
The following table summarizes the components of the Company's net periodic benefit cost:
| | | | | | | | | | | | | | | | | |
| For the Year Ended December 31, |
(in millions) | 2022 | | 2021 | | 2020 |
Service cost | $ | 4 | | | $ | 4 | | | $ | 3 | |
Interest cost | 7 | | | 6 | | | 7 | |
Expected return on assets | (7) | | | (8) | | | (8) | |
| | | | | |
Settlements | (1) | | | (1) | | | (1) | |
Total net periodic benefit costs | $ | 3 | | | $ | 1 | | | $ | 1 | |
The Company uses the corridor approach for amortization of actuarial gains or losses. The corridor is calculated as 10% of the greater of the plans’ projected benefit obligation or assets. The amortization period for plans with active participants is the average future service of covered active employees, and the amortization period for plans with no active participants is the average future lifetime of plan participants. The estimated service costs or net actuarial losses for the defined benefit pension plans amortized from AOCI into periodic benefit cost in 2023 are expected to be insignificant.
The following table summarizes amounts included in AOCI for the Company’s defined benefit plans:
| | | | | | | | | | | |
| As of December 31, |
(in millions) | 2022 | | 2021 |
Net actuarial loss | $ | 6 | | | $ | 2 | |
Prior service cost | 3 | | | — | |
Total | $ | 9 | | | $ | 2 | |
Contributions and Expected Benefit Payments
The Company's contributions to its pension plans for the years ended December 31, 2022, 2021 and 2020, and its projected contributions for the year ended December 31, 2023, are insignificant.
The following table summarizes the estimated future benefit payments for the Company's defined benefit plans:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(in millions) | 2023 | | 2024 | | 2025 | | 2026 | | 2027 | | 2028-2032 |
Estimated future benefit payments | $ | 11 | | | $ | 11 | | | $ | 12 | | | $ | 12 | | | $ | 12 | | | $ | 62 | |
Actuarial Assumptions
The Company's pension expense was calculated based upon a number of actuarial assumptions including discount rates, retirement age, mortality rates, compensation rate increases and expected long-term rate of return on plan assets for pension benefits.
The discount rate that was utilized for determining the Company’s projected benefit obligations as of December 31, 2022 and 2021, as well as projected 2023 net periodic benefit cost, for U.S. plans was selected based upon an interest rate yield curve. The yield curve is constructed based on the yields of a large number of U.S. Aa rated bonds as of December 31, 2022. The population of bonds utilized to calculate the discount rate includes those having an average yield between the 10th and 90th percentiles. Projected cash flows from the U.S. plans are then matched to spot rates along that yield curve in order to determine their present value and a single equivalent discount rate is calculated that produces the same present value as the spot rates.
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
Expected mortality is a key assumption in the measurement for pension benefit obligations. For KDP's U.S. plans, the Company used the Pri-2012 mortality tables and the Mortality Improvement Scale MP-2020 published by the Society of Actuaries’ Retirement Plans Experience Committee for each of the years ended December 31, 2022 and 2021.
The following table summarizes the weighted-average assumptions used to determine benefit obligations at the plan measurement dates for U.S. plans:
| | | | | | | | | | | |
| As of December 31, |
| 2022 | | 2021 |
Weighted average discount rate | 5.40 | % | | 2.85 | % |
Rate of increase in compensation levels | 3.00 | % | | 3.00 | % |
The following table summarizes the weighted average actuarial assumptions used to determine the net periodic benefit costs for U.S. plans:
| | | | | | | | | | | | | | | | | |
| For the Year Ended December 31, |
| 2022 | | 2021 | | 2020 |
Weighted average discount rate | 5.40 | % | | 2.55 | % | | 3.30 | % |
Rate of increase in compensation levels | 3.00 | % | | 3.00 | % | | 3.00 | % |
Expected long-term rate of return | 6.00 | % | | 4.00 | % | | 4.00 | % |
For the years ended December 31, 2022, 2021 and 2020, the expected long-term rate of return on U.S. pension fund assets held by the Company's pension trusts was determined based on several factors, including the impact of active portfolio management and projected long-term returns of broad equity and bond indices. The plans' historical returns were also considered. The expected long-term rate of return on the assets in the plans was based on an asset allocation assumption for fixed income and equity as follows:
| | | | | | | | | | | | | | | | | |
| For the Year Ended December 31, |
| 2022 | | 2021 | | 2020 |
Fixed income securities: | | | | | |
Asset allocation assumption | 80 | % | | 80 | % | | 80 | % |
Expected long-term rate of return | 6.0 | % | | 3.4 | % | | 3.4 | % |
| | | | | |
Equity securities: | | | | | |
Asset allocation assumption | 20 | % | | 20 | % | | 20 | % |
Expected long-term rate of return | 6.0 | % | | 6.5 | % | | 7.4 | % |
Investment Policy and Strategy
The Company has established formal investment policies for the assets associated with defined benefit pension plans. The Company's investment policy and strategy are mandated by the Company's Investment Committee. The overriding investment objective is to provide for the availability of funds for pension obligations as they become due, to maintain an overall level of financial asset adequacy and to maximize long-term investment return consistent with a reasonable level of risk. The Company's pension plan investment strategy includes the use of actively-managed securities. Investment performance both by investment manager and asset class is periodically reviewed, as well as overall market conditions with consideration of the long-term investment objectives. None of the plan assets are invested directly in equity or debt instruments issued by the Company. It is possible that insignificant indirect investments exist through its equity holdings. The equity and fixed income investments under the Company's sponsored pension plan assets are currently well diversified. The plans' asset allocation policy is reviewed at least annually. Factors considered when determining the appropriate asset allocation include changes in plan liabilities, an evaluation of market conditions, tolerance for risk and cash requirements for benefit payments. As of December 31, 2022 and 2021, the Company was in compliance with the investment policy for the U.S. defined benefit pension plans, which contains allowable ranges in asset mix of 5-15% for U.S. equity securities, 5-15% for international equity securities, and 70-90% for fixed income securities.
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
PRMB PLANS
The Company has several non-contributory defined benefit PRMB plans, each having a measurement date of December 31. The majority of these PRMB plans have been frozen. To participate in the defined benefit plans, eligible employees must have been employed by the Company for at least one year. The PRMB plans are limited to qualified expenses and are subject to deductibles, co-payment provisions and other provisions. The Company's PRMB plans are not significant to the Company's consolidated financial statements as of December 31, 2022 and 2021.
FAIR VALUE OF THE PENSION AND PRMB ASSETS
The fair value hierarchy is not only applicable to assets and liabilities that are included in the Company's Consolidated Balance Sheets, but is also applied to certain other assets that indirectly impact the Company's consolidated financial statements. Assets contributed by the Company to pension or other PRMB plans become the property of the individual plans. Even though the Company no longer has control over these assets, we are indirectly impacted by subsequent fair value adjustments to these assets. The actual return on these assets impacts the Company's future net periodic benefit cost, as well as amounts recognized in the Company's Consolidated Balance Sheets. As such, the Company uses the fair value hierarchy to measure the fair value of assets held by the Company's various pension and PRMB plans.
The following tables present the major categories of plan assets and the respective fair value hierarchy for the pension and PRMB plan assets:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | Fair Value Measurement as of December 31, |
| | | 2022 | | 2021 |
(in millions) | Fair Value Hierarchy Level | | Pension Assets | | PRMB Assets | | Pension Assets | | PRMB Assets |
Cash and cash equivalents | Level 1 | | $ | 3 | | | $ | — | | | $ | 4 | | | $ | — | |
U.S. equity securities(1)(2) | Level 2 | | 15 | | | — | | | 21 | | | 1 | |
International equity securities(1)(2) | Level 2 | | 5 | | | 6 | | | 11 | | | 8 | |
Fixed income securities(3) | Level 2 | | 103 | | | 1 | | | 154 | | | 1 | |
Total | | | $ | 126 | | | $ | 7 | | | $ | 190 | | | $ | 10 | |
(1)Equity securities are comprised of actively managed U.S. and international index funds.
(2)The NAV is based on the fair value of the underlying assets owned by the equity index fund or fixed income investment vehicle per share, multiplied by the number of units held as of the measurement date.
(3)Fixed income securities are comprised of domestic and international corporate bonds and U.S. government securities. Investments are provided by the investment managers using a unit price or NAV based on the fair value of the underlying investments.
MULTI-EMPLOYER PLANS
The Company has three multi-employer plans, which are trustee-managed multi-employer defined benefit pension plans for union-represented employees under certain collective bargaining agreements. The risks of participating in these multi-employer plans are different from single-employer plans, as assets contributed to the multi-employer plan by one employer may be used to provide benefits to employees of other participating employers. Additionally, if a participating employer stops contributing to the plan, the unfunded obligations of the plan may be borne by the remaining participating employers.
Contributions paid into the multi-employer plans are expensed as incurred. Multi-employer plan expenses were $5 million, $5 million and $7 million for the years ended December 31, 2022, 2021 and 2020, respectively.
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
Individually Significant Multi-Employer Plan
The Company participates in one multi-employer plan, Central States, which is considered to be individually significant. The following table presents information about Central States as of December 31, 2022:
| | | | | |
Plan's employer identification number | 36-6044243 |
Plan number | 001 |
Expiration dates of collective bargaining agreements(1) | May 6, 2023 through March 20, 2025 |
Financial Improvement Plan/Rehabilitation Plan status pending/implemented | Implemented |
Pension Protection Act zone status | Red |
Surcharge imposed | Yes |
(1)Central States includes seven collective bargaining agreements. The largest agreement, which is set to expire January 20, 2025, covers approximately 56% of the employees included in Central States. One of the collective bargaining agreements is set to expire during 2023, covering approximately 6% of the employees included in Central States.
The most recent Pension Protection Act zone status available as of December 31, 2022 is for the plan's year-end as of December 31, 2021. Central States has not utilized any extended amortization provisions that affect the calculation of the zone status.
The Company's contributions to Central States did not exceed 5% of the total contributions made to Central States for the years ended December 31, 2022, 2021 and 2020.
Future estimated contributions to Central States based on the number of covered employees and the terms of the collective bargaining agreements are as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(in millions) | 2023 | | 2024 | | 2025 | | 2026 | | 2027 |
Future estimated contributions to Central States | $ | 2 | | | $ | 2 | | | $ | 2 | | | $ | 2 | | | $ | 2 | |
DEFINED CONTRIBUTION PLANS
The Company sponsors various qualified defined contribution plans that cover U.S. and foreign based employees who meet certain eligibility requirements. The U.S. plans permit both pre-tax and after-tax contributions, which are subject to limitations imposed by IRS regulations. The Company makes matching contributions and discretionary profit sharing contributions to these plans. The Company incurred contribution expense of $61 million, $73 million and $77 million to the defined contribution plan for the years ended December 31, 2022, 2021 and 2020, respectively.
The Company also sponsors a non-qualified defined contribution plan for employees which is maintained in a rabbi trust and are not readily available to the Company. Although participants direct the investment of these funds, the investments are classified as trading securities and are included in other non-current assets. As such, the Company uses the fair value hierarchy to measure the fair value of these trading securities as follows:
| | | | | | | | | | | | | | | | | |
| | | As of December 31, |
(in millions) | Fair Value Hierarchy | | 2022 | | 2021 |
Marketable securities - trading | Level 1 | | $ | 30 | | | $ | 43 | |
The corresponding liability related to the deferred defined compensation plan is recorded in other non-current liabilities. Gains and losses in connection with these trading securities are recorded in Other expense (income), net with an offset for the same amount recorded in SG&A expenses. There were $8 million in losses, as well as $5 million and $8 million in gains associated with these trading securities during the years ended December 31, 2022, 2021 and 2020, respectively.
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
11. Stock-Based Compensation
Stock-based compensation expense is primarily recorded in SG&A expenses in the Consolidated Statements of Income. The components of stock-based compensation expense are presented below:
| | | | | | | | | | | | | | | | | |
| For the Year Ended December 31, |
(in millions) | 2022 | | 2021 | | 2020 |
Total stock-based compensation expense(1) | $ | 52 | | | $ | 88 | | | $ | 85 | |
Income tax benefit recognized in the Consolidated Statements of Income | (7) | | | (14) | | | (13) | |
Stock-based compensation expense, net of tax | $ | 45 | | | $ | 74 | | | $ | 72 | |
(1)Effective January 1, 2022, the Company changed its accounting policy for stock-based compensation expense with respect to forfeitures. The cumulative effect of this change resulted in a one-time reduction in stock-based compensation expense of $40 million recognized in the first quarter of 2022. Refer to Note 2 for additional information.
DESCRIPTION OF STOCK-BASED COMPENSATION PLANS
The Company previously adopted the 2009 Incentive Plan, under which employees and non-employee directors could be granted stock options, stock appreciation rights, stock awards, RSUs and PSUs, and grants subsequent to the DPS Merger were granted under the 2009 Incentive Plan. During the year ended December 31, 2019, the Company adopted the 2019 Incentive Plan, which expires in 2029 and otherwise contains substantially similar provisions as the 2009 Incentive Plan.
RSUs generally vest on the following schedule:
| | | | | | | | |
Period Granted | | Vesting Terms |
| | |
RSUs granted after the DPS Merger through 2019 | | 5-year term with cliff-vesting at the end of the term |
RSUs granted during 2020, 2021, and 2022 | | 5-year term with graded vesting as follows: 0% in year 1, 0% in year 2, 60% in year 3, 20% in year 4, 20% in year 5 |
However, from time to time, the Company grants RSUs outside of the normal grant cycle which have different terms and vesting conditions. For all RSU grants, the Company recognizes the expense ratably over the vesting period.
During the year ended December 31, 2020, the Company modified the terms of one RSU grant to a named executive officer. A grant of 868,056 RSUs with a five-year vesting term which were previously granted in September 2020 were forfeited, and a corresponding grant of 651,042 PSUs and 217,014 RSUs were granted. The PSUs will vest three years from the beginning date of a predetermined performance period, to the extent that the Company has achieved the performance criteria during the performance period. The performance criteria for the modified award includes a specified market condition which compares total shareholder return to that of certain indices. Additionally, the PSUs are required to be held by the grantee for one year after the awards have vested. The RSUs will vest ratably over a three-year term. As a result of the award modification, no incremental compensation expense will be recognized over the life of the award.
The Company's aforementioned incentive plans provide for the issuance of up to an aggregate of 27,425,720 shares of the Company's common stock in stock-based compensation awards.
RESTRICTED SHARE UNITS
The table below summarizes RSU activity for the year ended December 31, 2022:
| | | | | | | | | | | | | | | | | | | | | | | |
| RSUs | | Weighted Average Grant Date Fair Value | | Weighted Average Remaining Contractual Term (Years) | | Aggregate Intrinsic Value (in millions) |
Balance as of December 31, 2021 | 18,808,491 | | | $ | 25.74 | | | 2.2 | | $ | 693 | |
Granted | 4,035,861 | | | 35.76 | | | — | | | — | |
Vested and released | (1,123,292) | | | 24.66 | | | — | | | 42 | |
Forfeited | (3,682,315) | | | 28.59 | | | — | | | — | |
Balance as of December 31, 2022 | 18,038,745 | | | 27.46 | | | 1.6 | | 643 | |
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
The weighted average grant date fair value for RSUs granted for the years ended December 31, 2022, 2021 and 2020 was $35.76, $28.83 and $24.91, respectively. The aggregate intrinsic value of the RSUs vested and released for the years ended December 31, 2022, 2021 and 2020 was $42 million, $333 million and $3 million, respectively.
As of December 31, 2022, there was $192 million of unrecognized compensation cost related to unvested RSUs that is expected to be recognized over a weighted average period of 3.1 years.
PERFORMANCE SHARE UNITS
In 2020, the Compensation Committee of the Board approved a PSU plan in connection with the aforementioned award modification. Each PSU is equivalent in value to one share of the Company's common stock. The maximum payout percentage for all PSUs granted by the Company is 100%.
The PSUs that are subject to the market condition are valued using a Monte Carlo simulation model, which requires certain assumptions, including the risk-free interest rate, expected volatility, and the estimated dividend yield. The risk-free interest rate used in the Monte Carlo simulation model is based on zero-coupon yields implied by U.S. Treasury issues with remaining terms similar to the performance period on the PSUs. The performance period of the PSUs represents the period of time between the PSU grant date and the end of the performance period. Expected volatility is based on historical data of the Company and certain indices over the most recent time period equal to the performance period. For purposes of determining that the aforementioned award modification resulted in no incremental cost, the Monte Carlo simulation assumed a risk-free interest rate of 0.10%, expected volatility of 29.83% and a dividend yield of 2.08%.
The table below summarizes PSU activity for the year ended December 31, 2022:
| | | | | | | | | | | | | | | | | | | | | | | |
| PSUs | | Weighted Average Grant Date Fair Value | | Weighted Average Remaining Contractual Term (Years) | | Aggregate Intrinsic Value (in millions) |
Balance as of December 31, 2021 | 651,042 | | | $ | 28.80 | | | 1.1 | | $ | 24 | |
Granted | — | | | — | | | — | | | — | |
Vested and released | — | | | — | | | — | | | — | |
Forfeited | (214,844) | | | 28.80 | | | — | | | — | |
Balance as of December 31, 2022 | 436,198 | | | 28.80 | | | 0.5 | | 16 |
As of December 31, 2022, there was $6 million of unrecognized compensation cost related to unvested PSUs that is expected to be recognized over a weighted average period of 1.0 year.
STOCK OPTIONS
The table below summarizes stock option activity for the year ended December 31, 2022:
| | | | | | | | | | | | | | | | | | | | | | | |
| Stock Options | | Weighted Average Exercise Price | | Weighted Average Remaining Contractual Term (Years) | | Aggregate Intrinsic Value (in millions) |
Balance as of December 31, 2021 | 193,572 | | | $ | 12.09 | | | 3.7 | | $ | 5 | |
Granted | — | | | — | | | — | | | — | |
Exercised | (17,974) | | | 14.76 | | | — | | | — | |
Outstanding as of December 31, 2022 | 175,598 | | | 11.81 | | | 2.5 | | 4 | |
Exercisable as of December 31, 2022 | 175,598 | | | 11.81 | | | 2.5 | | 4 | |
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
12. Investments and Acquisitions
INVESTMENTS IN UNCONSOLIDATED AFFILIATES
The following table summarizes the Company's investments in unconsolidated affiliates:
| | | | | | | | | | | | | | | | | | | | |
| | | | December 31, |
(in millions) | | Ownership Interest | | 2022 | | 2021 |
| | | | | | |
Nutrabolt | | 29.8 | % | | $ | 874 | | | $ | — | |
Tractor | | 19.2 | % | | 49 | | | — | |
Athletic Brewing(1) | | 13.1 | % | | 51 | | | — | |
Dyla LLC | | 12.4 | % | | 12 | | | 12 | |
Force Holdings LLC(2) | | 33.3 | % | | 4 | | | 5 | |
Beverage startup companies(3) | | (various) | | 5 | | | 8 | |
Other | | (various) | | 5 | | | 5 | |
Investments in unconsolidated affiliates | | | | $ | 1,000 | | | $ | 30 | |
(1)In November 2022, the Company invested $51 million in exchange for a 13.1% ownership interest in Athletic Brewing.
(2)Force Holdings LLC has a 14.1% ownership interest in Dyla LLC.
(3)Beverage startup companies represent equity method investments in development stage entities and may include entities which are pre-revenue, in test markets, or in early operations.
Nutrabolt Investment
In December 2022, the Company invested $871 million, which includes $8 million of incremental third-party costs, in exchange for preferred equity units in Nutrabolt that represent a 29.8% ownership interest on an as-converted basis. The Company will earn the greater of (i) a 5% annual coupon on the preferred equity units plus any accretion for amounts not yet paid or (ii) our share of Nutrabolt’s earnings as if our preferred equity was converted into common units. During the year ended December 31, 2022, the Company recorded preferred dividends of $3 million, which increased the investment balance for Nutrabolt.
Tractor Investment
In May 2022, the Company invested $44 million in exchange for equity interests in Tractor. The Company also issued a $6 million convertible note to Tractor with an annual interest rate of LIBOR + 5% and a term of six months. The convertible note was converted into equity interests during the second quarter of 2022, increasing the Company’s total ownership in Tractor to 19.2%.
BodyArmor Investment
On November 1, 2021, Coca-Cola announced that it had acquired full ownership of BodyArmor for cash consideration of $5.6 billion for the remaining 85% of equity interests that Coca-Cola did not previously own. Prior to the transaction, KDP held an ownership interest in BodyArmor of 12.5% on an undiluted basis, which had a carrying value of approximately $52 million. As a result of BodyArmor’s change in control, KDP’s ownership interest was diluted to 10.6% as a result of the vesting of incentive equity compensation previously granted by BodyArmor to employees, athletes, and endorsers. KDP received cash consideration from the sale of its interests in BodyArmor, net of holdback liabilities, of $576 million on December 15, 2021, resulting in a gain on the sale of the investment of $524 million. This gain was recorded to Gain on sale of investment in the Consolidated Statements of Income.
In January 2022, KDP agreed to a $350 million payment from BodyArmor for a full settlement of all of the claims under the litigation against BodyArmor and in complete satisfaction of the holdback amount owed to ABC in association with the sale of ABC’s equity interest in BodyArmor in 2021. ABC received the settlement payment in January 2022 and the lawsuit was dismissed.
The Company allocated approximately $300 million of the settlement for resolution of the prior litigation, of which $299 million was recorded to Gain on litigation settlement and $1 million was applied against outstanding receivables from BodyArmor. Approximately $28 million of the $299 million gain on litigation settlement was held in unallocated corporate costs as a recovery of legal fees incurred during the litigation process, with the remaining $271 million of the $299 million recorded to our Packaged Beverages segment.
Approximately $50 million of the $350 million payment was allocated to the settlement of the holdback liability, which was recorded to Gain on the sale of our equity method investment.
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
Bedford Investment
The Company has a 30% ownership interest in Bedford, which has a carrying value of $0 as of December 31, 2022 and 2021. In December 2021, the board of directors of Bedford communicated to KDP that it was unable to obtain additional investors, and that Bedford will begin procedures to wind down the company. As part of the wind down procedures, KDP and ABI agreed to together fund a $68 million credit agreement to Bedford. KDP will fund 30% of this loan, in line with the Company’s ownership percentage in Bedford. Approximately $14 million of the Company’s responsibility under this credit agreement has been funded and impaired through December 31, 2022. The Company recorded $12 million and $2 million in impairment losses related to this credit agreement during the years ended December 31, 2022 and 2021, respectively, which are included in the impairment charges described below.
The Company has also issued various promissory notes to Bedford since 2020, which have been fully impaired and placed in non-accrual status. The Company has recorded impairment charges related to its investment and notes receivable in Bedford of $12 million, $17 million, and $86 million during the years ended December 31, 2022, 2021 and 2020, respectively. The impairment charges were recorded on the Impairment of investments and note receivable line in the Consolidated Statements of Income.
LifeFuels Investment
In September 2020, the Company tested its investment in LifeFuels, which is included in the Beverage startup companies line in the table above, for an other-than-temporary impairment as a result of continued losses, ongoing liquidity concerns and a lack of a buyer for LifeFuels. As a result of this analysis, the Company determined that the investment was fully impaired and recorded an impairment charge of approximately $16 million to the Impairment of investments and note receivable line in the Consolidated Statements of Income.
ACQUISITIONS
Revive
On July 31, 2020, the Company closed on a stock purchase agreement to obtain a 66.4% ownership interest in Revive from Peet's for cash consideration of $1, with Peet's retaining a minority ownership interest. Revive is an organic, non-alcoholic kombucha brand, available in both traditional refrigerated and shelf-stable varieties. The transaction was considered a common control transaction due to KDP's relationship with Peet's at the transaction date, through certain affiliates of JAB. The investment was accounted for as an acquisition of a controlling interest, and in accordance with the requirements of U.S. GAAP for common control transactions, KDP recognized all of Revive's assets and liabilities at their carrying values as of July 31, 2020, with the $3 million difference between the Company's ownership interest in the net assets and the purchase price recorded to additional paid-in capital. Refer to Note 1 for the Company's accounting policies with respect to the consolidation of Revive and accounting for the non-controlling interest.
13. Income Taxes
Income before provision for income taxes was as follows:
| | | | | | | | | | | | | | | | | |
| For the Year Ended December 31, |
(in millions) | 2022 | | 2021 | | 2020 |
U.S. | $ | 789 | | | $ | 2,353 | | | $ | 1,367 | |
International | 930 | | | 445 | | | 386 | |
Total | $ | 1,719 | | | $ | 2,798 | | | $ | 1,753 | |
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
The provision for income taxes has the following components: | | | | | | | | | | | | | | | | | |
| For the Year Ended December 31, |
(in millions) | 2022 | | 2021 | | 2020 |
Current: | | | | | |
Federal | $ | 320 | | | $ | 386 | | | $ | 297 | |
State | 97 | | | 136 | | | 103 | |
International | 156 | | | 100 | | | 79 | |
Total current provision | $ | 573 | | | $ | 622 | | | $ | 479 | |
| | | | | |
Deferred: | | | | | |
Federal | $ | (141) | | | $ | 41 | | | $ | (31) | |
State | (147) | | | (8) | | | (6) | |
International | (1) | | | (2) | | | (14) | |
Total deferred provision | (289) | | | 31 | | | (51) | |
Total provision for income taxes | $ | 284 | | | $ | 653 | | | $ | 428 | |
The following is a reconciliation of the provision for income taxes computed at the U.S. federal statutory tax rate to the provision for income taxes reported in the Consolidated Statements of Income:
| | | | | | | | | | | | | | | | | |
| For the Year Ended December 31, |
(in millions) | 2022 | | 2021 | | 2020 |
Statutory federal income tax rate | 21.0 | % | | 21.0 | % | | 21.0 | % |
State income taxes, net | 2.6 | % | | 3.8 | % | | 4.0 | % |
Impact of non-U.S. operations | (2.3) | % | | 0.1 | % | | 0.2 | % |
Tax credits | (3.9) | % | | (0.8) | % | | (1.3) | % |
Valuation allowance for deferred tax assets | — | % | | (0.1) | % | | (1.1) | % |
U.S. taxation of foreign earnings | 3.7 | % | | 0.7 | % | | 1.6 | % |
Deferred rate change | (5.2) | % | | (0.7) | % | | 0.5 | % |
Uncertain tax positions | 0.3 | % | | — | % | | (1.3) | % |
U.S. federal provision to return | (0.1) | % | | (0.3) | % | | 0.1 | % |
Excess tax deductions on stock-based compensation | (0.1) | % | | (1.0) | % | | — | % |
Other | 0.5 | % | | 0.6 | % | | 0.7 | % |
Total provision for income taxes | 16.5 | % | | 23.3 | % | | 24.4 | % |
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
Deferred tax assets and liabilities were comprised of the following:
| | | | | | | | | | | |
| December 31, |
(in millions) | 2022 | | 2021 |
Deferred tax assets: | | | |
Operating lease liability | $ | 226 | | | $ | 166 | |
Net operating losses carryforwards | 36 | | | 43 | |
Tax credit carryforwards | 35 | | | 49 | |
Accrued expenses | 149 | | | 125 | |
Share-based compensation | 41 | | | 32 | |
Multi-year upfront payments | 10 | | | 13 | |
Equity method investments | 48 | | | 50 | |
Other | 69 | | | 41 | |
Total deferred tax assets | 614 | | | 519 | |
Valuation allowances | (47) | | | (48) | |
Total deferred tax assets, net of valuation allowances | $ | 567 | | | $ | 471 | |
Deferred tax liabilities: | | | |
Brands, trade names and other intangible assets | $ | (5,685) | | | $ | (5,909) | |
Property, plant and equipment | (343) | | | (314) | |
Derivative instruments | (9) | | | (18) | |
Right of use assets | (222) | | | (164) | |
Other | (12) | | | (10) | |
Total deferred tax liabilities | (6,271) | | | (6,415) | |
Net deferred tax liabilities | $ | (5,704) | | | $ | (5,944) | |
| | | |
CARRYFORWARDS
As of December 31, 2022 and 2021, the Company had $36 million and $39 million, respectively, in tax-effected Luxembourg net operating loss carry forwards. Of the $36 million of net operating loss carryforwards as of December 31, 2022, $34 million will not expire and $2 million will begin to expire in the year 2034.
As of December 31, 2022, the Company has $34 million of U.S. foreign tax credit carryforwards and $1 million of other carryforwards, primarily related to U.S. state income tax. Foreign tax credits will begin to expire in 2024.
UNDISTRIBUTED INTERNATIONAL EARNINGS
For the tax year ended December 31, 2022, undistributed earnings in non-U.S. subsidiaries for which no deferred taxes have been provided totaled approximately $604 million. An actual repatriation from our non-U.S. subsidiaries could still be subject to additional foreign withholding taxes. The Company has analyzed our global working capital and cash requirements and continues to be indefinitely reinvested in its undistributed earnings except for amounts in excess of its working capital and cash requirements. The Company has recorded any potential withholding tax liabilities, if necessary, attributable to repatriation.
OTHER TAX MATTERS
The Company files income tax returns for U.S. federal purposes and in various state jurisdictions. The Company also files income tax returns in various foreign jurisdictions, principally Canada, Ireland, and Mexico. The U.S. and most state income tax returns for years prior to 2017 are closed to examination by applicable tax authorities. Canadian and Mexican income tax returns are generally open for audit for tax years 2018 and forward.
The Company has a tax holiday in Singapore, whereby the local statutory rate is significantly reduced if certain conditions are met. The tax holiday for Singapore is effective through June 2024. The impact of the tax holiday increased net income by approximately $6 million for each of the years ended December 31, 2022 and 2021, respectively, resulting in no impact to basic and diluted EPS for each of the years ended December 31, 2022 and 2021.
On August 16, 2022, the “Inflation Reduction Act” (H.R. 5376) was signed into law in the United States. The Company does not currently expect the Inflation Reduction Act to have a material impact on KDP’s consolidated financial statements.
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
UNRECOGNIZED TAX BENEFITS
The following is a reconciliation of the changes in the gross balance of unrecognized tax benefits:
| | | | | | | | | | | | | | | | | |
| For the Year Ended December 31, |
(in millions) | 2022 | | 2021 | | 2020 |
Balance, beginning of the period | $ | 12 | | | $ | 18 | | | $ | 43 | |
Increases related to tax positions taken during the current year | 4 | | | 2 | | | 2 | |
(Decreases) increases related to tax positions taken during the prior year | 3 | | | (3) | | | 2 | |
Decreases related to settlements with taxing authorities | (3) | | | (1) | | | (8) | |
Decreases related to lapse of applicable statute of limitations | (1) | | | (4) | | | (21) | |
Balance, end of the period | $ | 15 | | | $ | 12 | | | $ | 18 | |
The total amount of unrecognized tax benefits that would reduce the effective tax rate if recognized is $12 million after considering the federal impact of state income taxes. KDP does not expect a significant change to its unrecognized tax benefits, but it is reasonably possible that a change in the unrecognized tax benefits may occur within the next twelve months related to the settlement of audits or the lapse of applicable statutes of limitations.
KDP accrues interest and penalties on its uncertain tax positions as a component of its provision for income taxes. KDP recognized no expense related to interest and penalties for uncertain tax positions for the year ended December 31, 2022, and recognized expense of $1 million and benefit of $8 million for the years ended December 31, 2021 and 2020, respectively. The Company had a total of $2 million accrued for interest and penalties for its uncertain tax positions reported as part of other non-current liabilities as of both December 31, 2022 and 2021.
14. Restructuring and Integration Costs
DPS Integration Program
As part of the DPS Merger, the Company developed a program to deliver $600 million in synergies over a three-year period through supply chain optimization, reduction of indirect spend through new economies of scale, elimination of duplicative support functions and advertising and promotion optimization. Although the program was initially expected to be completed in 2021, as a result of delays due to COVID-19, KDP continued to recognize expenditures for certain initiatives which began during the integration period through 2022. The restructuring and integration program resulted in cumulative pre-tax charges of approximately $962 million, primarily consisting of professional fees related to the integration and transformation and costs associated with severance and employee terminations, through December 31, 2022.
Restructuring and integration charges incurred on the defined programs during the years ended December 31, 2022, 2021 and 2020 were as follows:
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
(in millions) | 2022 | | 2021 | | 2020 |
DPS Integration program | $ | 172 | | | $ | 202 | | | $ | 200 | |
| | | | | |
| | | | | |
Restructuring liabilities that qualify as exit and disposal costs under U.S. GAAP are included in accounts payable and accrued expenses on the consolidated financial statements. Restructuring liabilities for the DPS Integration Program, all of which were workforce reduction costs, as of December 31, 2022 and 2021 were as follows:
| | | | | |
(in millions) | Workforce Reduction Costs |
Balance as of December 31, 2020 | $ | 14 | |
Charges to expense | 41 | |
Cash payments | (36) | |
| |
Balance as of December 31, 2021 | 19 | |
Charges to expense | 66 | |
Cash payments | (30) | |
| |
Balance as of December 31, 2022 | $ | 55 | |
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
15. Accumulated Other Comprehensive Income (Loss)
The following table provides a summary of changes in AOCI, net of taxes:
| | | | | | | | | | | | | | | | | | | | | | | |
(in millions) | Foreign Currency Translation | | Pension and PRMB Liabilities | | Cash Flow Hedges | | AOCI |
Balance as of December 31, 2019 | $ | 104 | | | $ | — | | | $ | — | | | $ | 104 | |
OCI before reclassifications | (9) | | | (5) | | | (16) | | | (30) | |
Amounts reclassified from AOCI | — | | | 1 | | | 2 | | | 3 | |
Net current period other comprehensive loss | (9) | | | (4) | | | (14) | | | (27) | |
Balance as of December 31, 2020 | 95 | | | (4) | | | (14) | | | 77 | |
OCI before reclassifications | (14) | | | — | | | (102) | | | (116) | |
Amounts reclassified from AOCI | — | | | — | | | 13 | | | 13 | |
Net current period other comprehensive loss | (14) | | | — | | | (89) | | | (103) | |
Balance as of December 31, 2021 | 81 | | | (4) | | | (103) | | | (26) | |
OCI before reclassifications | (167) | | | (6) | | | 329 | | | 156 | |
Amounts reclassified from AOCI | — | | | — | | | (1) | | | (1) | |
Net current period other comprehensive (loss) income | (167) | | | (6) | | | 328 | | | 155 | |
Balance as of December 31, 2022 | $ | (86) | | | (10) | | | $ | 225 | | | $ | 129 | |
The following table presents the amount of losses reclassified from AOCI into the Consolidated Statements of Income:
| | | | | | | | | | | | | | | | | | | | | | | |
| | | For the Year Ended December 31, |
(in millions) | Income Statement Caption | | 2022 | | 2021 | | 2020 |
Pension and PRMB liabilities | SG&A expenses | | $ | — | | | $ | — | | | $ | 1 | |
Income tax benefit | | | — | | | — | | | — | |
Total, net of tax | | | $ | — | | | $ | — | | | $ | 1 | |
| | | | | | | |
Cash flow hedges: | | | | | | | |
Interest rate contracts | Interest expense | | $ | (6) | | | $ | — | | | $ | — | |
FX contracts | Cost of sales | | 5 | | | 18 | | | 2 | |
Total | | | (1) | | | 18 | | | 2 | |
Income tax benefit | | | — | | | (5) | | | — | |
Total, net of tax | | | $ | (1) | | | $ | 13 | | | $ | 2 | |
16. Property, Plant and Equipment
Property, plant and equipment, net consisted of the following:
| | | | | | | | | | | |
| December 31, |
(in millions) | 2022 | | 2021 |
Land | $ | 44 | | | $ | 50 | |
Buildings and improvements | 720 | | | 793 | |
Machinery and equipment | 2,566 | | | 2,369 | |
Cold drink equipment | 102 | | | 89 | |
Software | 459 | | | 404 | |
Construction-in-progress | 251 | | | 138 | |
Property, plant and equipment, gross | 4,142 | | | 3,843 | |
Less: accumulated depreciation and amortization | (1,651) | | | (1,349) | |
Property, plant and equipment, net | $ | 2,491 | | | $ | 2,494 | |
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
The following table summarizes the location of depreciation expense within the Consolidated Statements of Income:
| | | | | | | | | | | | | | | | | | | | |
| | For the Year Ended December 31, |
(in millions) | | 2022 | | 2021 | | 2020 |
Cost of sales | | $ | 229 | | | $ | 233 | | | $ | 215 | |
SG&A expenses | | 170 | | | 177 | | | 147 | |
Total depreciation expense | | $ | 399 | | | $ | 410 | | | $ | 362 | |
17. Other Financial Information
SELECTED BALANCE SHEET INFORMATION
The following tables provide selected financial information from the Consolidated Balance Sheets:
| | | | | | | | | | | |
| December 31, |
(in millions) | 2022 | | 2021 |
Inventories: | | | |
Raw materials | $ | 475 | | | $ | 330 | |
Work in process | 8 | | | 6 | |
Finished goods | 858 | | | 577 | |
Total | 1,341 | | | 913 | |
Allowance for excess and obsolete inventories | (27) | | | (19) | |
Inventories | $ | 1,314 | | | $ | 894 | |
Prepaid expenses and other current assets: | | | |
Other receivables | $ | 167 | | | $ | 112 | |
Prepaid income taxes | 49 | | | 5 | |
Customer incentive programs | 25 | | | 21 | |
Derivative instruments | 35 | | | 144 | |
Prepaid marketing | 19 | | | 12 | |
Spare parts | 89 | | | 72 | |
| | | |
Income tax receivable | 17 | | | 14 | |
Other | 70 | | | 67 | |
Total prepaid expenses and other current assets | $ | 471 | | | $ | 447 | |
Other non-current assets: | | | |
Operating lease right-of-use assets | $ | 881 | | | $ | 673 | |
Customer incentive programs | 46 | | | 59 | |
Derivative instruments | 140 | | | 3 | |
Equity securities(1) | 48 | | | 58 | |
| | | |
Equity securities without readily determinable fair values | 1 | | | 1 | |
| | | |
| | | |
Other | 136 | | | 143 | |
Total other non-current assets | $ | 1,252 | | | $ | 937 | |
(1)Equity securities are comprised of assets held in a rabbi trust in connection with a non-qualified defined contribution plan, as well as our ownership interest in Vita Coco. Refer to Note 10 for additional information about the rabbi trust. Unrealized mark-to-market losses on the Vita Coco investment of $4 million and $5 million for the years ended December 31, 2022 and 2021, respectively, are recorded in Other (income) expense, net.
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
| | | | | | | | | | | |
| December 31, |
(in millions) | 2022 | | 2021 |
Accrued expenses: | | | |
Customer rebates & incentives | $ | 429 | | | $ | 446 | |
Accrued compensation | 246 | | | 227 | |
Insurance reserve | 53 | | | 33 | |
Interest accrual | 76 | | | 55 | |
Accrued professional fees | 7 | | | 19 | |
Other accrued expenses | 342 | | | 330 | |
Total accrued expenses | $ | 1,153 | | | $ | 1,110 | |
Other current liabilities: | | | |
Dividends payable | $ | 281 | | | $ | 265 | |
Income taxes payable | 87 | | | 144 | |
Operating lease liability | 100 | | | 76 | |
Finance lease liability | 95 | | | 79 | |
Derivative instruments | 112 | | | 39 | |
| | | |
Other | 10 | | | 10 | |
Total other current liabilities | $ | 685 | | | $ | 613 | |
Other non-current liabilities: | | | |
Operating lease liability | $ | 803 | | | $ | 608 | |
Finance lease liability | 618 | | | 621 | |
Long-term pension and postretirement liability | 37 | | | 40 | |
Insurance reserves | 69 | | | 75 | |
Derivative instruments | 195 | | | 143 | |
Deferred compensation liability | 30 | | | 43 | |
Other | 73 | | | 47 | |
Total other non-current liabilities | $ | 1,825 | | | $ | 1,577 | |
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
18. Commitments and Contingencies
KDP is occasionally subject to litigation or other legal proceedings. Reserves are recorded for specific legal proceedings when the Company determines that the likelihood of an unfavorable outcome is probable and the amount of loss can be reasonably estimated. As of December 31, 2022 and 2021, the Company had litigation reserves of $12 million and $14 million, respectively, which includes the specific amounts disclosed below. KDP has also identified certain other legal matters where we believe an unfavorable outcome is reasonably possible and/or for which no estimate of possible losses can be made. The Company does not believe that the outcome of these, or any other, pending legal matters, individually or collectively, will have a material adverse effect on the results of operations, financial condition or liquidity of KDP.
ANTITRUST LITIGATION
In February 2014, TreeHouse Foods, Inc. and certain affiliated entities filed suit against KDP’s wholly-owned subsidiary, Keurig, in the U.S. District Court for the Southern District of New York (“SDNY”) (TreeHouse Foods, Inc. et al. v. Green Mountain Coffee Roasters, Inc. et al.). The TreeHouse complaint asserted claims under the federal antitrust laws and various state laws, contending that Keurig had monopolized alleged markets for single serve coffee brewers and single serve coffee pods. The TreeHouse complaint sought treble monetary damages, declaratory relief, injunctive relief and attorneys’ fees. In March 2014, JBR, Inc. filed suit against Keurig in the U.S. District Court for the Eastern District of California (JBR, Inc. v. Keurig Green Mountain, Inc.). The claims asserted and relief sought in the JBR complaint were substantially similar to the claims asserted and relief sought in the TreeHouse complaint.
Beginning in 2014, a number of putative class actions asserting similar claims and seeking similar relief to the matters described above were filed on behalf of purported direct purchasers of Keurig’s products in various federal district courts. In June 2014, these various actions, including the TreeHouse and JBR suits, were transferred to a single judicial district for coordinated pre-trial proceedings (the “Multidistrict Antitrust Litigation”). A consolidated putative class action complaint by direct purchaser plaintiffs was filed in July 2014. In January 2019, McLane Company, Inc. filed suit against Keurig (McLane Company, Inc. v. Keurig Green Mountain, Inc.) in the SDNY asserting similar claims and was also transferred into the Multidistrict Antitrust Litigation. These actions are now pending in the SDNY (In re: Keurig Green Mountain Single-Serve Coffee Antitrust Litigation). Discovery in the Multidistrict Antitrust Litigation concluded in 2021, with plaintiffs collectively claiming more than $5 billion of monetary damages. Keurig strongly disputes the merits of the claims and the calculation of damages. As a result, Keurig has fully briefed a summary judgment motion that, if successful, would end the cases entirely. Keurig has also fully briefed other significant motions, including challenges to the validity of plaintiffs’ damages calculations. Keurig is also pursuing its opposition to direct purchaser plaintiffs’ motion for class certification.
In July 2021, BJ’s Wholesale Club, Inc. filed suit against Keurig (BJ’s Wholesale Club, Inc. v. Keurig Green Mountain, Inc.) in the U.S. District Court for the Eastern District of New York (“EDNY”) asserting similar claims and also was transferred into the Multidistrict Antitrust Litigation. In August 2021, Winn-Dixie Stores, Inc. and Bi-Lo Holding LLC filed suit against Keurig (Winn-Dixie Stores, Inc. et al. v. Keurig Green Mountain, Inc. et al.) in the EDNY asserting similar claims and was also transferred into the Multidistrict Antitrust Litigation. Discovery in these cases is expected to continue into early 2023.
A number of putative class actions asserting similar claims and seeking similar relief were previously filed on behalf of purported indirect purchasers of Keurig’s products. In July 2020, Keurig reached an agreement with the putative indirect purchaser class plaintiffs in the Multidistrict Antitrust Litigation to settle the claims asserted for $31 million. The settlement class consists of individuals and entities in the United States that purchased, from persons other than Keurig and not for purposes of resale, Keurig manufactured or licensed single serve beverage portion packs during the applicable class period (beginning in September 2010 for most states). The court granted preliminary approval of the settlement in December 2020, and the Company paid the settlement amount in January 2021. In June 2021, the Court granted final approval of the settlement, entered final judgment, and dismissed the indirect purchasers’ claims.
Separate from the U.S. actions described above, a statement of claim was filed in September 2014 against Keurig and Keurig Canada Inc. in Ontario, Canada, by Club Coffee L.P., a Canadian manufacturer of single serve beverage pods, asserting a breach of competition law and false and misleading statements by Keurig. To date, this plaintiff has not taken substantive action to prosecute its claims.
KDP intends to vigorously defend the remaining lawsuits described above. At this time, the Company is unable to predict the outcome of these lawsuits, the potential loss or range of loss, if any, associated with the resolution of these lawsuits or any potential effect they may have on the Company or its operations. Accordingly, the Company has not accrued for a loss contingency. Additionally, as the timelines in these cases may be beyond our control, we cannot assure you if or when there will be material developments in these matters.
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
PROPOSITION 65 LITIGATION
In May 2011, CERT filed a lawsuit in the Superior Court of the State of California, County of Los Angeles, (Council for Education and Research on Toxics v. Brad Barry LLC, et al., Case No. BC461182), alleging that Keurig, and certain other defendants who manufacture, package, distribute or sell coffee, failed to warn persons in California that Keurig's coffee products expose persons to the chemical acrylamide in violation of Proposition 65.
Keurig, as part of a joint defense group organized to defend against the lawsuit, disputed CERT's claims and asserted multiple affirmative defenses. The case was scheduled to proceed to a third phase for trial on damages, remedies and attorneys' fees, but such trial did not occur in light of California’s Office of Environmental Health Hazard Assessment proposal of a new Proposition 65 regulation clarifying that cancer warnings are not required for chemicals, such as acrylamide, that are present in coffee as a result of roasting coffee beans. After the regulation took effect in October 2019, the litigation continued based on, among other items, CERT’s contentions that the regulation is legally invalid and, alternatively, cannot be applied to its pending claims. In August 2020, the court granted the defendants' motion for summary judgment, effectively ending CERT's Proposition 65 litigation at the trial court level. CERT appealed the trial court’s ruling, and the California Court of Appeals affirmed the trial court’s ruling in October 2022. On February 15, 2023, the California Supreme Court denied CERT’s petition to review the Court of Appeals’ affirmance. This action effectively concludes the litigation, and accordingly, no loss contingency will be recorded.
ENVIRONMENTAL, HEALTH AND SAFETY MATTERS
The Company operates many manufacturing, bottling and distribution facilities. In these and other aspects of the Company's business, it is subject to a variety of federal, state and local environmental, health and safety laws and regulations. The Company maintains environmental, health and safety policies and a quality, environmental, health and safety program designed to ensure compliance with applicable laws and regulations. However, the nature of the Company's business exposes it to the risk of claims with respect to environmental, health and safety matters, and there can be no assurance that material costs or liabilities will not be incurred in connection with such claims.
The federal Comprehensive Environmental Response, Compensation and Liability Act of 1980, also known as the Superfund law, as well as similar state laws, generally impose joint and several liability for cleanup and enforcement costs on current and former owners and operators of a site without regard to fault or the legality of the original conduct. The Company was notified by the Environmental Protection Agency that it is a potentially responsible party for study and cleanup costs at a Superfund site in New Jersey. Investigation and remediation costs are yet to be determined, therefore no reasonable estimate exists on which to base a loss accrual. The Company participates in a study for this site with other potentially responsible parties.
PRODUCT WARRANTIES
KDP offers a one year warranty on all Keurig brewing systems it sells. KDP provides for the estimated cost of product warranties, primarily using historical information and current repair or replacement costs, at the time product revenue is recognized. Product warranties are included in accrued expenses in the accompanying Consolidated Balance Sheets.
| | | | | |
(in millions) | Accrued Product Warranties |
Balance as of December 31, 2020 | $ | 10 | |
Accruals for warranties issued | 21 | |
Settlements | (18) | |
Balance as of December 31, 2021 | 13 | |
Accruals for warranties issued | 23 | |
Settlements | (23) | |
Balance as of December 31, 2022 | $ | 13 | |
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
19. Transactions with Variable Interest Entities
Transactions with Veyron SPEs
The Company has a number of leasing arrangements and one licensing arrangement with special purpose entities associated with the same sponsor, which are referred to as the Veyron SPEs. The Veyron SPEs are VIEs for which KDP is not the primary beneficiary, as KDP has limited power based on the contractual agreements to direct the activities that most significantly impact the VIEs’ performance.
Leasing Arrangements
As of December 31, 2022, the Company has entered into fifteen lease transactions with the Veyron SPEs, fourteen of which were associated with asset sale-leaseback transactions. Refer to Note 6 for additional information about the asset sale-leaseback transactions. Each lease has a RVG based on a percentage of the Veyron SPEs’ purchase price; however, the Company concluded it was not probable that the Company will owe an amount at the end of each individual lease term, as the fair values of the properties are not expected to fall below the RVGs at the end of each individual lease term. As such, the Company recorded each lease obligation excluding the associated RVG. The aggregate maximum undiscounted RVG associated with the leasing arrangements as of December 31, 2022 and 2021 were $650 million and $549 million, respectively. This aggregate maximum value assumes that the fair value of each property at the end of either the original lease term or renewal term is equal to zero, which the Company has concluded is not probable.
The following table provides the carrying amounts of the right-to-use assets and lease obligations recorded on the Company’s Consolidated Balance Sheets associated with these leasing arrangements related to the VIEs as of December 31, 2022 and 2021:
| | | | | | | | | | | | | | |
| | December 31, |
(in millions) | | 2022(1) | | 2021(2) |
Current assets | | $ | — | | | $ | 19 | |
Non-current assets | | 430 | | | 312 | |
Current liabilities | | 22 | | | 13 | |
Non-current liabilities | | 419 | | | 323 | |
(1)The leasing agreements included as of December 31, 2022 include nine manufacturing sites, four distribution centers, one multipurpose property and our Frisco, Texas headquarters.
(2)The leasing agreements included as of December 31, 2021 include seven manufacturing sites, two distribution centers and our Frisco, Texas headquarters.
Licensing Arrangement
ABC, a wholly-owned subsidiary of KDP, has provided a guarantee in connection with its distribution agreement with the Veyron SPEs to be paid only in the event the Veyron SPEs sell specific distribution rights and the value of those distribution rights does not exceed $142 million, which is the maximum undiscounted amount that KDP could pay under the guarantee. All obligations with respect to the guarantee will cease upon termination of the distribution agreement, which would occur upon notice by ABC not to renew the distribution agreement, KDP no longer being investment grade at the end of the term, or the sale of the distribution rights by the Veyron SPEs. As of December 31, 2022, KDP has not recorded a liability as it is not probable that the Company will have to make any payments required under the residual value guarantee, as the fair value of the distribution rights is not expected to fall below $142 million over the term of the agreement.
As of December 31, 2022, KDP had $100 million in fixed service fee commitments related to the 15-year distribution agreement which was effective on December 28, 2020, with Veyron SPEs. These commitments were used to assist the Veyron SPEs in obtaining financing. Such fixed service fee payments began on January 1, 2021.
Fixed service fees over the next five years are expected to be as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| For the Years Ending December 31, |
(in millions) | 2023 | | 2024 | | 2025 | | 2026 | | 2027 |
Fixed service fees | $ | 8 | | | $ | 8 | | | $ | 8 | | | $ | 8 | | | $ | 8 | |
KEURIG DR PEPPER INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(CONTINUED)
Transaction with Nutrabolt
The Company has a preferred equity investment in Nutrabolt, which will earn the greater of (i) a 5% annual coupon on the preferred equity units plus any accretion for amounts not yet paid or (ii) KDP’s share of Nutrabolt’s earnings as if KDP’s preferred equity was converted into common units. As the other investors of Nutrabolt have to share in Nutrabolt's earnings with KDP if in excess of the 5% annual coupon, the other investors lack certain characteristics of a controlling financial interest, which qualifies Nutrabolt as a VIE. KDP is not the primary beneficiary of the VIE and therefore is not required to consolidate Nutrabolt, as the primary shareholder of the VIE has control over the board and decision-making for the activities that most significantly impact the VIE’s economic performance, including sales, marketing, and operations. KDP has no obligation to provide additional funding to Nutrabolt, and thus the Company’s maximum exposure and risk of loss related to Nutrabolt is limited to the carrying value of KDP’s investment. Refer to Note 12 for additional information about the transaction with Nutrabolt and the carrying value of the investment.
20. Related Parties
IDENTIFICATION OF RELATED PARTIES
Prior to August 19, 2020, KDP was indirectly controlled by JAB, a privately held investor group. Since August 19, 2020, JAB continues to hold a significant but non-controlling interest in KDP. As of December 31, 2022, JAB beneficially owned approximately 31% of KDP's outstanding common stock. JAB and its affiliates also hold investments in a number of other companies that have commercial relationships with the Company. These commercial relationships may take the form of KDP’s purchase of raw materials, KDP’s license of the companies’ trademarks for use in the manufacturing of K-cup pods, KDP’s sale of products for resale to retail customers, or KDP’s manufacture or distribution of products to, or on behalf of, these companies.
KDP holds investments in certain brand ownership companies, and in certain instances, the Company also has rights in specified territories to bottle and/or distribute the brands owned by such companies. KDP purchases inventory from these brand ownership companies and sells finished product to third-party customers primarily in the U.S. Additionally, any transactions with significant partners in these investments, such as ABI, are considered related party transactions. ABI purchases Clamato from KDP and pays the Company a royalty for use of the brand name. Refer to Note 12 for additional information about the Company's investments in unconsolidated affiliates.
RECEIPT AND PAYMENT TRANSACTIONS WITH RELATED PARTIES
Trade accounts receivable, net from related parties were $12 million and $17 million as of December 31, 2022 and 2021, respectively, primarily related to product sales and royalty revenues. Accounts payable to related parties were $8 million and $7 million as of December 31, 2022 and 2021, respectively, primarily related to purchases of finished goods inventory for distribution.
Revenues from and payments to these related parties were as follows:
| | | | | | | | | | | | | | | | | | | | |
| | For the Year Ended December 31, |
(in millions) | | 2022 | | 2021 | | 2020 |
Revenues from related parties | | $ | 127 | | | $ | 113 | | | $ | 112 | |
Payments to related parties | | 64 | | | 67 | | | 73 | |
NOTE RECEIVABLE FROM BEDFORD
KDP has issued various promissory notes to Bedford since 2020, all of which have been fully impaired and placed in non-accrual status. Refer to Note 12 for additional information.